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1 
Introduction 
  
The reported prevalence of mental health problems in the working population of developed 
countries ranges from 10 –18 %1;2 and the prognosis after presentation is far from ideal for 
about 20% of the patients3. Mental health problems often affect functioning to such an extent 
that they result in sick leave. Furthermore, deterioration of symptoms may lead to chronicity 
and loss of work4-6. Since the comprehensive disability insurance act for employees (WAO) 
was introduced in the Netherlands in 1967, the number of workers collecting disability 
benefits has increased from 150,000 to almost one million in the beginning of the new 
Millennium. Disquietingly, young female employees with mental health problems now 
constitute the majority of the group of workers who enter the disability benefit system7. In up 
to 90% of the disability benefits paid because of mental health problems, the initial context or 
cause is stress- related8-12. Ever since the introduction of the disability insurance act, there 
has been a strong and ongoing disability debate in Dutch society and politics. For a long time 
prevention of work incapacity has played a minor role in employers’ and government policies. 
However, the comparatively high sickness absence rates and large numbers of disability 
benefit recipients have fostered preventive policies. The Dutch government set up a special 
committee, which developed a general guideline on how to improve the management of 
(preventing) sick leave due to mental health problems13. The main aspects in this guideline 
are keeping up regular contacts between employee and employer after sick-leave, early and 
adequate diagnosis and intervention, and early activation.   
Most people having Stress-related Mental Disorders (SMDs) with sick leave consult their 
general practitioner (GP) at an early stage, and GPs experience two kinds of problems in 
dealing with SMDs. First, diagnosing SMDs is not always straightforward. It can be difficult to 
recognize depressive and anxious reactions, and to differentiate between general distress on 
the one hand, and specific psychiatric and somatic symptoms on the other hand. There is 
also a substantial and fluctuating overlap between the relevant psychological dimensions and 
co-morbidity. Second, GPs often do not recognize the patients’ tendencies to avoid 
problems, thereby increasing the risk for prolonged disability.  
To set a first step in addressing this important problem form a general practice perspective, 
we developed a generic Minimal Intervention teaching package to help GPs in the 
management of Stress-related mental disorders with Sick leave (MISS). 
 
Main concepts 
 
Outline of the setting: GP consulting hours  
Pleased to see he was only ten minutes behind schedule, Mr Workhard, a GP in Amsterdam, 
the Netherlands, returned to his desk. He was ready to invite the next patient in. Mrs 
Braveheart, 34 years old, visits about once a year for a common cold or the flu. Mrs 
Braveheart entered the room and sat down in front of him, after giving a frail hand, looking 
away. By a quick look at the electronic medical record system, doctor Workhard saw that 
‘fatigue’ was the given reason for her encountering. “Well, Mrs Braveheart, can you please 
tell me what is the matter?” he opened the conversation, as he was friendly looking in her 
direction. “Well, see doctor”, she started, “I have been feeling really tired lately. In fact, last 
week it was only getting worse and I could not pull up with everyone constantly placing 
requests on me. So, as a result I decided to temporally cancel work, for just a few days, but 
currently I am still on sick leave because things have not got better yet. And initially my sick 
leave was quite a relief, but when I think of the huge amount of work that is waiting for me 
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when I re-enter… It all is very unpleasant and now I hardly sleep at night and in the day I am 
too tired and stressed out to do anything valuable, like preparing a proper diner for my family. 
I keep ruminating and worrying about the whole situation I am in and really I don’t know what 
to do”. Mrs Braveheart looked agitated and a little helpless as she ended her story.  
 
Medical approach to mental disorders 
Historically, a categorical definition of diagnoses has been used to promote communication 
and define straightforward psychiatric morbidity. Established psychiatric diagnostic schemes 
such as the Diagnostic and Statistical Manual of Mental Disorders (DSM)14 and chapter V of 
the International Statistical Classification of Diseases and Related Health Problems (ICD)15 
were developed to classify the psychological and behavioural diseases found among 
psychiatric inpatients16;17. Definitions of mental disorder typically involve that the pattern of 
symptoms experienced by an individual adversely affects everyday functioning18. The DSM-
IV19 requires that symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. The DSM-IV does not conceptually or 
operationally define the term distress, or impairment17. According to the ICD-1015, a disorder 
implies the existence of a clinically recognizable set of symptoms or behaviour associated in 
most cases with distress and with interference with personal functions. Also in the literature 
distress is referenced frequently, but seldom is defined as a distinct concept. Mostly it is 
embedded in the context of depression and anxiety.  
The DSM and ICD criteria reflect the medical approach, which argues that distress reflects 
an underlying illness20, the focus is on diagnosis. Although the scope of the DSM and ICD 
has broadened with successive revisions, they remain more applicable to patients who are 
seen by psychiatrists than the much larger proportion who are considered by their GP to 
have mental health problems. The practice of medicine has changed, and identification and 
treatment of mental disorders have shifted towards primary care. Yet, there is no necessary 
conflict between the concepts of mental disorders used by psychiatrists and those used by 
GPs, but the kind of disorders are somewhat different, and GPs must necessarily work in 
ways different from those of the psychiatrists21. In primary care, psychiatric morbidity seldom 
separates out into discrete diagnostic entities. It may better be conceptualised as a 
continuum on a dimensional scale22, with focus on the context.  
So, both categorical systems of DSM and ICD played an important and valuable role in 
providing a common nomenclature for mental disorders. Subsequently, a number of studies 
report relevant dimensions of psychopathology, in order to obtain a more comprehensive 
assessment of psychological morbidity in primary care. The Dimensional model from 
Goldberg & Huxley 22 was designed on the basis of finding two highly correlated dimensions: 
anxiety and depression. Subsequently, the tripartite model of Clark & Watson23 denotes 
general distress, in addition to depression and anxiety, as a separate dimension. 
Furthermore, Ormell et all.24 found three relevant dimensions: next to depression, anxiety 
was split into generalized anxiety and phobic anxiety. Then, Terluin25 found 4 relevant 
dimensions: distress, depression, anxiety, and somatization. He stated that it is important for 
treatment of mental disorders in general practice to differentiate between general distress on 
the one hand, and psychiatric symptoms- depression, anxiety and somatization- on the other 
hand. Last but not least, Clarke16 found even more relevant dimensions; he added a 
differentiation in grief and somatic symptoms dimensions and the elaboration of 
demoralisation. Demoralisation may be viewed as a combination of distress and subjective 
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incompetence, and it is distinguishable from depression by the absence of anhedonia. As 
opposed to psychiatric illness, demoralisation is considered to be a normal response to 
adversity26.  
 
Sociological approach to mental disorders 
Distinct to the medical approach, with its focus on the underlying illness, another approach 
on mental disorders is sociological of nature. This perspective argues that distress is the 
consequence of a failure to respond adaptively to social challenge. Here, the focus is on 
understanding and clarifying patient’s dilemma’s in their failure to respond adaptively, as 
opposed to solely a focus on the diagnosis. Distress is described in relation to control and 
demands27 and in relation to coping style28. Common psychopathology, as seen in primary 
care, often starts with failure to cope with personal, social or occupational demands. The 
ability to cope or readjust is overtaxed, and this increases the probability that psychological 
distress will follow. The importance of work related psychosocial factors to the development 
of mental disorders is illustrated with Karasek’s Demand-Control (DC) model27. Moreover, 
Lazarus and Folkman (1980)28 define coping responses as cognitions and behaviours that a 
person uses to reduce stress and to moderate its emotional impact. Their model, the Ways of 
Coping model (WOC), includes two opposite coping strategies: approach and avoidant 
coping. Approach coping strategies are either behavioural or psychological responses 
designed to change the nature of the stressor itself or how one thinks about it, whereas 
avoidant coping strategies lead people into activities (such as alcohol use) or mental states 
(such as withdrawal) that keep them from directly addressing stressful events. Approach 
coping strategies are thought to be better ways to deal with stressful events, and avoidant 
coping strategies appear to be a psychological risk factor or marker for adverse responses to 
stressful life events29. 
  
Treatment of SMDs with sick leave in primary care  
There are general practice guidelines available for the treatment of depression30 and 
anxiety31, but these do not cover stress as a separate aspect of the problem or consider 
functional recovery as an effect-generator for well-being. The care that is provided for SMD 
patients on sick leave is very heterogeneous and sub-optimal5. For a long time the usual 
approach to SMDs with sick leave was the advice to take rest and not return to work before 
all complaints had disappeared. Furthermore, GPs are not always aware of the potential 
harmful consequences of sick leave and stress, because the symptoms seem to be self-
limiting. Last but not least, GPs may be overly cautious and not question the continuation of 
sick leave or ask the patient to take the responsibility and make more effort to cope with the 
situation, because they may feel that this undermines the mutual trust between patient and 
doctor32;33. 
 
Our intervention: the MISS 
While depressive disorders and anxiety disorders received much attention and have been 
studied thoroughly, and it is clear and evidence- based to treat major psychiatric disorders 
with medication or counselling, evidence- based interventions for the whole range of SMDs 
are still under development. Taken into account that GPs only have limited time during 
consulting hours, Terluin and Van der Klink34 have outlined an activating intervention for 
patients having a SMD with sick leave, that already proved to be effective in reducing sick 
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leave by 30% in an occupational health care setting35. By using specific communication and 
the minimal amount of time necessary, the GP helps the patient on the accurate and time-
contingent course. The training comprised two sessions of 3.5 hours and 2 regular follow-up 
sessions of 2 hours (total 11 hours).  
 
Objectives and outline of the thesis 
In this thesis, we focus on the diagnosis and treatment of stress-related mental disorders in 
primary care. In chapter 2, the problems of stress and coping in relation to common mental 
disorders in general practice patients are described, along with a presentation of our 
intervention, the MISS. In chapter 3 the setting and design of our study are specified, in order 
to ascertain the study complies with the requirements for a cluster randomised controlled trial 
(RCT) as stated by the guidelines in the Consolidated Standards of Reporting Trials 
(CONSORT)36. The main purposes of this study, as presented in chapters 4 and 5, were to 
assess the effectiveness and cost-effectiveness of our Minimal Intervention for Stress-related 
mental disorders with Sick leave (MISS) in primary care. Next, as described in chapter 6, we 
proceeded with a process evaluation to explore the implementation, receipt, and setting of 
our intervention. We distinguished between components of the intervention and assessed the 
reach of the intervention. Chapter 7 deals with the test-retest reliability of an instrument that 
may help to diagnose mental disorders in primary care, the Primary Care Evaluation of 
Mental Disorders (PRIME-MD), and illustrates some limitations in the current system of 
diagnosing mental disorders in primary care. Finally, in chapter 8 the findings described in 
this thesis are discussed, and the implications for general practice and future research are 
addressed.   
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Abstract 
Many general practice patients present with common mental disorders. Irrespective whether 
these disorders are diagnosable or not according to standard psychiatric classifications, most 
- if not all - of them are stress-related to some extent. Stress results from an imbalance 
between demands and resources to cope with these demands. A breakdown of coping 
results in demoralisation. In patients with paid jobs such a “nervous breakdown” leads to sick 
leave, which is often long-lasting, carrying the risk of social marginalisation due to long-
standing mental disability, subsequent loss of employment, and costs. Persistent avoidance 
is hypothesised to be an important determinant of such a poor outcome. Recovery from a 
“nervous breakdown” requires that the patients switch from avoiding to actively confronting 
their problems. We developed a minimal intervention strategy for general practitioners (GPs) 
to help their patients make that switch. Through the use of relatively simple, empowering 
interventions like education, support, advice and homework assignments, the intervention 
specifically aims at damming avoiding tendencies and at promoting an active approach of 
psychosocial difficulties. 
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Introduction 
Common mental disorders (CMDs) are prevalent in general practice; estimates of CMDs in 
consecutive attendees vary between 20 and 50%, depending on the methods of 
assessment.1-3 There is ample evidence that most - if not all - CMDs are stress-related 
insofar that life events and psychosocial difficulties influence their onset, course and 
resolution.3-8 This applies equally to disorders that are diagnosable according to standardised 
diagnostic criteria (DSM-IV or ICD-10)9;10 and disorders that are not diagnosable in primary 
care. Since many of these stress-related disorders are not diagnosable according to 
standard psychiatric classifications,11-13 GPs often use ideosyncratic diagnostic labels such 
as “(chronic) stress”, “distress” or “nervous breakdown”, or they use “problem-diagnoses” 
indicating just the social difficulty (e.g. “marital problem” or “overworked”), expressing the 
stress-relatedness of the disorders they encounter.14-17 In Dutch general practice the 
incidence of recorded “nervous breakdown” was found to be 5-14 per 1000 practice 
population.14;15 In Australian general practice “stress-related disorders” were diagnosed in 
2.6% of consecutive patients, only second in place after mood disorders (4%).17  
 
Stress, nervous breakdown and demoralisation 
Stress results from an imbalance between demands and perceived abilities to cope with 
those demands.18 Demands include such diverse issues as commitments (e.g. work, 
housekeeping, child care), life events (e.g. marriage, job change, loss of a loved one) and 
psychosocial difficulties (e.g. financial problems, marital conflict, work overload). Coping, 
comprising cognitive and behavioural actions used to manage the demands, can be 
distinguished into two broad categories: approach and avoidance.19;20 Approach coping, also 
called problem-focused coping, aims at changing or controlling the demands, whereas 
avoidant coping, also called emotion-focused coping, aims at reducing the negative affective 
consequences of the demands. In the face of stress, worry, irritability, feeling tense, 
disturbed sleep, emotional instability and fatigue are common symptoms of distress. The 
level of distress actually reflects the amount of mental effort that individuals have to put into 
coping with their stressors while trying to preserve their habitual level of psychosocial 
functioning.21 A failure to cope results in a breakdown of psychosocial functioning, often 
called a “nervous breakdown” by the lay public.22;23 Dutch GPs actually use the same label as 
a proper diagnosis in daily practice.24 Since formally used diagnostic classification systems 
lack such a category and there is very little reported research on the actual diagnoses GPs 
utilise in everyday practice, we are not aware of any diagnostic labels such as “nervous 
breakdown” being employed by GPs in other countries. A “nervous breakdown” is the 
breaking point where the individual becomes demoralised, as described by Jerome 
Frank,25;26 and gives in. Demoralisation may be viewed as a combination of distress and 
subjective incompetence, and it is distinguishable from depression by the absence of 
anhedonia.27 As opposed to psychiatric illness, demoralisation is considered to be a normal 
response to adversity.28 At the heart of demoralisation is a breakdown in coping; the person 
no longer knows what to do.29 
 
Adverse consequences of demoralisation and sick leave 
Published evidence suggests that CMDs are a risk factor for sickness absence from work.30-
34
 We believe that demoralisation is an important linking pin between CMDs and sick leave, 
which is often long-lasting. The significance of demoralisation leading to sick leave, has not 
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been widely recognised.35;36 However, sick leave for psychosocial reasons can have serious 
adverse consequences, as we will elaborate below. 
The event of giving in comprises an element of avoidant coping - that is, the individual 
withdraws from the difficult situation in which the struggle to get control over the situation is 
threatened to be lost.20 As long as the avoidance provides a temporary solution, to alleviate 
the pressure and to give the person time to re-appraise the situation and to recuperate from 
the tension and exhaustion brought on by the distress, there is nothing wrong with 
avoidance. However, some individuals cling on to the avoidance, as they are not able to think 
of any other solutions. Persistent distress may give rise to functional somatic complaints and 
subsequent somatisation.37 Moreover, some distressed patients go on to develop a true 
psychiatric disorder, notably major depression or anxiety disorder, based on specific 
vulnerabilities.38 Both the persistence of avoidance and the occurrence of somatisation, 
depression or anxiety can interfere with attempts to restore social functioning and return to 
work, which may result in long-term sickness absence and even in disability benefit claims. 
Some older Dutch studies of sick-listed employees with a “nervous breakdown” showed that 
1 in every 5 employees stayed on sick leave for more than one year.39 A more recent study 
of a similar Dutch cohort of employees revealed that this outcome has not changed: sickness 
absence exceeded a whole year in 20% of the cases.40 In The Netherlands the total costs 
government and employers spend on sickness absence and disability benefits for 
psychological reasons are estimated to amount up to 8.2 billion Euros annually.41 About one 
third of all disability benefits (about 3 billion Euros annually) is being paid on behalf of mental 
disorders.42 There are no reasons to believe that mental disorders leading to long-term 
sickness absence is an exclusive Dutch problem.43 In Norway sickness absence was 
attributed to psychological problems in 16% of all cases.33 In the UK 11% of all sickness 
absence is attributable to stress.44 Among London civil servants psychological problems were 
found to be the second most important cause of long-term sickness absence.30 Work is a 
significant contributor to the quality of life. A job structures a person’s life and offers 
opportunities for self-realisation and satisfaction. Whereas work makes people feel useful 
and valued, long-term sickness absence and being on disability benefits carry a great risk of 
social marginalisation.36 
 
Recovery from a breakdown 
Clinical observation of people recovering from a “nervous breakdown” has shown that the 
recovery process involves three stages: crisis, problem solving, and restoring social 
functioning.45 This three-staged process bears a striking resemblance to the treatment model 
of stress inoculation training (SIT) with its 3 phases.46 The first SIT-phase is an educational 
phase aimed at helping the patient better understand the nature of stress and its effects. The 
second phase focuses on the acquisition of a repertoire of coping skills, and the third phase 
involves the application of these skills to increasingly challenging situations. 
Stage 1: crisis. Being surprised by a sudden unanticipated breakdown, patients often are 
more or less “in crisis”.47 They have dropped major social roles, especially the occupational 
role. Since they were not able to cope with their difficulties anymore, the patients are 
extremely distressed and demoralised. They wish be “as far away from it all” as possible. 
The first step towards recovery involves acceptance of the situation, including the 
breakdown, as it is, and acknowledgement of the inadequacy of their coping strategies 
employed so far. The next step involves a reorientation to the problematic situation and to 
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alternative possibilities to cope with it. Whereas giving in implies loss of control, acceptance, 
acknowledgement and reorientation imply the beginning of regaining that control. As the 
patients develop more and more understanding of their situation and how they got there, the 
demoralisation and distress decrease.  
Stage 2: problem solving. Once the patients have a full understanding of their problems, how 
they were trying to cope with them and why that did not work, they start to consider 
alternative possibilities for coping with their various problems. Since in many cases multiple 
problems are implicated, and solving all of them at the same time does not seem feasible, it 
is helpful to prioritise the problems.48 It is also helpful to involve significant others in the 
problem solving process.47  
Stage 3: restoring social functioning. As more and more problems are successfully solved - 
or at least made manageable - the patients are able to take up (parts of) the social roles they 
have dropped earlier. This often involves talking to, or negotiating with, significant others, for 
instance the manager. Partial return to work appears to facilitate full return to work at a later 
time.49  
Although recovery from a “nervous breakdown” seems to be simple and straightforward - 
and, indeed, many patients manage to recover within an acceptable time span with no more 
assistance than the help from their family and friends - a substantial minority of patients stay 
at home and “away from it all” for considerable periods of time, risking social marginalisation. 
Since avoidant coping is consistently associated with poor mental health outcomes,19 we 
presume that whether or not the patient is able to switch from avoidance to “approach 
coping” early in stage 1 is probably the crucial factor determining the outcome of a “nervous 
breakdown”.45 
 
The role of general practice 
Nearly all employees who are on sick leave for psychological reasons consult their GP.50 
Most patients with a “nervous breakdown” are exclusively managed in primary care, and not 
referred to specialised secondary care.24 In most cases the GP will have no problem 
recognising the mental disorder because, in the relation of trust that the patients and doctor 
are having, the distressed patients will be readily prepared to share their concerns with their 
doctor. However, the GP does experience problems in discerning diagnosable depressive 
and anxiety disorders in these patients. One out of five patients diagnosed by their GP as 
having a “nervous breakdown” has in fact prominent, but unrecognised, symptoms of 
depression or anxiety, which are associated with poor recovery.51  
GPs see their “nervous breakdown” patients on average almost three times and they often 
go along with the patients’ desire to be left alone.24 GPs advice their “nervous breakdown” 
patients more often to go or stay on sick leave, to take rest and to seek distraction and 
relaxation, than to actively approach the difficulties.24 In this manner, GPs - unintentionally - 
stimulate passive avoidance in stead of actively coping with the situation, and increase the 
risk of prolonged disability and ultimate loss of employment.45 Potentially harmful 
consequences are loss of daily structure, diminished social contacts and deterioration of self-
esteem. The distress of a persisting crisis may, in vulnerable people, even when a 
diagnosable mental disorder (major depression or anxiety disorder) was not yet present 
shortly after the breakdown, lead to the development of such a disorder later on. The risk of 
long-term sickness absence, loss of employment and marginalisation has been mentioned 
above.  
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Collaboration between GPs and the occupational health care system seems to be in the best 
interest of patients with a “nervous breakdown”. However, co-operation is not common 
practice and poor communication leaves room for improvement.52 Recently, the Dutch 
College of General Practitioners and the Netherlands Society of Occupational Medicine 
issued a guideline for the collaboration of GPs and occupational physicians with respect to 
the treatment of patients with a “nervous breakdown”.53  
 
The Minimal Intervention for Stress-related mental disorders with Sick leave (MISS) 
We have outlined an activating intervention for patients with a “nervous breakdown”,45 which 
proved to be effective in reducing sick leave by 30% in an occupational health care setting.54 
Taking into account that GPs only have limited time to spend on their patients, we have 
developed a Minimal Intervention for patients with Stress-related mental disorders who are 
on Sick leave (MISS) in general practice. The leading question was: if GPs have no more 
than three consultations available for each “nervous breakdown” patient, then what should 
they do in these three consultations? We judged that the GPs should focus primarily on the 
first stage of the recovery process, especially on the switch the patients have to make from 
passive avoidance to active “approach coping”. The GPs should try to put their patients on 
the right track to recovery as soon as possible, using a minimal amount of time, effort and 
skills. The MISS consists basically of 5 elements: assessment, education, advice, monitoring, 
and referral (if necessary). 
 
Assessment implies first of all detecting mental disorders and having patients acknowledge 
their distress. Moreover, the GP should detect diagnosable depressive and anxiety disorders 
and, when present, deal with these disorders separately.47 The Four-Dimensional Symptom 
Questionnaire (4DSQ) is used to quantify the level of distress, and to detect depression, 
anxiety, and somatization.55 Guidelines from the Dutch College of General Practitioners are 
available to support the diagnosis and treatment of diagnosable depressive and anxiety 
disorders.56;57 During the first consultation, often a provisional diagnosis is made, especially 
when physical illness has not yet been ruled out. Between the first and second consultation, 
which are scheduled one week apart, the patient fills in the 4DSQ and may have some 
somatic diagnostic examinations performed. Usually, it is possible to make a definite 
diagnosis during the second consultation. 
Education aims, in line with the SIT-model,46 at promoting the patients’ understanding and 
acceptance of the origin and cause of the breakdown. Furthermore, information is given on 
the recovery process of a “nervous breakdown”, and the patients’ active role in this process 
is emphasised. “Nervous breakdown” is explained as a natural response to overwhelming 
stress.28 Evoking positive and realistic expectations by providing an acceptable rationale is a 
powerful intervention.47;58 An information leaflet, which also contains advice and tips on how 
to deal with the breakdown (see below), is available for the patient to read at home and 
discuss with family and friends. When the suspicion of a stress-related mental disorder is 
relatively high, although the diagnosis may not yet be definite, the education is already 
provided in the first consultation in order not to lose precious time. The GP also provides 
information about the role and function of the occupational physician in the Netherlands.  
Advice is giving in the first two consultations about coping with the breakdown, making a start 
with solving the problems, and planning to take up social functioning gradually. In analogy 
with the dual process of coping with bereavement,59 the GP explains that it is important not 
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only to take rest and to relax, but also to alternate this avoiding of the problems with actively 
approaching them. One of the first “approaching” activities is writing down the troubling 
things the patient tends to be brooding about all the time.60 These so-called “worry sessions”, 
one or two times a day for 30-45 minutes, promote coming to grips with the difficulties and 
exploring potential solutions.47;61;62 The patients are also advised to schedule necessary 
activities of daily living, such as child care and housekeeping, and to think about ways to 
partially return to work even when not all problems have been solved. The patients are 
advised to adhere to a daily schedule in which the activities mentioned above find a place. 
Finally, the patients are advised to see their occupational physician at an early stage, to help 
solve problems in the workplace when necessary, and to help prepare gradual work 
resumption when possible.  
Monitoring is about ensuring the patient is getting on the right track towards recovery. The 
right track implies a focus on problems (and possible solutions) instead of a focus on 
symptoms. The patients have to investigate their problems and consider alternative ways of 
coping.47 The switch in the patients’ focus has often already occurred before the second 
consultation, but it should in any case have occurred after four weeks, when the third 
consultation is scheduled.  
Referral is indicated if the necessary switch - i.e. the switch from symptoms to problems, 
from avoidance to approach of the difficulties - has not occurred, and the patients are still in 
crisis after 4 weeks of sick leave. The GP should realise that the patients at that point are at 
risk for prolonged sick leave and loss of employment in the long run. As the patients are not 
likely to benefit from more time off, a more specialised treatment is warranted. The GP may 
refer the patients to a counsellor, social worker or a (cognitive behavioural) psychotherapist, 
preferably after consulting with the occupational physician.  
In order to learn to use the MISS intervention, we have developed an 11-hours training 
course comprising 4 sessions in 2.5 months time. 
 
Discussion 
We have asked attention for the problems of stress and coping in relation to common mental 
disorders in general practice patients. More specifically, we have described demoralisation 
and “nervous breakdown” as hazardous consequences of a failure to cope with the demands 
in a person’s life. We do not conceptualise demoralisation/“nervous breakdown” as a distinct 
diagnostic category that should be included in existing diagnostic classification systems 
(such as the DSM-IV) next to depressive and anxiety disorders. Rather, we look upon 
demoralisation/“nervous breakdown” as an important dimension of mental disorders that cuts 
across all established diagnostic categories. In addition, demoralisation/“nervous breakdown” 
may be the most important mental problem in cases where no formal psychiatric disorders 
are diagnosable. We feel that it is important for GPs to pay attention to the patients’ stress in 
their lives, how they (are trying to) cope with that, and what the consequences are, and not to 
concentrate too much (and certainly not exclusively) on whether the patients fulfil the 
requirements of a formal mental disorder diagnosis.  
Furthermore, we have described the risks involved in long-standing sick leave when patients 
continue not coping, and presented the Minimal Intervention for patients with Stress-related 
mental disorders who have gone on Sick leave (MISS) to activate the patients to more active 
coping strategies. Through the use of relatively simple, empowering interventions like 
education, support, advice and homework assignments, the intervention specifically aims at 
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damming avoiding tendencies and at promoting an active approach of psychosocial 
problems. The ultimate goal is to prevent long-term sickness absence, loss of employment 
and social marginalisation. We have argued that GPs should focus on the first crisis-like 
stage of the breakdown, helping their patients to regain control and start coping again. We 
have recently completed a randomised controlled trial to evaluate the effectiveness of 
teaching GPs to deliver the MISS,63 and demonstrated a significant reduction of sick leave in 
patients identified by their GP as having stress-related mental disorders (hazard ratio for 
return to work: 1.72, p = 0.005).64  
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Abstract 
Background. The main aims of this paper are to describe the setting and design of a 
Minimal Intervention in general practice for Stress-related mental disorders in patients on 
Sick leave (MISS), as well as to ascertain the study complies with the requirements for a 
cluster randomised controlled trial (RCT). The potential adverse consequences of sick leave 
due to Stress-related Mental Disorders (SMDs) are extensive, but often not recognised. 
Since most people having SMDs with sick leave consult their general practitioner (GP) at an 
early stage, a tailored intervention given by GPs is justified. We provide a detailed 
description of the MISS; that is more accurate assessment, education, advice and monitoring 
to treat SMDs in patients on sick leave. Our hypothesis is that the MISS will be more 
effective compared to the usual care, in reducing days of sick leave of these patients.  
Methods. The design is a pragmatic RCT. Randomisation is at the level of GPs. They 
received the MISS-training versus no training, in order to compare the MISS vs. usual care at 
patient level. Enrolment of patients took place after screening in the source population, that 
comprised 20-60 year old primary care attendees. Inclusion criteria were: moderately 
elevated distress levels, having a paid job and sick leave for no longer than three months. 
There is a one year follow up. The primary outcome measure is lasting full return to work. 
Reduction of SMD- symptoms is one of the secondary outcome measures. Forty-six GPs 
and 433 patients agreed to participate.  
Discussion. In our study design, attention is given to the practical application of the 
requirements for a pragmatic trial. The results of this cluster RCT will add to the evidence 
about treatment options in general practice for SMDs in patients on sick leave, and might 
contribute to a new and appropriate guideline. These results will be available at the end of 
2006.  
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Background   
Stress-related mental disorders (SMDs) 
Stress results from an imbalance between demands and resources1. It is a psychological, 
physiological and behavioural response by individuals when they perceive a lack of 
equilibrium between the demands placed upon them and their ability to meet those demands. 
This response, over a period of time, leads to ill-health2 and it is important to respect the 
roles of personal, social, economic, occupational and physical health problems in 
determining and shaping this psychological disability3. Fatigue, tenseness, irritability, apathy, 
sleeping disorder, emotional instability, rumination and concentration- problems are 
examples of common symptoms related to stress and a failure to cope with demands while 
resources (i.e. the abilities to meet those demands) are not sufficient. In addition, some 
patients with persistent distress go on to develop a psychiatric disorder, notably major 
depression or anxiety disorder, based on specific vulnerabilities. Plus, persistent distress 
may give rise to somatic complaints and subsequent somatization4. It is clear and evidence- 
based to treat major psychiatric disorders with medication or counselling, whereas evidence- 
based interventions for the whole range of Stress-related Mental Disorders (SMDs) are still 
under development.    
 
SMDs and sick leave 
The societal and financial costs of dysfunction in terms of (long term) sick leave due to SMDs 
are extensive. In the Netherlands, almost one million workers are entitled to disability 
benefits (9 percent of the working population), this prevalence is high compared with other 
countries5. About one third of the 9.407 billion Euros in 2004 of the disability benefits in the 
Netherlands was paid to persons with mental health problems6. Whereas only ten percent of 
those receiving disability benefits have an actual psychiatric disorder, ninety percent is due to 
what patients and care-providers consider to be SMDs7. Furthermore, the composition of the 
group of workers who receive disability benefit in the Netherlands is changing disquietingly: 
currently young female employees, mostly with mental health problems, constitute the 
majority of new cases8. Chronicity of SMDs with sick leave is growing, although several 
studies indicate that SMDs can be treated successfully if they are diagnosed and treated at 
an early stage9. However, for a long time the usual approach to SMDs with sick leave was 
the reverse: advice to take rest and not return to work before all complaints had disappeared. 
Last but not least, patients with SMDs being on sick leave definitely cannot be reduced to 
only an economic problem; of course much personal suffering is involved. Moreover, the 
value of work is undisputed and in cases of (prolonged) sick leave there is a risk of 
permanent loss of employment.  
 
General Practice treatment of SMDs in patients on sick leave  
Nearly every employee contacts the GP at the beginning of the sick leave. Most patients 
having SMDs are managed in primary care, and not referred to specialised secondary care. 
And despite the fact that mental health problems are common in primary care, GP’s may still 
find it difficult to diagnose and treat them, unless they have a high index of suspicion10. Due 
to the collaborative nature of the doctor-patient relationship in general practice, many GPs 
may be overly cautious to attribute symptoms to a psychosocial cause. Another issue is an 
adequate differential diagnosis; many patients in primary care have symptoms related to 
anxiety, depression, somatization, or all three. In one out of five patients having a SMD there 
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are prominent, although unrecognised symptoms of depression or anxiety, which are 
associated with a poor prognosis. A further pitfall is that GPs often tend to go along with the 
patient’s request for rest and being left alone. Often GPs advise to go or stay on sick leave, 
to take rest, seek distraction and relaxation, instead of actively confront and cope with the 
difficulties. The distress of a lasting crisis combined with existing vulnerabilities may lead to 
prolonged disability and contribute to the development of serious mental disorders, e.g. 
depression or anxiety disorders. Earlier research revealed that about 20% of patients having 
a SMD stayed on sick leave for more than a whole year11. Cooperation between GPs and the 
occupational health care system seems to be in the best interest of all involved and also the 
preferred way to manage SMDs with sick leave.  
 
The Minimal Intervention for Stress-related mental disorders with Sick leave (MISS)  
Terluin and Van der Klink12 have outlined an activating intervention for patients having a 
SMD with sick leave, that already proved to be effective in reducing sick leave by 30% in an 
occupational health care setting13. Taken into account that GPs only have limited time during 
consulting hours, we developed the Minimal Intervention for Stress-related mental disorders 
with Sick leave (MISS) for general practice. In the MISS the principle of time contingency is 
used. Also, parts of more specialised psychological treatments like Cognitive Behavioural 
Therapy (CBT14) and Problem Solving Treatment (PST15;16) are incorporated. With respect to 
the role of gatekeeper in primary care practice, only basic principles of CBT and PST were 
considered relevant for GPs17.  
The MISS is a prototypical intervention for SMDs with sick leave in general practices, aiming 
specifically at successful rehabilitation and preventing long-lasting sick leave. By using 
specific communication and the minimal amount of time necessary, the GP helps the patient 
on the accurate and time-contingent course. The MISS should take no more than 3 
consultations of 10-20 minutes, and consists basically of 5 elements: assessment, education, 
advice, monitoring and, if necessary, referral.   
Assessment implies in the first place to identify patients having a SMD and help them to 
acknowledge their distress. Second, the GP detects significant depression and anxiety, and 
propose management steps for these problems separately. The Four-Dimensional Symptom 
Questionnaire (4DSQ18) is used in the MISS to quantify the level of distress, and to detect 
symptoms of depression and anxiety. Guidelines from the Dutch College of General 
Practitioners are available to support the diagnosis and treatment of possible depression and 
anxiety disorders19;20. When physical illness has not yet been ruled out, the patient may have 
some somatic diagnostic examinations done, next to filling in the 4DSQ.  
Education aims at promoting the patient’s understanding and acceptance of the cause of the 
breakdown. Information is given on the normal course after having a SMD with sick leave, in 
this the patient’s own active role is emphasised. The GP also gives information about the role 
and function of the occupational physician in the health care system. When the diagnosis 
may not yet be definitive, although the suspicion of a SMD is present, the education is still 
provided in the first consultation in order not to lose precious time. 
Advice is given on coping with the breakdown, making a start with solving the problems, and 
planning to gradually take up social functioning. The GP underlines the importance of a 
balance in taking rest and making an active approach towards the problems, like using a 
rumination session (that is writing down what specifically troubles the patient) one or two 
times a day for 30-45 minutes. The patient is also advised to schedule necessary activities of 
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daily living, such as children’s care and housekeeping. Furthermore the patient is 
recommended to visit his or her occupational physician without delay, and to explore ways 
after which it is possible to partially return to work, even when not all symptoms have 
disappeared.  
Monitoring is about ensuring the patient is moving towards the accurate course. This implies 
a focus on the problems (and possible solutions) in stead of symptoms. The patient has to 
investigate the specific problems and consider different ways to cope. The switch in the 
patient’s focus has often already occurred before the second consultation; however it should 
in any case have occurred after four weeks of sick leave.  
Referral to specialised care comes into play when there is no evidence of progression after 
four weeks of sick leave. The GP should realize that the patient is at risk for prolonged sick 
leave and ultimately loss of employment. A more specialised treatment is necessary since 
the patient is not likely to benefit from more time off. The GP may refer the patient to a 
counsellor, social worker or a (cognitive behavioural) psychotherapist, ideally after consulting 
with the occupational physician.  
 
Methods 
Objective 
The central aim of this pragmatic cluster randomised controlled trial (RCT) is to investigate 
the effectiveness of the MISS in general practice. Our hypothesis is that GPs who carry out 
the MISS will be more effective than GPs who perform usual care in reducing the number of 
days of sick leave, as well as in reducing symptoms of SMDs in patients. Usual care in 
general practice contains the guidelines on depression21 and anxiety22. In the case of the 
MISS, GPs are trained in topic- specific knowledge on patients with SMDs on sick leave. 
Because GPs, who have learned to apply the MISS, cannot be expected to perform this 
intervention in some patients and treat others as they used to do prior to the training, 
randomisation at the level of individual patients was not feasible. To avoid possible 
contamination between the conditions, a cluster design randomising at the level of GPs was 
chosen. There will be a one year follow up on the patients to assess the outcome measures 
and factors involved in the process of sick leave and return to work. The study design, 
protocol and procedures were approved by the Medical Ethics Committee of the VU 
University Medical Centre. 
 
Participants  
GPs. The recruitment of GPs was split up in four different rounds. We approached GPs in 
two different districts where the Department of General Practice of the VU University Medical 
Centre has some type of network positioned. A total of 46 GPs signed informed consent. 
Patients. In order to recruit enough eligible patients, we made use of the computerised 
patient record system and approached the source population of patients (n= 22.740) by mail. 
The source population consisted of all primary care attendees (20-60 years) who visited 
consulting hours of the participating GPs. GP’s excluded only patients with very severe 
psychiatric disorders (mania or psychosis), patients with terminal illness or an inadequate 
command of the Dutch language. The source population of attendees was asked only to 
respond when they met our criteria: moderately elevated distress level (measured with 3 
questions of the 4DSQ distress scale23), having paid work and being (partially) on sick leave 
for no longer than three months (see table 1).  
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Every one or two weeks we approached the source population, until enrolment of a sufficient 
number of patients from a particular GP was realised. Final recruitment took place by phone 
survey of the patients who returned the questionnaire and met the criteria. A total of 433 
patients (1,9%) who could and also wanted to participate were enrolled (see figure). The 
overall response percentage on our screening method was 51.5%, this was measured in a 
group of 336 randomly selected attendees.  This labour-intensive however highly successful 
method of screening ensures that we recruited patients having SMDs with sick leave in stead 
of patients who actually get an intervention for their complaints.  
 
Table 1. Eligibility criteria 
 
Intervention at the level of general practitioners  
In order to use the intervention, additional training in the MISS was given to intervention GPs 
by one of the authors (BT), and an occupational physician. This training existed of two times 
3,5 hours and 2 times follow-up of 2 hours (total of 11 hours). Skills needed for successful 
treatment were accentuated. The participating GPs own experiences were evaluated; they 
were expected to provide case histories and to practice with the different parts of the 
intervention during the training. Screening of eligible patients started after the MISS group 
got the second training. When a patient had signed the informed consent (about four weeks 
after oral informed consent in the telephonic baseline measure), the GP was informed of the 
participation. Actual application of the elements of the MISS and steps in usual care are 
measured with a questionnaire.   
 
Intervention at the level of the patients  
During the baseline interview all patients were asked whether they had planned another visit 
to their GP. If not they were advised to consider this, in order to give the GPs the opportunity 
to start with an intervention. Even though, it should be noted that neither the GPs were 
obliged to apply the MISS or any other intervention for mental disorders, nor were the 
patients obliged to go visit their GPs. No intervention was done on the actual completion or 
successfulness of the application of the MISS, the present method comprises real clinical 
practice in primary care.    
 
Outcome measures 
Sick leave. The primary outcome measure is defined as: duration of sick leave in calendar 
days from the first day of sick leave to full return to work, lasting at least 4 weeks without 
  
No 
 
Sometimes 
 
Regularly or often 
1. During the past week, did you suffer from worry?* 0 1 2 
2. During the past week, did you suffer from listlessness?*  0 1 2 
3. During the past week, did you feel tense?* 0 1 2 
   
4. Total score 4 or higher?  
  Yes  No 
5. Do you currently have a paid job?  
 Yes  No 
6. Have you been on sick leave, now for a maximum period of three months?  
 Yes  No 
Patients were asked to only  return the questionnaire if they answered ‘yes’ to items 4,5 and 6 and were willing to 
participate. 
*Four-Dimensional Symptoms Questionnaire Distress scale, (4DSQ, [23]) 
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(partial or full) relapse. Variables of the rehabilitation process itself, like the time to first 
(partial or full) return to work, total days of sick leave in the whole year, and (partial or full) 
return to work rates after 2, 6 and 12 months, are secondary outcome measures. Sick leave 
in the past year is considered to be a prognostic factor for our primary outcome measure, as 
are job content data24;25. 
 
Table 2. Outcome measures 
 
Reduction of SMD symptoms. An important secondary outcome measure is reduction in 
symptoms of depression, anxiety, somatization and distress, measured with the 4DSQ26. 
Life-events and problems, chronic illnesses and neuroticism27 are prognostic measures for 
this outcome. Problem evaluation28 and coping styles29 are measured to evaluate the 
effective components of the MISS: problem- and solution focus skills of patients.  
Economic evaluation. Cost effectiveness will be evaluated from societal perspective (that is, 
irrespective of who is paying for the costs to gain an effect) by using the Tic-P30. The 
employers perspective (expenditures for the employer) is represented by the HPQ31;32. The 
EuroQol33 measures general health state, and as a result quality of life status, that can be 
compared with a wide range of conditions in health care.  
 
Data collection  
At baseline, patients who entered the study were measured by a phone survey and received 
a questionnaire by mail. Follow-up measurements, again a phone survey followed by a 
questionnaire, were scheduled at 2, 6 and 12 months after baseline. All outcomes were 
                                                                       
Baseline 
Follow up in 
months 
Outcome measure  Instrument 0 2 6 12 
Primary outcome (dependent) 
     
Lasting return to work: duration of sick leave in calendar days from 
the first day of sick leave to full return to work, for at least 4 weeks 
without (partial or full) relapse 
Patients report   X X X X 
Secondary outcomes (dependent)  
     
Time to first (full or partial) return to work Patients report   X X X X 
Return to work rates  Patients report   X X X X 
Total days of sick leave during one year follow up  Patients report   X X X X 
Recurrence of sick leave Patients report    X X X X 
Reduction of symptoms   4DSQ 36;40 X X X X 
Health state profile  Euroqol 33 X X X X 
Costs of health care and loss of productivity Tic-P 30 X X X X 
Absenteeism, quality and quantity of work  HPQ 41;42 X  X  
Problem evaluation  Psychlops (MYMOP) 43;44 X X X X 
Coping processes  Ways of Coping Questionnaire 29 X X X X 
Patient satisfaction  Patients report  X X X 
Application of the MISS: number of visits, diagnosis, advice & 
treatment, proceeding of recovery process over the past year 
Medical record & questionnaire 
filled in by GP 
   X 
Prognostic measures (independent predictor or covariate) 
     
Mental disorders PRIME-MD 45;46 X    
Sick leave in year before Patients report X    
Problems, life events, chronic illnesses  Patients report X  X X 
Work experience / burn out  UBOS 24 X   X 
Job content data, job stress JCQ 25 X    
Critical incidents HPQ 47 X  X  
Neuroticism NEO-FFI 27 X    
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measured at the level of the patient, except for the GP interventions and skills. These were 
reported by the GPs two months after baseline. Moreover, data on received health care were 
extracted from the medical records after the completion of the one year follow-up.   
 
Power & sample size  
Proportions used to determine the sample size needed, were adopted from a related study 
completed in the occupational health care setting34. In that study, after a period of 3 months 
79% in the intervention group versus 64% in the control group had fully returned to work. In 
order to detect a relevant difference in survival analysis on our primary outcome measure, 
nQuery Advisor 35 was used to calculate the sample size. With a power of 80% at a 0.05 level 
two-sided log-rank test for equality of survival curves between the MISS group proportion still 
on sick leave of 0.21 and a usual care group proportion of 0.36 at the given time of 3 months, 
the sample size needed in each group was 126 (with a constant hazard ratio of 1.528). 
Taking into account an intracluster correlation coefficient (ICC) of .025 (clustering effect in 
our groups is not presumed to be large) for randomisation at GP level and 7 patients per 
cluster (GP), a total of 290 patients are needed. Assuming a dropout rate of 30% 
(approximately 10% at each follow up), inclusion of a total of 415 patients is necessary.  
 
Randomisation 
Randomisation took place at the level of GPs, after each of the four recruitment moments 
and after the GPs signed informed consent. Because balance between groups in size and 
characteristics was presumed all four times GPs were randomised, no blocking or 
stratification was used. We developed the following procedure to conceal allocation. The 
names of the GP’s (and dummy in an uneven group) were put on a list of which the order 
was subsequently randomised by one person (IMB). Another person (BT) independently 
drew up a randomised list of codes (1 = MISS group and 2 = control group) with an equal 
number of ‘1’ and ‘2’ codes up to the number of GPs being randomised. Finally, these two 
lists were brought together and the first GP on the list was allocated to the group indicated by 
the first code; and so on. As a result, 24 GPs were allocated to the intervention (MISS) group 
and 22 GPs were allocated to the control (usual care) group.  
 
Implementation 
After assigning the GPs and training was given to the MISS group, patients were enrolled by 
screening the source population (see participants). The general practice team gave entrance 
to data on the source population, the source population was given the inclusion criteria 
through a screening questionnaire. The research assistance team was responsible for the 
final recruitment. They gave information in a phone survey and asked the patient informed 
consent to participate.       
 
Blinding 
Patients were kept unaware that two different interventions were studied; both groups were 
given exactly the same information and questionnaires. The patients, as well as the external 
interviewers who carried out the phone surveys, were told that the study was about stress 
and sick leave. Finally, the internal research assistance team responsible for the process of 
data collection knew that the study involved a training of half of the GPs; nevertheless the 
internal research team had no information on which GPs were allocated to what conditions.  
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 Statistical methods 
First of all, baseline similarity between the MISS and usual care groups will be examined, 
and baseline characteristics of drop outs and completers will be compared. Cox regression 
analyses will be used to investigate the intervention effect, by analysing differences in 
outcome with survival analysis of the primary outcome measure between the MISS and usual 
care group. To correct for misclassification of patients and severity of complaints (inclusion is 
only by level of distress with sick leave), and as a consequence to avoid bias in the effect, 
baseline measures of psychological symptoms (by means of the 4DSQ 36 & PRIME-MD 37), 
as well as medical records will be examined. Additionally, subgroup analysis can be done by 
level of severity of complaints. 
Linear and logistic multilevel analyses will be used to investigate the intervention effect on all 
secondary outcome measures: rates of return to work, psychological symptoms, problem 
experience and coping style. Also, longitudinal multivariate analysis will be used to examine 
differences in improvement in all secondary outcome measures between the treatment 
groups. Analysis will be performed on an intention-to-treat basis and intra-class-correlation 
will be calculated to correct for possible clustering of observations. Levels included will be: 
repeated measures, patients and GPs. Subgroups for analysis will be modelled by the 
prognostic factors mentioned.  
Costs will be measured and valued from a societal perspective. Mean direct and indirect 
medical costs (measured with the Tic-P30), costs of productivity loss due to sick leave 
(measured with the WHO HPQ38) and total costs will be compared between both groups. 
Confidence intervals around mean differences will be estimated with bootstrapping methods. 
With regard tot the primary outcome, sick leave, a cost benefit analysis will be performed, in 
which costs of productivity loss due to sick leave will be compared with direct en indirect 
medical costs. 
A cost-effectiveness analysis will be performed to assess the incremental costs per unit 
improvement on the 4DSQ 39. Bootstrapping methods will be used to estimate the confidence 
interval for the cost-effectiveness ratio and to a draw cost-effectiveness plane. Similarly, 
utility assessed with the EuroQol 33 will be used to estimates the incremental costs per Qualy 
gained in a cost-utility analysis. 
As regards the prognostic measures, univariate analyses will be used to select relevant 
factors, with a focus on identifying prognostic factors for our primary outcome measure. 
Subsequently, Cox regression analyses and logistic regression analysis will be performed on 
these relevant factors.  
 
Discussion 
SMDs in primary care 
This project is developed for the primary care setting with its’ typical case load of stress-
related mental disorders, and not for specialised care in which patients have more clearly 
defined mental disorders. We provide an intervention that is aimed at better recognition, 
good communication, and a time-contingent framed recovery process. Our approach of 
SMDs, with the need to identify specific psychiatric disorders where they exist and also to 
respect the roles of daily life in determining and shaping psychological disability, is an 
example of specified stepped care in general practice. Potential risk factors for chronicity are 
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pointed out in our training, and early recognition and treatment is the main goal of the MISS. 
The role of more specialised care is well acknowledged in the intervention.  
 
Benefits of our screening method 
Particular strength of our study protocol is the method of recruiting patients. By using the 
computerised patient record system, we screened the whole population of general practice 
attendees and thereby determined who entered the study, instead of chartering the GPs to 
select their patients. Therefore, similarity in both groups is assured and we avoided selection 
bias. Also, we did not have difficulties in including enough eligible patients, which is often a 
problem in primary care trials. Furthermore, the current method allows us to consider the 
pragmatic effectiveness and to avoid interference with daily practice of consulting hours. In 
this trial, follow-up is on patients having SMDs with sick leave, instead of patients who 
actually get an intervention for their complaints. Good external validity (i.e. generalizability) is 
accomplished by this rather heterogeneous, and therefore highly representative, group of 
patients with SMDs on sick leave. To assure as much internal validity as possible in this 
pragmatic trial, we randomised on the level of GPs to avoid contamination. In addition, 
research assistants who collected the data and also the patients were blinded.  
 
Prospect on outcomes 
Notably, effectiveness instead of efficacy is studied. We are evaluating what is possible in 
real clinical practice, rather than under ideal circumstances. As a consequence, mental 
health state will vary between the participants. Through subgroup analysis on severity of 
complaints and levels of distress (measured with the PRIME-MD and 4DSQ), we can classify 
possible high or low risk groups for prolonged disability within this heterogeneous group. 
Identification of a high risk group for non-recovery may lead to better suited guidelines on 
stepped care and treatment. We cannot assure that everyone in the MISS group has 
received the intervention; the GPs were given total freedom in actually delivering the MISS. 
Nevertheless, the number of visits, diagnoses, recommendations, treatments and 
proceedings will give us information about the compliance of the GPs and their influence on 
the effect of the MISS. In this way, daily practice is measured in stead of ideal 
circumstances. To avoid social desirable answers from the GPs on their advises and 
treatments, we will also check the medical records of the patients. 
Finally, many requirements for a high quality trial are being met. Results of this cluster RCT 
will contribute to treatment options for patients having SMDs with sick leave in general 
practice, and might contribute to new and better suited guidelines and stepped care. Results 
will be available in the end of 2006. 
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Not been 
able to 
contact by 
phone 
n= 20 
Not been 
able to 
contact by 
phone  
n= 16 
GPs approached N= 139 
Excluded (N=90) 
Sick leave › 3 months N=49 
No sick leave N=17 
No paid job N= 1 
No distress N=2 
No interest N=12 
Language problems N=2 
 
No time available  N=1 
Too much (emotional) strain N=2 
Emigration ahead N=1 
Reason unknown N=3 
 
 
GPs participating N=46 
Randomisation 
Allocated MISS training  
N= 24 
-23 followed complete course- 
Usual care group 
N=22 
Patients screened 
N= 10781 (100%) 
Patients screened 
N= 11959 (100%) 
 
Patients responding 
and meeting criteria  
N= 335 (3.1%) 
Patients responding and 
meeting criteria  
N= 311 (2.6%) 
 
Been able to contact 
by phone  
n= 315 (2.9%) 
Participants at baseline 
n= 227 (2.1%) 
 
 
MISS group  
 
Participants at baseline 
n= 206 (1.8%) 
 
 
Usual Care group 
 
Been able to contact  
by phone 
n= 296 (2.5%) 
Excluded (N=88) 
Sick leave › 3 months N=47 
No sick leave N=15 
No paid job N= 6 
No distress N=1 
No interest N=18 
Language problems N=1 
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Abstract  
Objectives: Mental health problems often affect functioning to such an extent that they result 
in sick leave. The worldwide reported prevalence of mental health problems in the working 
population is 10%–18%. In developed countries, mental health problems are one of the main 
grounds for receiving disability benefits. In up to 90% of cases the cause is stress-related, 
and health-care utilisation is mainly restricted to primary care. The aim of this study was to 
assess the effectiveness of our Minimal Intervention for Stress-related mental disorders with 
Sick leave (MISS) in primary care, which is intended to reduce sick leave and prevent 
chronicity of symptoms. 
Design: Cluster-randomised controlled educational trial. 
Setting: Primary health-care practices in the Amsterdam area, The Netherlands. 
Participants: A total of 433 patients (MISS n = 227, usual care [UC] n = 206) with sick leave 
and self-reported elevated level of distress. 
Interventions: Forty-six primary care physicians were randomised to either receive training 
in the MISS or to provide UC. Eligible patients were screened by mail. 
Outcome measures: The primary outcome measure was duration of sick leave until lasting 
full return to work. The secondary outcomes were levels of self-reported distress, depression, 
anxiety, and somatisation. 
Results: No superior effect of the MISS was found on duration of sick leave (hazard ratio 
1.06, 95% confidence interval 0.87–1.29) nor on severity of self-reported symptoms. 
Conclusions: We found no evidence that the MISS is more effective than UC in our study 
sample of distressed patients. Continuing research should focus on the potential beneficial 
effects of the MISS; we need to investigate which elements of the intervention might be 
useful and which elements should be adjusted to make the MISS effective. 
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Introduction 
Mental health problems often affect functioning to such an extent that they result in sick leave 
[1]. The worldwide reported prevalence in the working population is 10%–18% [2,3]. These 
problems cause a public health burden resulting in enormous personal and financial costs 
[4–7]. Sick leave often lasts for a long period of time, and in developed countries, mental 
health problems are one of the main grounds for receiving disability benefits [8,9]. In up to 
90% of mental health problems the cause is stress-related [4–6,10] and health-care 
utilisation is mainly restricted to primary care [9]. 
Common psychopathology, as seen in primary care, often starts with failure to cope with 
personal, social, or occupational demands. The ability to cope or readjust is overtaxed, and 
this increases the probability that psychological distress will follow [11–13]. Sick leave 
indicates a process of depleting psychological resources; the patient has stopped trying to 
cope, and gives in. When not due to more severe psychiatric conditions such as depressive 
disorder or anxiety disorder, this condition is known as adjustment disorder (Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition) [14,15], neurasthenia (International 
Classification of Diseases, tenth revision) [16], or nervous breakdown. Because such 
patients are labelled with a number of inter-related terms and definitions, we use the term 
stress-related mental disorder (SMD) to indicate relevant dimensions of psychopathology 
that are subacute, but not yet chronic, and clearly related to stress. Subsequently to SMDs, 
persistent distress contributes to more severe psychopathology and chronic conditions such 
as depression and anxiety disorders [17]. 
As yet, there are no evidence-based primary care interventions to improve functioning and to 
prevent long-term sick leave in patients with SMDs. Primary care physicians (PCPs) are not 
always aware of the potentially harmful consequences of sick leave and stress, because the 
symptoms seem to be self-limiting. Or, PCPs may be overly cautious and not question the 
continuation of sick leave nor ask the patient to make more effort to cope with the situation, 
feeling that this type of response undermines the mutual trust between patient and doctor 
[18,19]. 
 
Methods 
The present study is a cluster-randomised controlled effectiveness trial in which PCPs were 
randomised to an intervention group that was trained to deliver a minimal intervention for 
stress-related mental disorders, or to a control group that delivered care as usual. Distressed 
patients on sick leave visiting the practices of both PCP groups were screened, included, and 
followed up for one year [20]. The Medical Ethics Committee of the VU University Medical 
Center approved the study protocol and procedures. 
 
Participants 
We approached 139 PCPs in two districts where the Department of General Practice of the 
VU University Medical Center has some type of network positioned. A total of 46 PCPs 
signed informed consent, both for participating in our trial and for being randomised to either 
the intervention training or to the usual care (UC) group. 
In order to recruit enough eligible patients, we made use of the computerised patient record 
system and approached the source population of patients (n = 22,740, see Figure 1) by mail.  
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Figure 1. Patient screener 
 
The source population consisted of all primary care attenders (20–60 y) who visited 
consulting hours of the participating PCPs. PCPs excluded only patients with very severe 
psychiatric disorders (mania or psychosis), patients with terminal illness, or patients with an 
inadequate command of the Dutch language. The source population of attenders was asked 
to respond only if they met our criteria. Patient inclusion criteria were symptoms of SMD, and 
sick leave for no longer than three months from a paid job. Symptoms of SMD were 
measured by means of self-reported levels of distress (e.g., worrying, listlessness, feeling 
tense—see Figure 1) in order to recruit patients. We approached the source population every 
one or two weeks, until a sufficient number of patients from a particular PCP were enrolled. 
Final recruitment took place by phone survey. All patients who had returned the 
questionnaire and screened positive on distress and sick leave were contacted. Next, the 
inclusion criteria on distress and sick leave for no longer than three months were checked 
again. Since there are no diagnostic criteria, we did not attempt to make a diagnosis of SMD. 
If positive, patients were asked for their informed consent to be included in the study and to 
have their data collected and analysed. If the patient consented, the telephonic baseline 
interview was started. This method of recruitment, unaffected by the PCPs’ diagnostic or 
therapeutic behaviour, ensured that the recruited patients included in the intervention and 
control groups were comparable, and at least not subjected to selection bias. 
 
Interventions 
Over a period of 6–10 wk, the PCPs randomised into the intervention group received training 
in the Minimal Intervention for Stress-related mental disorders with Sick leave (MISS). The 
training comprised two sessions of 3.5 h and two regular follow-up sessions of 2 h (total 11 
h). The tutors during the training were the PCP who developed the intervention (BT) and an 
occupational physician. During the training, the PCPs were instructed to use specific 
methods of communication to help the patient, within three consultations on a time-
contingent course, to achieve functional recovery. The MISS takes into account the time 
constraints under which a PCP works, as well as the position of a PCP as a generalist who 
does not have the capacity to apply highly specialised interventions. The necessary set of 
skills was clearly defined and taught to the PCPs. First, the PCPs were taught to diagnose an 
SMD, and to detect symptoms of depression and anxiety. They were then taught how to give 
information and promote the patient’s understanding and how to emphasise the importance 
of the patient’s active role with regard to successful return to work. Subsequently, they 
  
No 
 
Sometimes 
 
Regularly or often 
1. During the past week, did you suffer from worry?* 0 1 2 
2. During the past week, did you suffer from listlessness?*  0 1 2 
3. During the past week, did you feel tense?* 0 1 2 
   
4. Total score 4 or higher?  
  Yes  No 
5. Do you currently have a paid job?  
 Yes  No 
6. Have you been on sick leave, now for a maximum period of three months?  
 Yes  No 
Patients were asked to only  return the questionnaire if they answered ‘yes’ to items 4,5 and 6 and were willing to 
participate. 
*Four-Dimensional Symptoms Questionnaire Distress scale, (4DSQ, [23]) 
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practised giving advice on the content of functional rehabilitation. Furthermore, the PCPs 
were taught active monitoring to evaluate whether the patient had made efforts to translate 
the (work) situation into a problem that could be solved. Lastly, the PCPs were instructed to 
consider referral to more specialised care in case no progress had been made, since the 
patient was not likely to benefit from more time off work. The PCPs in the UC group received 
no information or advice about the content of the intervention beforehand, but were offered 
the training at the end of the trial. Guidelines for PCPs are available for the treatment of 
depression [21] and anxiety [22], but not yet specifically for SMDs. 
Actual treatment of the participating patients was left to the discretion of the PCPs, who were 
informed of a patient’s participation only after a month. At baseline, patients were asked 
whether or not they had planned another visit to their PCP. If not, they were asked if they 
were considering another visit. The PCP was not obliged to apply the MISS or any other 
intervention, nor were the patients obliged to visit their PCP. 
 
Objectives 
The aim of this study was to assess the effectiveness of our MISS in primary care, which is 
intended to reduce sick leave and prevent chronicity of SMD symptoms in patients. We 
hypothesised that the MISS would be more effective than UC, particularly in patients who 
had been diagnosed with SMD by the PCP. 
 
Outcomes 
The primary outcome was duration of sick leave in calendar days from the first day of sick 
leave until full (not part-time) return to work, lasting for a period of at least 4 wk without partial 
or full relapse into sick leave. Patients were asked to record their days of sick leave, and this 
information was collected at baseline and after 2, 6, and 12 mo during telephone interviews. 
The secondary outcome measures were self-reported symptoms of distress, depression, 
anxiety, and somatisation. These were measured with the Four-Dimensional Symptom 
Questionnaire (4DSQ [23]) at baseline and at 2, 6, and 12 mo by mailed questionnaires. 
Elevated depression, anxiety, and somatisation scores are indicative of the existence of a 
depressive, anxiety, or somatisation disorder, whereas, in the absence of elevated 
depression, anxiety, and somatisation scores, an elevated distress score is indicative of an 
SMD. Two months after the baseline assessment, the PCPs in both groups were asked to fill 
in a structured questionnaire on the care provided and any diagnoses or working hypotheses 
in the past 3 mo according to their electronic medical record. All outcomes were measured at 
individual level. 
 
Sample Size 
To estimate the required sample size, we used a method that takes into account potential 
clustering of effects within practices, the expected difference in outcome between 
intervention groups and the required power of the study. Sample size calculation was done 
with nQuery Advisor (Statistical Solutions, 
http://www.statsol.ie/html/nquery/nquery_home.html). A related study completed in 
occupational health care showed a difference of 15% in full return to work after a period of 
three months [24], which we considered to be a relevant difference for our trial. Expecting a 
proportion still on sick leave after 3 mo of 21% in the MISS group and 36% in the UC group, 
the sample size needed in each group was 126 (with a power of 80% at a 0.05 level two-
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sided log-rank test for equality of survival curves). Taking into account an intracluster 
correlation coefficient of 0.025 because of randomisation at physicians’ level and seven 
patients per cluster, a total of 290 patients was needed. Assuming a dropout rate of 30% 
(approximately 10% at each moment of follow-up), enrolment of 415 patients was needed. 
 
Randomisation and Blinding 
The PCPs were randomly allocated at four different recruitment moments, with block sizes of 
n = 10, n = 7, n = 14, and n = 15. A standard procedure was followed to conceal allocation: 
the names of the PCPs (and dummy in an uneven group) were put on a list in random order. 
Independently, a randomly ordered list of codes (1 = MISS, 2 = UC) was generated. These 
lists were brought together and the first PCP on the list was allocated to the group indicated 
by the first code, and so on. As a result, 24 PCPs were allocated to the MISS group and 22 
to the UC group. After the PCPs were assigned and the MISS group had received 7 h of 
training, the patients were enrolled by screening the source population. Patient selection was 
performed by the research team, in order to prevent selection bias due to the MISS training. 
The PCPs gave entrance to the names and addresses of the source population, and the 
source population was given the inclusion criteria through a screening questionnaire. The 
research assistance team contacted the patients who returned the questionnaire by phone, 
gave information about the study, and was responsible for the final recruitment. The internal 
research team, responsible for the process of data collection, knew the study involved was a 
randomised controlled trial, but they had no information on which PCP was allocated to what 
condition. Patients and external interviewers were blinded. They were kept unaware that two 
different groups were formed, and were told that the study was about stress and sick leave. 
 
Statistical Methods 
To evaluate the effectiveness of the MISS compared to UC, we used Cox regression 
analysis in STATA 8.0 (Stata, http://www.stata.com/stata8/) with robust standard errors [25] 
on our primary outcome measure. Differences in duration of sick leave were expressed as 
hazard ratios (HRs) and corresponding confidence intervals (95% confidence interval [CI]) for 
the MISS group, compared to the UC group. Estimates of the intervention effects on our 
secondary outcome measure were obtained from linear mixed models in SPSS 12.0 (SPSS, 
http://www.spss.com). 
All analyses were conducted according to the intention-to-treat principle and corrected for the 
clustered design. The analyses were performed in several stages. First, baseline similarity of 
the two groups was examined for all potential confounders (age, gender, marital status, level 
of education) and baseline values of symptom scores (distress, depression, anxiety, and 
somatisation). Secondly, the unadjusted association between the groups (MISS versus UC) 
and both outcome measures were calculated. This association was then adjusted for each of 
the potential confounders separately. A forward selection procedure was followed to include 
the potential confounders. For our primary outcome measure this was done in order of 
highest change in the regression coefficient. Only those factors that changed the regression 
coefficient by more than 10% were considered to be confounders, and retained in the model. 
For our secondary outcome measure this was done by checking the significance of the p-
values. Confounders were retained if they significantly contributed to the model (p < 0.05). 
Furthermore, we were interested in potential modification of the treatment effects by the 
PCPs’ diagnosis of SMD, and therefore preplanned subgroup analyses on diagnosis in the 
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Cox regression analysis and linear mixed models effect evaluation. Baseline measures of 
self-reported symptoms, as well as diagnoses from the electronic medical records were 
examined, so we were able to check for classification of patients and severity of complaints 
(inclusion is only by self-reported level of distress with sick leave). We added product terms 
for the possible effect-modifier “diagnosis” (with categories SMD, other mental health 
problems, or somatic health problems) and condition (MISS or UC) to the model and 
checked for significance of the interaction term (p < 0.10). If significant, we proceeded with 
subgroup analyses. Since the diagnostic behaviour of the PCPs in the MISS group might 
have been changed as a result of the training, we were aware of confounding by selection 
bias. If the MISS PCPs detected more patients with an SMD than their UC counterparts, they 
would possibly detect a significantly higher proportion of patients with relatively mild 
disorders, which in itself could explain any differences in the patient outcomes of the groups. 
Therefore, we tested again for confounding of the association between the intervention and 
the outcome by baseline values of symptom scores (distress, depression, anxiety, and 
somatisation). 
 
Results  
Participant Flow, Baseline Data, and Numbers Analysed 
Between September 2003 and October 2004, a screening letter was sent to the source 
population of 22,740 patients. The overall response percentage on our screening method 
was 51.5%; this was measured in a group of 336 randomly selected attenders. A total of 433 
patients (1.9% of 22,470) were included in the study, 66.3% of whom were women. 
Table 1 shows that baseline demographics and clinical characteristics of patients were 
largely similar, and only a small difference in level of education was found. The mean 
number of visits to the PCP, counted from the day of sick leave up to 3 mo, was 2.55 
(standard deviation [SD] 2.12) in the MISS group, and 2.50 (SD 2.23) in the UC group (p = 
0.839). With regard to clinical characteristics, baseline measures of self-reported symptoms 
were taken into account. Up to 80% of the patients scored above threshold on self-reported 
symptoms of distress, almost half scored above threshold on symptoms of depression, and 
about one-third scored above threshold on symptoms of anxiety. Symptoms of somatisation 
also were above threshold in more than half of the patients. 
The participant flow from baseline up to 12 mo follow-up is represented in a Flow Chart. For 
our primary outcome measure—duration of sick leave—data on 197 of the 227 (87%) of the 
patients from the MISS group and 174 of 206 (84%) of the patients from the UC group were 
available. During follow-up, 44 (19.4%) of the patients in the MISS group and 47 (22.8%) of 
the patients in the UC group withdrew from the study (see Flow chart). Only small differences 
were found with regard to baseline demographics and the clinical characteristics measured 
with the 4DSQ scores between the drop-outs and completers. 
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Inclusion in study 
Participants at baseline  
n= 206 (100%) 
Screening 
All patients visiting PCPs 
(20-60 years) 
n= 11959 
Written baseline measure  n = 159   
Primary outcome: lasting full return to work 
0 -12 months follow-up on sick leave period   
n = 174 (85%) 
Primary outcome: lasting full return to work 
0 -12 months follow-up on sick leave period 
n= 197 (88%) 
Written baseline measure  n = 178    
MISS group 24 PCPs 
 
46 PCPs randomised 
 
Screening 
All patients visiting PCPs (20-
60 years) 
n= 10781 
Inclusion in study 
Participants at baseline  
n= 227 (100%)  
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Drop-out n= 32* 
Written 12 month follow up  n= 139  
Drop-out n= 30* 
Written 12 month follow up n= 167  
Screened positive on distress + sick 
leave n= 266 
 
 
Screened positive on distress + sick 
leave n= 243 
 
Written 2 month follow up N=142  
Written 6 month follow up N=146 
Written 2 month follow up N=174  
Written 6 month follow up n=164  
Drop-out N= 0* Drop-out N= 7* 
Drop-out N= 13* 
 
Drop-out N= 0* 
Informed 
consent to 
check medical 
records  
N= 172 (83%) 
Informed 
consent to 
check medical 
records  
N= 203 (89%) 
*Reasons for overall drop-out (MISS n = 44/ 19.4%; UC n= 47/ 22.8%) were: 
‘no time or too busy’ (MISS n= 9, UC n= 5), ‘burden too heavy’ (MISS n =7, UC n=7), ‘no longer willing to participate’ 
(MISS n= 10, UC n=13), ‘moved’ (MISS n=3, UC n=3), ‘lost to follow-up’ (MISS n=10, UC n=15), ‘no distress’ (UC 
n=1) or unknown (MISS n=6, UC n=5). 
UC group 22 PCPs 
MISS 
Drop-out N= 4* 
Drop-out N=  7* 
Missing n= 4 
Missing n= 3 
UC 
Table 1. Characteristics of patients with SMD symptoms and < 3 months sick leave  
   
Patients baseline measures 
MISS (N=227) Usual Care (N=206) 
   
Women N (%) 153 (67) 134 (65) 
Mean age (SD) 41.97 (8.8) 39.50 (9.6) 
Married or cohabiting N (%) 174 (77) 148 (72) 
Level of education N (%)   
 Low 59 (27) 46 (22) 
 Intermediate 94 (42) 102 (50) 
 High 70 (31) 57 (28) 
 
Mean (SD) number of visits to the PCP, counted from 
the day of sick leave + 3 months 
 
2.55 (2.12) 
 
2.50 (2.23) 
4DSQ scores available* MISS N= 180 (80%) 
 
UC N= 161 (78%) 
 
Distress           N above threshold (%) 140 (78.2) 
86 (48.0) 
54 (30.2) 
103 (57.5) 
131 (81.9) 
72 (45.0) 
48 (30.0) 
86 (53.7) 
Depression      N above threshold (%) 
Anxiety           N above threshold (%) 
Somatization   N above threshold (%) 
*See Table 3 for mean scores, score ranges and elevated level scores. 
 
 
Table 2. Median number of days of sick leave before lasting full return to work* 
 
Outcomes and Estimation 
All analyses were adjusted for the clustering effect of PCPs. Tables 2 and 3 present the 
scores for primary and secondary outcome measures. Analysis showed no superior overall 
effect of the MISS on our primary outcome measure, days of sick leave (unadjusted HR 1.06, 
95% CI 0.87–1.29; see Table 3). The median number of sick leave days before return to 
work was 96 (95% CI, 81–111) in the MISS group and 102 (95% CI, 75–182) in the UC 
group. Multilevel analyses showed that the analyses on our secondary outcome measure 
needed to be adjusted for the correlation of repeated measures within patients. Over 12 mo 
follow-up, the severity of all symptoms was reduced significantly in both groups (p < 0.001), 
and on our secondary outcome measure no significant differences were found between the 
MISS group and the UC group. A considerable number of patients still scored above 
threshold on self-reported symptoms after 12 mo follow-up. As can be seen in Table 3, this 
accounts for around 40% of the patients on symptoms of distress, and about one-quarter of 
the patients on symptoms of depression. 
 
 
MISS 
Number of days (95% CI) 
 
N= 
 
Usual Care  
Number of days (95% CI) 
 
N= 
 
 
Hazard ratio (95% CI) 
 
 
P-value 
      
 
96 (81-111) 
 
197 
 
102 (75 – 182) 
 
174 
 
1.06 (.87 - 1.29) 
 
0.562 
*Since the duration of sick leave does not have a normal distribution, we report the median number of days 
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Table 3. Symptom scores at follow-up 
4DSQ scores 
     
 
ICC    p = 
 
MISS  Usual Care  F    p-value 
Distress mean (SD)  0.028 0.107 
  
 1.213 0.304* 
Score range: 0- 32 
  
 
Baseline 
 
19.21 (8.5) 18.79 (8.1) 
  
Elevated level; score >10   2 month follow up 14.26 (9.37) 15.24 (8.84)   
   6 month follow up 11.73 (9.08) 13.16 (9.06)   
 
  1 year follow up 10.81 (8.91) 10.49 (8.64)   
 
N above threshold (%) after 1-year follow-up  
 
 
75 (44.9%) 55 (39.6%)   
 
Depression mean (SD) 0.015 0.206 
 
  0.332 0.802* 
Score range: 0-12 
   
Baseline 3.46 (3.7) 3.38 (3.6) 
  
Elevated level; score >2   2 month follow up 2.54 (3.53) 2.59 (3.50)   
   6 month follow up 2.11 (3.31) 2.20 (3.25)   
   1 year follow up 1.74 (2.92) 1.89 (3.04)   
 
N above threshold (%) after 1-year follow-up 
  
40 (24.0%) 40 (28.8%)   
 
Anxiety mean (SD)  0.021 0.219 
 
  0.899 0.441* 
Score range: 0-24 
  
 
Baseline 5.51 (5.5) 5.41 (5.5) 
  
Elevated level; score > 7   2 month follow up 4.19 (5.32) 4.74 (5.61)   
   6 month follow up 3,12 (4.63) 4.03 (5.20)   
 
  1 year follow up 2.83 (4.55) 3.14 (4.54)   
 
N above threshold (%) after 1-year follow-up 
  
23 (13.8%) 18 (12.9%)   
 
Somatization mean (SD)  0.048 0.054 
 
  1.295 0.275** 
Score range: 0-32 
  
 
Baseline 12.88 (6.9) 12.35 (6.8)   
Elevated level; score > 10   2 month follow up 11.22 (8.01) 10.96 (7.26)   
 
  6 month follow up 9.76 (7.48) 10.33 (6.87)   
   1 year follow up 8.34 (6.67) 9.00 (6.96)   
 
N above threshold (%) after 1-year follow-up 
  
51 (30.5%) 46 (33.6%)   
*adjusted for age, **adjusted for age and level of education.  
MISS baseline N= 180 (80%), 2-month follow-up N =174 (76.7%), 6-month follow-up N=164 (72.2%), 1-year follow-up N = 167 (73.6%) /  UC 
baseline N= 161 (78%), 2-month follow-up N= 142 (68.9%), 6-month follow-up N= 146 (70.9%), 1-year follow-up N=139 (67.5%) 
 
 
Ancillary Analyses 
The baseline diagnoses from the medical records are shown in Table 4, divided into three 
categories: SMDs, other mental health problems, and somatic problems. As can be seen in 
Table 4, more PCPs in the MISS group recognised patients as having SMD (p = 0.068). 
These diagnosis categories showed interaction with the intervention in the Cox regression 
analysis on differences in duration of sick leave (p = 0.033). The PCPs’ diagnosis of both 
SMDs and other mental health problems was associated with a longer median duration of 
sick leave, compared to the diagnosis of somatic health problems.  
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Table 4. Diagnosis by primary care physician at baseline 
 
Diagnosis* 
 
 
MISS 
 
UC 
SMD n (%) 
 
90 (45) 66 (39) 
Other mental health problems n (% within category) 
 
67 (33) 49 (29) 
• Depression 24 (36) 17 (35) 
• Anxiety states; panic disorder 5 (7) 1 (2) 
• Threshold psychiatric disorders 7 (10) 5 (10) 
• Non-specific distress  9 (13) 12 (24) 
• Somatoform problems 8 (12) 3 (6) 
• Social and/or private problems 
 
15 (22) 12 (24) 
Somatic problems n (% within category) 
 
44 (22) 56 (33) 
• Pain in back, neck or upper extremities 28 (64) 32 (57) 
• Gastrointestinal, respiratory, cardiovascular, digestive or 
dermatological     problems.  
16 (36) 24 (43) 
*Chi-squared, p = 0.068   
 
Table 5 shows the subgroup analyses, and among patients diagnosed with SMDs, time to 
return to work was shorter in the MISS group than in the UC group (unadjusted HR 1.49 
[0.98–2.26], and adjusted HR 1.72 [1.18–2.51]). The HRs for return to work in the subgroups 
other mental health problems and somatic problems slightly favoured the UC group. 
However, these differences were small and not statistically significant. For our secondary 
outcome measure, severity of symptoms, the interaction of intervention with diagnosis 
showed no significant results, so no subgroup analyses were performed. Although the 
subgroup analyses were planned out before the trial took place, in no case can this result be 
regarded as evidence for a difference between the MISS group and UC group. 
 
Table 5. Median number of days of sick leave before lasting full return to work, by subgroups 
#Chi-squared, p= 0.033 
¹HR adjusted for baseline values for distress.  
²HR adjusted for baseline values for age, level of education and anxiety.  
³HR adjusted for baseline values for anxiety. 
 
MISS 
Number of days 
(95% CI) 
 
N= 
Usual Care 
Number of days 
(95% CI) 
 
N= 
Unadjusted Hazard 
ratio  
(95% CI) 
 
P-
value 
Adjusted  
Hazard ratio 
(95% CI) 
 
P-
value 
Subgroups of 
diagnosis# 
        
  
 
 
 
 
   
Stress-related 
mental disorder  
 
 
97 (75- 119) 
 
90 
 
170 (143 – 197) 
 
66 
 
1.49 (0.98 - 2.26) 
 
0.060 
 
1.72  (1.18 - 
2.51) 
 
 
0.005¹ 
Other mental 
health problems 
 
 
109 (86 – 132) 
 
67 
 
75 (32 – 118) 
 
50 
 
0.91 (0.61-1.36) 
 
0.638 
 
 
0.81  (0.46 - 
1.40) 
 
0.445² 
Somatic 
problems 
 
78 (13- 143) 
 
 
44 
 
21 (8 – 34) 
 
56 
 
0.73  (0.49-1.07) 
 
0.106 
 
0.76  (0.47 - 
1.12) 
 
0.159³ 
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Discussion 
Interpretation 
We were unable to prove our hypothesis that the MISS would be more effective than UC, 
either on our primary outcome measure nor on the secondary. The median number of days 
on sick leave before return to work was substantial in both groups and a considerable 
number of patients still scored above threshold on the self-reported symptoms. However, the 
severity of symptoms was reduced significantly during the 1 y follow-up. 
The MISS did not show an overall effect in our study sample of patients with symptoms of 
distress on sick leave. Possible explanations for the failure to find an effect can be sought 
within the patients, the PCPs, and the intervention used. First of all, we shall discuss the 
patients. There might have been a problem with the inclusion criteria used. It is possible that 
we misclassified a substantial part of the patients because our criteria might have been much 
too broad at both sides of the severity continuum. As can be seen with the self-reported 
symptoms of depression, 24.0% in the MISS group and 28.8% in the UC group still scored 
above threshold level after one year. This substantial group of patients may have had 
conditions that were of a more chronic nature (e.g., depressive disorder) and needed more 
extensive care. The difficulty here is that relevant dimensions of psychopathology that are 
subacute, but not yet chronic, and clearly related to stress (e.g., SMD), could not be 
distinguished in a straightforward way from more severe psychopathology or from an 
admixture of somatic and psychological symptoms. Nevertheless, we used only three 
questions on distress symptoms and one question on sick leave to recruit patients who had 
visited their PCP. We were convinced of the importance of undertaking this study, and for 
that reason might have underestimated the challenge of diagnosing SMDs. Thus, it is clear 
that the evidence base on criteria for the diagnosis of SMD in patients has to grow 
substantially. 
 
Table S1. Baseline scores on 4DSQ symptoms, and number of visits to the PCP, stratified into 
subgroups 
 MISS UC 
Subgroup SMD   
Distress 20.56 19.08 
Depression 3.94 2.64 
Anxiety 6.31 4.50 
Somatization 14.52 10.86 
   
Mean # of visits to the GP¹ 2.60  2.34  
Subgroup other mental health problems    
Distress 17.47 20.41 
Depression 2.89 3.93 
Anxiety 4.69 6.41 
Somatization 10.25 14.54 
   
Mean # of visits to the GP¹ 3.13 3.20 
Subgroup somatic diagnosis   
Distress 17.80 17.03 
Depression 2.80 2.74 
Anxiety 6.12 3.84 
Somatization 12.64 12.14 
   
Mean # of visits to the GP¹ 2.03 1.88 
¹ Counted from the day of sick leave + 3 months 
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Furthermore, the lack of effect might be due to the PCPs. They are the gatekeepers of health 
care and have extensive workloads. The MISS takes into account the time constraints under 
which a PCP works, as well as the position of a PCP as a generalist who does not have the 
capacity to apply highly specialised interventions. Nevertheless, the PCPs may have been 
too busy to carry out any intervention at all. Alternatively, the intervention might have been 
too minimal, or the training hours too short for the PCPs to actually learn the necessary skills. 
Unfortunately, except for detection and labelling of symptoms, the extent to which the PCPs 
actually applied their skills was not addressed in this study. 
Ancillary analyses showed there was an interaction between the intervention and detection of 
SMDs, other mental health problems, or somatic problems. Both SMDs and other mental 
health problems were more frequently diagnosed by the PCPs in the MISS group than by the 
PCPs in the UC group. Since, as a result of the training, the MISS PCPs were more sensitive 
to mental disorders and more keen to diagnose SMDs in particular, it seems logical to expect 
that this result would be biased. It seems likely that the SMD patients in the MISS group were 
significantly less severely affected than the SMD patients in the UC group. This in turn could 
have caused differences in outcome of the SMD patients in the study group, giving a false 
(confounded) impression of the effect of the MISS. However, the SMD patients in the MISS 
group actually turned out to have higher baseline levels of symptoms than the SMD patients 
in the UC group (see Table S1). We tested baseline variables for confounding and as a result 
controlled for severity of symptoms, but that did not make the effect of the intervention in the 
SMD patients disappear. Nevertheless, it should be noted that this was an ancillary analysis, 
and because of the selection of the SMD patients by the PCPs’ diagnosis, although it was a 
preplanned subgroup analysis, in no case can this result be regarded as evidence of a 
difference between the MISS group and UC group. 
 
Generalisability 
We carried out a randomised controlled trial with only a few exclusion criteria and thereby 
allowed considerable variation due to context, diagnosis, and treatment, so flattering 
performances or overestimation of application are unlikely to be issues. Instead, the 
considerable variation increases the relevance of our results because it reflects routine 
clinical practice instead of ideal circumstances. 
 
Overall Evidence 
As far as we know, this is the first randomised controlled trial to evaluate the effects of an 
intervention in primary care for SMDs with sick leave as a primary outcome. At the start of 
our study, the only comparable study had been performed in occupational health care by Jac 
van der Klink et al. [24], who reported high return-to-work rates after three months (78% in 
the intervention group and 63% in the UC group, p = 0.02). In our study, these rates were 
lower (51% in the MISS group and 57% in the UC group, p = 0.239). In the meantime, the 
results of one other randomised controlled trial performed in primary care have been 
published [1]. In that trial, social workers were trained to apply the intervention, while PCPs 
provided UC for patients in the other group. The study found no differences between the 
conditions. Return-to-work rates after three months were 37% in the intervention group and 
40% in the UC group. The more favourable outcomes of this study seem to indicate that the 
occupational setting may be exceptional, and that the results may not equally apply to 
primary care. Moreover, our trial addressed a wider range of patients than the trial of van der 
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Klink et al., who excluded patients with major depression or anxiety. The more beneficial 
effects of the MISS among patients with a PCP’s diagnosis of SMD may indicate that these 
patients more strongly resemble the participants in the occupational study. 
 
Conclusions 
This project represents a further step in the development of an evidence-based intervention 
for the treatment of distressed patients on sick leave. We were unable to show an effect of 
the MISS on duration of sick leave. In subgroup analyses a possible direction for further 
research was identified: namely, whether patients diagnosed with SMDs may benefit from an 
effect of the MISS on duration of sick leave. We feel that emphasis on functional 
rehabilitation of the patient is important, because continuation of sick leave may lead to 
chronicity and deterioration of symptoms. Unfortunately, diagnosis of SMD in primary health 
care turns out to be less straightforward than we expected, and the evidence base on criteria 
for this diagnosis will need to grow substantially before definite conclusions can be drawn. 
Researchers should take into account the importance of a diagnostic work-up to differentiate 
between common mental health problems, because there is still a lack of generally accepted 
criteria to diagnose “uncomplicated SMD” as a level of psychopathology. 
Furthermore, continuing research should focus on the potential beneficial effects of the 
MISS; we need to investigate which elements of the intervention might be useful and which 
elements should be adjusted to make the MISS effective. 
 
 
 
 
Chapter 4  
54
Reference List 
 
1.  Brouwers EPM, Tiemens BG, Terluin B, Verhaak PFM (2006) Effectiveness of an intervention 
to reduce sickness absence in patients with emotional distress or minor mental disorders: a 
randomized controlled effectiveness trial. General Hospital Psychiatry 28: 223-229. 
2.  Kessler RC, Frank RG (1997) The impact of psychiatric disorders on work loss days. 
Psychological Medicine 27: 861-873. 
3.  Wang JL, Adair CE, Patten SB (2006) Mental health and related disability among workers: A 
population-based study. American Journal of Industrial Medicine 49: 514-522. 
4.  OECD Economic Surveys: Netherlands (2004) Reform of the sickness and disability benefit 
schemes.  
5.  National Mental Health Association USA. (2004) Mental health facts. www.nmha.org.  
6.  The Mental Health Foundation UK (2003) Statistics on mental health, the costs of mental 
health problems. www.mentalhealth.org.uk.  
7.  Henderson M, Glozier N, Elliott KH (2005) Long term sickness absence - Is caused by 
common conditions and needs managing. British Medical Journal 330: 802-803. 
8.  Nieuwenhuijsen K, Verbeek JHAM, Siemerink JCMJ, Tummers-Nijsen D (2003) Quality of 
rehabilitation among workers with adjustment disorders according to practice guidelines; a 
retrospective cohort study. Occupational and Environmental Medicine 60: 21-25. 
9.  Anema JR, Jettinghoff K, Houtman ILD, Schoemaker CG, Buijs PC, van den Berg R (2006) 
Medical care of employees long-term sick listed due to mental health problems: A cohort study 
to describe and compare the care of the occupational physician and the general practitioner. 
Journal of Occupational Rehabilitation 16: 41-52. 
10.  Nystuen P, Hagen KB, Herrin J (2001) Mental health problems as a cause of long-term sick 
leave in the Norwegian workforce. Scandinavian Journal of Public Health 29: 175-182. 
11.  Lazarus RS, Folkman S (1984) Stress, appraisal and coping. New York: Springer Publishing 
Company.  
12.  Thoits PA (1995) Stress, Coping, and Social Support Processes - Where Are We - What Next. 
Journal of Health and Social Behavior 35: 53-79. 
13.  Goldberg D, Huxley P (1992) Common Mental Disorders - A Biosocial Model . London: 
Tavistock/ Routledge.  
14.  American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders 
DSM-IV. Washington, D.C.: American Psychiatric Association.  
15.  Casey P, Dowrick C, Wilkinson G (2001) Adjustment disorders - Fault line in the psychiatric 
glossary. British Journal of Psychiatry 179: 479-481. 
16.  World Health Organisation (1992) The ICD-10 classification of mental and behavioural 
disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.  
17.  Wang JL (2005) Work stress as a risk factor for major depressive episode(s). Psychological 
Medicine 35: 865-871. 
18.  Sawney P (2002) Current issues in fitness for work certification. British Journal of General 
Practice 52: 217-222. 
19.  Hussey S, Hoddinott P, Wilson P, Dowell J, Barbour R (2004) Sickness certification system in 
the United Kingdom: qualitative study of views of general practitioners in Scotland. British 
Medical Journal 328: 88-91. 
20.  Bakker IM, Terluin B, van Marwijk HWJ, Gundy CM, Smit JH, van Mechelen W, Stalman WAB 
(2006) Effectiveness of a Minimal Intervention for Stress-related mental disorders with Sick 
leave (MISS); study protocol of a cluster randomised controlled trial in general practice 
[ISRCTN43779641]. BMC Public Health 6: 124. 
21.  Van Marwijk H.W.J, Grundmeijer HGLM, Bijl D, Van Gelderen M.G, De Haan M, Van Weel-
Baumgarten E.M., Burgers JS, Boukes FS, Romeijnders ACM (2003) Dutch College of 
55 
  
General Practioners Guideline Depression, first revision [NHG-Standaard Depressieve 
stoornis (depressie). Eerste herziening. In Dutch]. Huisarts en Wetenschap 46: 614-633. 
22.  Terluin B, Van Heest FB, Van der Meer K, Neomagus GJH, Hekman J, Aulbers LPJ, 
Starreveld JS, Grol MH (2004) Dutch College of General Practioners Guideline Anxiety 
disorder, first revision [NHG- standaard Angststoornissen, eerste herziening, In Dutch]. 
Huisarts en Wetenschap 47: 26-37. 
23.  Terluin B, Van Marwijk H.W.J, Ader HJ, de Vet HC, Penninx BW, Hermens ML, van Boeijen 
CA, van Balkom AJ, van der Klink JJ, Stalman WAB (2006) The Four-Dimensional Symptom 
Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to 
assess distress, depression, anxiety and somatization. BMC Psychiatry 6: 34. 
24.  Klink JJLvd, Blonk RWB, Schene AH, van Dijk FJH (2003) Reducing long term sickness 
absence by an activating intervention in adjustment disorders: a cluster randomised controlled 
design. Occupational and Environmental Medicine 60: 429-437. 
25.  Lin DY, Wei LJ (1989) The Robust Inference for the Cox Proportional Hazards Model. Journal 
of the American Statistical Association 84: 1074-1078. 
 
 
 
Chapter 4 
56
  
 
 
 
 
 
 
5 
Cost-effectiveness of a minimal intervention strategy 
for stress-related sick leave in general practice: 
results of an economic evaluation alongside a 
pragmatic randomized controlled trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kimi Uegaki 
Ingrid M Bakker 
Martine de Bruijne 
Allard van der Beek 
Berend Terluin 
Harm WJ van Marwijk 
Wim AB Stalman 
Willem van Mechelen 
 
Submitted 
  
Abstract 
Objective: The objectives were to: 1. determine the cost-effectiveness of a general 
practitioner-based minimal intervention strategy for stress-related sick leave in reducing sick 
leave days compared to usual care; 2. evaluate the cost-effectiveness in terms of improving 
quality-adjusted life years; and 3. determine the potential cost offset. 
Methods: An economic evaluation from a societal perspective was conducted alongside a 
pragmatic, cluster-randomized controlled trial with a 12-month follow-up. Analyses were 
based on complete cases. Uncertainty around cost differences and incremental cost-
effectiveness ratios were estimated by nonparametric bootstrapping, cost-effectiveness 
planes and acceptability curves. Sensitivity analyses, including multiple imputation of missing 
values and alternative valuations of productivity gains were conducted. Ancillary analyses 
based on preplanned subgroups were performed.  
Results: There were no significant differences in outcomes or costs. The incremental cost 
per day less of gross sick leave was € 33, and per QALY, € 76,046. The potential cost offset 
ranged from a loss of € 135 to a savings of € 1369. Results of the sensitivity analyses were 
similar to the main findings. Ancillary analyses suggested that the intervention may be cost-
effective for the subgroup, stress-related mental disorders. 
Conclusions: Although there was no statistically significant evidence that the minimal 
intervention strategy was clinically or economically superior to usual care, it may a promising 
intervention for the subgroup, stress-related mental disorders. Future research is needed to 
confirm this observation. Also, in order to improve the meaningfulness of future studies, 
further attention to how health-related productivity changes are measured and valued is 
needed.  
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Introduction 
Poor mental health is a widespread phenomenon. The prevalence of mental health problems 
in the working population has been reported to range between 10-18% [1-3], and it has been 
estimated that by 2020, the global burden will be second only to ischemic heart disease [4]. 
In up to 90% of all workers with mental health problems, stress has been identified as the 
underlying cause [5,6]. Moreover, mental health problems can have a negative effect on 
quality of life, and lead to suboptimal productivity with considerable socioeconomic 
consequences [7]. An upward trend of stress-related sick leave and early retirement has 
been reported across the European Union [8]. The annual cost of sick leave and productivity 
loss in the U.S.A. has been estimated around $200 billion [9]. In The Netherlands, one-third 
of all long-term sick leave or work disability cases are attributable to stress-related mental 
health problems, and in 2004, approximately € 3 billion in disability benefits were paid out to 
individuals with this problem [10-12]. 
Worldwide, 60-95% of those with mental health problems first seek assistance in primary 
care [13]. In The Netherlands, the key point of contact is the general practitioner (GP). While 
stress-related mental health problems can significantly affect an individuals’ ability to work 
and result in (prolonged) sick leave, this functional aspect is often not addressed by GPs 
[14].  
Recently, a pragmatic, cluster-randomized controlled trial with a 12-month follow-up was 
conducted in the primary care setting to evaluate the effectiveness of a minimal intervention 
strategy for stress-related mental disorders with sick leave (MISS) for GPs compared to 
usual care (UC) [15]. Although the MISS was not found to be more effective than UC in 
reducing the time to lasting full RTW, a positive economic impact may still exist with respect 
to total sick leave, quality of life, and differential use of resources and cost offsets. Thus, the 
three objectives of this study were to determine: 1. the cost-effectiveness of the MISS in 
reducing total sick leave days compared to UC; 2. the cost-effectiveness of the MISS in 
improving quality-adjusted life years compared to UC; and 3. the potential cost offset of MISS 
compared to UC. 
 
Methods 
Study design 
An economic evaluation was conducted from a societal perspective alongside a pragmatic, 
cluster-randomized controlled trial with a 12-month follow-up. The protocol was approved by 
the medical ethical committee of the VU University Medical Center (Amsterdam, The 
Netherlands), and details of the study design and the minimal intervention strategy for stress-
related mental disorders with sick leave (MISS) have been reported elsewhere [16]. A brief 
overview is presented below.  
 
MISS 
Recently, an activating approach for occupational physicians for the treatment of workers 
with adjustment disorder was found effective in the occupational health care setting [17]. This 
approach was customized to the general practice setting, with particular attention to 
practicing physicians’ time constraints and nature as generalists. It was designed to equip 
GPs with skills to perform five key tasks within three consultations to help activate patients 
on stress-related sick leave to return to work. The five tasks were: 1. diagnosing stress-
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related mental disorders; 2. providing education about the problem and importance of taking 
an active role in one’s functional recovery; 3. advising patients on how to reflect, cope and 
problem-solve; 4. monitoring progress; and 5. referring to specialists. 
 
Participants 
GPs were recruited at four different time points, and at each moment, those consenting to 
participate were randomized to either usual care (UC; N = 22) or MISS (N = 24). The GPs 
who were randomized to the MISS group followed an 11-hour course consisting of two 3.5-
hour training and two 2-hour follow-up sessions. The training was provided by the developer 
of the MISS intervention and an experienced occupational physician. 
Participants were recruited by the researchers from a source population accessed via 
participating GPs’ computerized medical record systems. Patients who had a severe 
psychiatric disorder (i.e. mania or psychosis), a terminal illness, or poor command of the 
Dutch language were excluded by the GPs. Remaining patients who had a consultation 
during the previous one to two weeks and were aged between 20 and 60 years, were mailed 
an information packet about the study along with a screening questionnaire. If the responses 
on the returned screening questionnaires were positive for a moderately elevated distress 
level (as measured by three questions of the Four Dimensional Symptom Questionnaire (4-
DSQ) distress scale [18]), gainful employment, as well as (partial) sick leave for no longer 
than three months, the respective patient was contacted by telephone. Enrollment in the 
study was finalized during the telephone contact, following verification of the inclusion criteria 
and receipt of oral informed consent. Written informed consent for participation and access to 
the subject’s medical records was obtained separately.   
 
Outcomes 
A combination of telephone interviews and questionnaires were used to collect outcome data 
at baseline and 2-, 6- and 12-months follow-up. The number of sick leave days beginning 
from the first day of sick leave to 1-year thereafter was used as the outcome in the cost-
effectiveness analysis (CEA). The quantity of sick leave days was operationalized in two 
ways: gross and net. The former was defined as the total number of calendar days that 
subjects were completely or partially sick-listed, and the latter accounted for partial return-to-
work [19]. Quality-adjusted life years (QALY) was the outcome in the cost-utility analysis 
(CUA). Quality of life was measured by the EuroQol-5D [20], and the QALYs for the 12-
month follow-up were computed by multiplying the utilities [21] by the time spent in the given 
health state, and then linearly interpolating the transitions between the four measured health 
states [22].   
 
Resource use 
GP consultations and laboratory tests were extracted from the computerized medical records 
for a 12-month period starting from the first day of sick leave. Data on additional resource 
use over 4-week periods were collected via telephone interviews and questionnaires at 
baseline and 2-, 6- and 12-months follow-up. These data were extrapolated over 12-months 
by linear interpolation. 
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Valuation 
The cost prices used for valuation are presented in Table 1. Wherever possible, the volume 
of resource use was valued using standard cost prices according to Dutch Manual for  
 
Table 1: Cost prices used for valuation of resource use in the economic evaluation (Year 2004) 
 
Units [Units of measurement] 
 
Cost price 
Health care sector  
Primary Care  
 General practitioner  
  Office consultation  [No.] € 20.44 * 
  Telephone consultation /renewal of prescription  [No.] € 10.22 * 
  House call [No.]  € 40.88 * 
  After-hours telephone consultation [No.] € 24.30 † 
 Diagnostic tests  
  Blood [No.]  € 21.66 * 
  Urine [No.]  € 14.42 * 
  X-rays [No.] € 49.80 ‡ 
  Other diagnostic tests [No.] Variable † 
 Psychologist in private practice [No. of sessions]  € 76.90 * 
 Social worker [No. of sessions]  € 48.43 † 
 Physical therapist [No. of sessions]  € 23.02 * 
 Other paramedical professionals [No. of  sessions] Variable ‡ 
 Medications [per medication ] Variable § 
Secondary Care  
 Regional Institute for Community Mental Health Care                                       
(including Drug & Alcohol Abuse Centre) [No. of sessions] 
€ 125.47 * 
Hospital-based psychiatrist – [No. of sessions] € 64.18 * 
Part-time psychiatric day programs  - General hospital [No. of sessions] € 90.58 * 
Medical specialist – Outpatient  [No. of consultations] € 56.66 * 
Medical specialist – ER [No. of consultations] € 140.64 * 
Hospitalization – General hospital [No. of days]  € 340.99 * 
Professional home health care [per hour, all services]  € 31.06 * 
Professional family home assistance [per hour]  € 27.10 * 
Alpha help [per hour]  € 12.85 * 
Other sector  
 Occupational physician [No. of consultations] € 21.50 ‡ 
Patient/family  
 Alternative care [No. of  sessions]  Variable ‡ 
 Support group/self-help courses [No. of sessions] Variable ‡ 
 Informal help [per hour]  € 8.40 * 
Productivity losses  
 Sick leave from paid work [per day]  € 254.81 ¶ 
Intervention costs   
 Training costs for MISS [per MISS subject] € 120.46 ** 
Cost price sources: * Dutch Manual for Costing; † Dutch Central Organization for Health Care Charges (CTG) ;‡ Respective 
providers or professional organizations; § Royal Dutch Society for Pharmacy; ¶ Per hour cost price from the Dutch Manual for 
Costing converted to day cost price according to a 36-hour work week; ** Determined via a bottom-up calculation. 
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Costing [23]. If standard cost prices were not available, tariffs, or an average price according 
to providers or professional organization, were used. Medication costs were determined  
Productivity loss costs were estimated from a societal perspective by both the Friction Cost 
Method (FCM) and Human Capital Approach (HCA) [25,26]. According to the FCM, 
productivity losses are limited to the time (i.e. friction period) needed to restore production 
back to its initial level (i.e. time needed to find and train a replacement), which can be shorter 
than the actual sick leave duration of the ill worker [26]. In this study, an average friction 
period of 154 days was used. Productivity loss costs were estimated by multiplying the gross 
number of sick leave days (up to a maximum of 154 days) by an average daily wage and an 
elasticity of 0.8 that reflects a less than proportional decrease in productivity with respect to 
time worked in the Dutch context [23]. Under the HCA, no such assumptions are made, and 
the productivity loss costs are estimated by multiplying the total gross number of sick leave 
by an average daily wage.   
 
Data analysis  
The economic evaluation was performed according to the intention-to-treat principle, and the 
main analyses were based on cases with complete cost and outcome data. The effect of 
MISS compared to UC on QALYs and resource use were assessed using t-tests and chi-
square tests (SPSS version 12.0.2). The mean cost and sick leave differences were 
determined and respective 95% confidence intervals were obtained by bias corrected and 
accelerated (Bca) bootstrapping with 2000 replications [27]. For the cost-effectiveness  
 
Table 2: Overview of the bottom-up calculation of the training costs for the MISS group.  
 
Resources 
 
Description 
 
Aggregated cost  
Trainer costs  Two trainers for all four training series, 
including preparation. 
€ 12,830.40 
GP attendance Time (11 contact hours) of each GP 
invested to follow the MISS training. 
€ 9,467.04 
Travel costs Average return travel to Amsterdam (60 
km) and parking for each training 
session. 
€ 1,823.96 
Room/equipment/refreshment 
costs 
For rental of meeting room at VU 
University campus. 
Equipment includes projector, screen & 
flip board. 
Refreshments during breaks. 
€ 3,082.50 
Study material for 24 GPs  Binder, dividers & 75 printed pages € 140.52 
Total training costs € 27,334.41 
Average cost per MISS subject € 120.46 
 
analysis (CEA), the difference in the investment costs (i.e. sum of total direct and training 
costs) between the MISS group and UC was divided by the difference in gross number of 
sick leave days. Note that productivity loss costs due to sick leave were not included in the 
costs as the difference in sick leave was the effect of interest. In the cost-utility analysis 
(CUA) comparing MISS to UC, the difference in total costs (i.e. the sum of investment costs, 
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and productivity loss costs estimated by the FCM) was divided by the difference in QALYs. 
The 95% confidence intervals around the ratios were calculated by a bias-corrected 
percentile bootstrapping method [28], the bootstrapped cost-effect pairs were plotted in a 
cost-effectiveness plane [29], and acceptability curves were generated [30]. Lastly, the 
potential cost offset of the MISS compared to UC was investigated by weighing the relevant 
investment costs against alternative valuations of productivity gains.  
 
Sensitivity analysis 
Four sensitivity analyses were conducted to test the robustness of the main results. First, the 
CEA was repeated with the difference in net number of sick leave days as the effect 
measure, in the denominator. Second, the CUA was repeated with the difference in total 
costs where the productivity loss cost component was estimated by the HCA, in the 
numerator. Third, the analyses were repeated following multiple imputation of missing cost 
and outcome data based on a Multivariate Imputation by Chained Equations (MICE) 
procedure [31].  Lastly, the potential cost offset was determined from a company’s 
perspective. 
To evaluate the cost offset from a company’s perspective, ‘Other sector’ costs were weighed 
against four valuations of productivity gains. The four methods used were: 1. HCA using the 
gross number of sick leave days; 2. HCA using the net number of sick leave days to take into 
consideration that workers are productive when they (resume) work on a part-time basis; 3. 
the net HCA estimation multiplied by a median wage multiplier of 1.28, which reflects recent 
findings that the cost to a company due to missed work is often greater than an estimation 
based on wage loss [32]. This is related to three key characteristics of a given function: the 
ease with which a perfect replacement can be found, the extent to which work is performed 
as part as a team and the time sensitivity of the output [33]; and 4. the net HCA estimation 
multiplied by an elasticity of 0.55, reflecting the assumption that productivity loss may be 
tempered by compensation by workers on their return, or by colleagues [34].  
 
Ancillary analysis 
Ancillary analyses were conducted for three pre-planned subgroups that were identified from 
the total study population according to the GPs’ diagnosis and/or working hypothesis 
extracted a posteriori from their electronic databases. The first subgroup, stress-related 
mental disorder (SMD), referred to those with elevated yet uncomplicated distress or, in other 
words, the absence of a depressive or anxiety disorder, and resembling adjustment 
disorders, neurasthenia or nervous breakdown. The second, other mental health problems 
(Other MHP), referred to those who present with mental health problems, including anxiety or 
depressive disorders in addition to elevated distress. The third, somatic problems (SP), 
included those who have physical complaints along with elevated distress levels.  
 
Results 
Patients and data availability 
Between September 2003 and October 2004, a screening letter was sent to the source 
population of 22,740 patients. Ultimately, 433 patients enrolled in the study (MISS = 227; UC 
= 206), and the overall number of drop-outs was 91 (21%; MISS = 44; UC = 47). No 
significant differences were observed in demographic characteristics (i.e. age, gender, 
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education level or marital status) nor baseline symptom severity between the drop-outs and 
completers. 
 
Table 3: Means and standard deviations (S.D.) of resource use and utilization rate (%) per 
group during the 12-month follow-up   
 
Units [Units of measurement] 
 
MISS (N = 109 ) 
 
UC (N = 83 ) 
Health care sector Mean  S.D.  % Mean  S.D.  % 
Primary Care       
 General practitioner       
  Office consultation  [No.] 6.1 4.5 95.4% 6.3 4.7 96.4% 
  Telephone consultation /renewal of prescription  [No.] 0.2 0.5 15.6% 0.2 0.6 12.0% 
  House call [No.]  0.0 0.1 1.8% 0.0 0.2 3.6% 
  After-hours telephone consultation [No.] 0.1 0.2 6.4% 0.1 0.4 8.4% 
 Diagnostic tests       
  Blood [No.]  0.4 0.7 28.4% 0.3 0.6 26.5% 
  Urine [No.]  0.3 0.8 14.7% 0.2 0.6 13.3% 
  X-rays [No.] 0.1 0.4 11.0% 0.2 0.5 16.9% 
  Other diagnostic tests [No.] 0.1 0.6 2.8% 0.0 0.3 1.2% 
 Psychologist in private practice [No. of sessions]  4.1 8.0 38.5% 2.6 5.3 28.9% 
 Social worker [No. of sessions]  1.6 3.6 23.9% 1.2 2.7 25.3% 
 Physical therapist [No. of sessions]  5.6 11.6 34.9% 6.7 12.8 41.0% 
 Other paramedical professionals [No. of  sessions] 0.3 1.4 4.6% 0.5 1.7 7.2% 
 Medications [per medication ] -- -- 78.9% * -- -- 62.7% 
Secondary Care       
 Regional Institute for Community Mental Health Care                              
(including Drug & Alcohol Abuse Centre) [No. of sessions] 
1.0 4.9 7.3% 0.6 2.4 7.2% 
Hospital-based psychiatrist [No. of sessions] 0.4 1.8 7.3% 0.1 0.9 2.4% 
Medical specialist [No. of consultations] 1.8 3.6 34.9% 3.0 4.8 39.8% 
Part-time psychiatric day program [No. of sessions]  0.1 0.5 3.7% 0.0 0.0 0.0% 
Hospitalization [No. of days]  0.2 0.8 7.3% 0.4 1.6 7.2% 
Professional home health care [per hour, all services]  0.5 4.0 1.8% 0.8 7.0 1.2% 
Professional family home assistance [per hour]  0.0 0.0 0.0% 0.0 0.0 0.0% 
Alpha help [per hour]  0.0 0.0 0.0% 0.0 0.0 0.0% 
Other sector       
 Occupational physician [No. of consultations] 4.5 4.8 74.3% 4.5 5.1 65.1% 
Patient/family       
 Alternative care [No. of  sessions]  1.5 † 3.9 20.2% 4.1 11.0 27.7% 
 Support group/self-help courses [No. of sessions] 0.4 2.0 5.5% 1.9 15.6 3.6% 
 Informal help [per hour]  40.2 69.3 100% 39.1 56.1 100% 
Productivity losses       
 Gross days of sick leave  120.4 101.0 100% 126.5 115.7 100% 
 Net days of sick leave 97.5 84.1 100% 98.5 93.1 100% 
* Medication utilization rate in MISS group significantly higher than UC (X2-test; p < 0.05). 
† Mean number of visits to an alternative care provider in MISS group significantly less than UC (t-test; p < 0.05). 
 
For the economic evaluation, sick leave data were available for 371 (86%) subjects, QALYs 
for 253 (58%), resource use from the computerized medical records for 332 (77%), and other 
resource use from telephone interviews and questionnaires for 364 (84%). Of the latter, 230 
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subjects had a complete set of data. GP diagnoses were available for 375 (87%) subjects. In 
total, there were 192 (44%) complete cases (MISS = 109; UC = 83) available for the CEA 
and cost offset analysis, and complete data from 184 (42%) subjects (MISS = 103; UC = 81) 
for the CUA. There were no relevant differences in the aforementioned baseline 
characteristics between the complete cases and incomplete cases. Furthermore, within the 
complete cases, no significant between-group differences were observed.  
 
Outcomes 
There were no statistically significant differences in gross and net sick leave days over a 12-
month follow-up between the MISS group and UC (Table 3). The mean gross difference was 
6.2 days (95% CI: -26.5; 36.0) and mean net difference, 1.0 (95% CI: -23.9; 26.4). No 
statistically significant between-group difference was observed in QALYs (MISS: mean = 
0.80, S.D. = 0.15; UC: mean = 0.78, S.D. = 0.17; mean difference: 0.02; 95% CI: -0.03; 
0.06).  
 
Resource use 
The mean volume of resource use and utilization rates per group over 12-months are 
presented in Table 3. Except for the difference in mean number of visits to alternative 
practitioners (MISS: mean = 1.5, S.D. = 3.9; UC: mean = 4.1, S.D. = 11.0; p < 0.05), there 
were no other statistically different findings in health care utilization. All subjects, regardless 
of group allocation, received help from family members or other informal sources outside the 
health care sector. Medication use and consultations with the occupational physician ranged 
from 63% to 79%, and utilization of psychosocially-geared services ranged from 0% to 39%.  
With the exception of medication use, there were no statistically significant between-group 
differences in utilization rates (p < 0.05). 
 
Table 4: Mean resource use costs per patient per group and mean cost differences (MISS 
versus UC), in Euros, over the 12-month follow-up.   
Resource use 
categories 
MISS                              
(N = 109) 
Usual Care             
(N = 83) 
Mean 
difference  
95% CI 
Mean S.D. Mean S.D Lower Upper 
Health care sector 1,301.54 1,623.28 1,101.34 1,188.34 200.20 -213.21 562.97 
Other sectors 96.26 102.35 95.58 110.55 0.67 -30.96 31.23 
Patient/family 421.92 627.09 540.67 732.60 -118.75 -302.27 73.74 
Total direct costs * 1,819.72 1,863.88 1,737.59 1,608.90 82.12 -422.63 579.94 
Productivity loss costs 
via FCM † 
19,603.07 12,335.96 19,264.86 14,262.41 338.21 -3,416.12 4,292.03 
Productivity loss costs 
via HCA † 
30,666.03 25,746.52 32,238.07 29,493.26 -1572.04 -9,604.33 6,110.00 
MISS training costs 120.46 -- -- -- 120.46 -- -- 
Total investment costs ‡ 1,940.18 1,863.88 1,737.59 1,608.90 202.58 -289.63 710.61 
Total costs via FCM § 21,543.25 12,863.52 21,002.46 14,857.05 540.79 -3,195.71 4,838.93 
Total costs via HCA § 32,606.21 26,210.87 33,975.66 29,980.54 -1,369.45 -9,213.99 7,267.86 
*
 Total direct costs reflect the aggregation of the costs from the health care sector, other sectors and patient/family.  
†
 The inverse of the difference in productivity loss costs reflect the monetary equivalent in terms of productivity gains of MISS 
compared to UC from a societal perspective. 
‡
 The total investment costs from a societal perspective is the sum of total direct costs and MISS training costs. 
§
 Total costs reflect the aggregation of the total direct costs, productivity loss costs (estimated either by the Friction Cost Method 
or Human Capital Approach) and MISS training costs. 
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Costs  
The mean costs and mean cost differences are presented in Table 4. Mean health care 
sector costs were higher for the MISS group while the mean patient/family costs were higher 
in the UC group. Costs in the category, Other sectors, were similar. The mean costs for the 
aggregated cost categories, total direct and investment, were higher in the MISS group. The 
productivity loss costs, and associated total cost estimate, were higher in the MISS according 
to the FCM, but not the HCA. None of the cost differences were statistically significant.  
 
Cost-effectiveness analysis, cost-utility analysis and cost offset 
The difference in costs and effects as well as the incremental cost-effectiveness ratios 
(ICERs) and the distribution across the cost-effectiveness plane of the 2000 bootstrapped 
estimates for the main CEA and CUA are presented in Table 5. The bootstrapped cost-effect 
pairs, and acceptability curves from the CEA are shown in Figure 1 and Figure 2, 
respectively. The mean incremental cost of MISS compared to UC for a day less of sick 
leave was € 33 and the mean incremental costs per QALY was € 76,046. The maximum 
probability that MISS was cost-effective compared to UC was 0.6, reached at a ceiling ratio 
of € 30. CE-planes and acceptability curves for the CUA are not shown. The potential offset 
from an mean investment of € 203, ranged from a potential loss of € 135 to a savings of  € 
1369 (c.f. Table 4).  
 
Sensitivity analysis  
Findings of the sensitivity analysis were similar to the main analyses. Following multiple 
imputation, the mean between-group difference in gross sick leave days and costs were 
smaller, and the mean between-group difference in QALYs was larger. With respect to the 
CEA, a shift in cost-effects pairs from the quadrants I to quadrants II (more effective/less 
costly) was observed. For the CUA, a shift from quadrant IV (less effective/more costly) to II 
was noted (Table 5). For the same range of ceiling ratios, there was no relevant 
improvement in probability of cost-effectiveness. The potential offset in savings in 
productivity loss costs associated with the MISS intervention compared to UC from a 
company’s perspective are presented in Table 6. An investment of less than € 1 may result in 
an offset from € 142 to € 1571. 
 
Ancillary analysis 
The cost, effect and ICER subgroup findings are presented in Table 7. With respect to the 
SMD subgroup, those in the MISS group incurred significantly less gross and net sick leave 
days than UC. The mean gross difference was 74.0 days (95% CI: 14.7; 132.9). The 
direction of the mean differences in gross and net sick leave days, although not significant, 
was in favor of the UC group for Other MHP (mean gross difference =  22.0 days, 95% CI: -
36.5; 83.4), and the difference in the SP group was small (mean gross difference = 4.5 days, 
95% CI: -38.1; 49.6). There were no statistically significant between-group differences in 
QALYs for neither of the subgroups. The cost-effectiveness of MISS shifted toward quadrant 
I in the SMD group (Figure 1) and the mean ICER suggested that the extra costs for a day 
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Table 5: Cost differences, effect differences, and incremental cost-effectiveness ratios from the cost-effectiveness and cost-utility analyses from 
the complete case analysis for the total group and following multiple imputation for missing data.  
*
 Refers to the northeast quadrant of the CE-plane, which indicates that MISS is more effective and more costly than UC.  
†
 Refers to the southeast quadrant of the CE-plane, which indicates that MISS is more effective and less costly than UC. 
‡
 Refers to the southwest quadrant of the CE-plane, which indicates that MISS is less effective and less costly than UC. 
§
 Refers to the northwest quadrant of the CE-plane, which indicates that MISS is less effective and more costly than UC. 
 
 
 Sample size  Cost difference          
(95% CI) 
Effect difference       
(95% CI) 
ICER                        Distribution in CE-plane 
 MISS UC    I * II † III ‡  IV § 
Complete case analysis          
Gross sick leave days 109 83 202.58                                    
(-289.63; 710.61) 
6.17                             
(-26.49; 36.02) 
32.84                             48% 15% 5% 31% 
QALY 103 81 1208.93                                   
(-2,785.54; 5,404.51) 
0.02                            
(-0.03; 0.06) 
76,046.63                         55% 23% 4% 17% 
After multiple imputation          
Gross sick leave days 227 206 98.11                                      
(-445.98; 642.20) 
2.79                           
(-17.78; 23.35) 
35.19                           35% 26% 10% 29% 
QALY 227 206 416.52                                      
(-2,249.26; 3,082.30) 
0.02                           
(-0.01; 0.06) 
16,723.50                        55% 35% 2% 8% 
6
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Table 6: Potential cost offset from a company’s perspective of MISS compared to UC for the 
total group with respect to productivity gains reported in 2004 Euros  
Investment *                                                                             Productivity gains  Potential 
offset ‡ 
Relevant 
resources   
Mean difference    
(95% CI) 
Estimation method † Mean gains          
(95% CI) 
 
 
 
 
Occupational 
physician 
 
 
 
0.67                               
(-30.96; 31.23) 
Gross days of sick leave - 
HCA  
1572.04                             
(-6110.00; 9604.33) 
€ 1571.36 
Net days of sick leave - 
HCA 
260.14                                 
(-6942.79; 6271.14) 
€ 259.46 
Net days with median 
multiplier of 1.28  
332.97                                 
(-8397.14; 8468.76) 
€ 332.30 
Net days with an elasticity 
of 0.55 
143.08                               
(-3655.95; 3743.87) 
€ 142.40 
 
* Relevant resource investment costs from a company’s perspective in the Dutch context.  
†
 Methods of estimating productivity loss costs from a company’s perspective.  
‡
 Depending on the socioeconomic context, which may influence the relevant investment costs and the 
method chosen to estimate productivity loss costs, the actual offset will vary accordingly.  
 
 
less in gross sick leave was € 4. The probability that the MISS was cost-effective compared 
to UC approached 1 at a ceiling ratio of € 30 (Figure 2). 
With regards to the incremental costs per QALY, the cost-effect pairs of the SMD subgroup 
were largely found in quadrant II, indicating dominance of the MISS over UC. The potential 
cost offsets from both a societal and employer’s perspective may be considerable for the 
SMD group, ranging from € 6,832 to € 16,364 for the former and from € 6,982 to € 16,485 for 
the latter (Results not shown).  
 
Discussion 
Affected individuals, their families, the workplace, health care sector and society have much 
to gain by the development, identification and implementation of effective and efficient care 
for stress-related mental health problems. To supplement findings of a recently conducted 
pragmatic randomized controlled trial, this study investigated the efficiency of a new 
approach for GP management of persons with stress-related mental health problems, the 
minimal intervention strategy for workers with stress-related sick leave (MISS), compared to 
usual care. 
The first and second objectives were to determine the cost-effectiveness and cost-utility, 
respectively, of a MISS compared to usual care. There was no statistically significant 
evidence that the MISS intervention was more cost-effective in reducing sick leave than 
usual care nor in improving the quality-adjusted life years (QALYs) over a 12-month period. 
The ancillary analysis indicated that the MISS intervention may be cost-effective for the SMD 
subgroup for a day of sick leave, and that the MISS is dominant when the incremental costs 
per QALY are considered. The opposite was observed for Other MHP and SP. These 
observations are in line with the results found in the effectiveness study and underscore the 
fact that not all (pre-clinical/mild) stress-related mental health problems seen in the primary 
care setting are the same nor can they be treated in a similar fashion. 
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Table 7: Cost differences, effect differences, and incremental cost-effectiveness ratios from the cost-effectiveness and cost-utility analyses from 
the ancillary subgroup complete case analysis.  
 Sample size  Cost difference     
(95% CI) 
Effect difference       
(95% CI) 
ICER                        Distribution in CE-plane 
 MISS UC    I * II † III ‡  IV § 
Stress-related mental disorders (SMD)          
Gross sick leave days 57 26 297.64                                     
(-372.42; 1,002.80) 
74.00                  
(14.75; 132.85) 
4.02                                         77% 22% 0% 1% 
QALY 56 26 -6157.70                                 
(-12,261.08; 1,229.37) 
0.03                            
(-0.04; 0.09) 
-193,892.06                         1% 84% 15% 1% 
Other mental health problems (MHP)          
Gross sick leave days 28 25 664.17                     
(-300.39; 1,519.14) 
-21.98                        
(-83.37; 36.45) 
-30.22                                 19% 4% 3% 75% 
QALY 26 25 2015.75                                   
(-5,397.10; 100,006.85) 
0.01                             
(-0.08; 0.11) 
214,088.31                     39% 22% 7% 32% 
Somatic problems (SP)          
Gross sick leave days 24 30 -43.40                                      
(-780.81; 812.15) 
-4.48                     
(-49.60; 38.07) 
9.68                                  18% 28% 21% 33% 
QALY 21 28 4,707.45                                  
(-3,681.04; 12,291.21) 
-0.03                           
(-0.13; 0.06) 
-135,885.50                         22% 4% 10% 64% 
 
*
 Refers to the northeast quadrant of the CE-plane, which indicates that MISS is more effective and more costly than UC.  
†
 Refers to the southeast quadrant of the CE-plane, which indicates that MISS is more effective and less costly than UC . 
‡
 Refers to the southwest quadrant of the CE-plane, which indicates that MISS is less effective and less costly than UC . 
§
 Refers to the northwest quadrant of the CE-plane, which indicates that MISS is less effective and more costly than UC . 
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The negative finding based on the total group, yet positive result for a pre-planned subgroup, 
may be attributable to the variability in the psychopathology of study population, reflective of 
the broad inclusion criteria. This suggests that a future clinical trial comparing MISS to UC 
should be conducted in which individuals with a stress-related mental disorder (SMD) are 
identified a priori, in order to confirm the current finding. A related challenge, however, is that 
primary care patients typically have an admixture of psychological and somatic symptoms. 
Current primary care diagnostic or dimensional systems to distinguish between patients with 
subacute psychopathology that is clearly related to stress (SMD) from those with an 
admixture of symptoms fall short. Thus, further efforts to improve GP’s diagnostic abilities are 
needed. 
The third objective was to investigate the cost offset of the MISS compared to UC in terms of 
productivity gains. The range of findings from both a societal and company’s perspective is 
reflective of the different assumptions underlying the methods used to estimate the monetary 
equivalent of productivity changes. The cost offset was also evaluated from a company’s 
perspective as the results based on a societal perspective may not be meaningful [35-37]. 
Furthermore, companies are key stakeholders in preventing work disability, and decision 
makers within them can have direct influence on workplace factors that affect health-related 
productivity [38]. With respect to the FCM and HCA to value productivity changes from a 
societal perspective, the fact that the offset becomes negative when the number of sick leave 
days are capped as in the FCM, is indicative of slightly more outliers in the UC group, which 
have been “adjusted” by the capping process. It should also be noted that the potential offset 
of any intervention compared to another may be affected by how the friction period is 
defined, as the duration of the friction period is a dynamic entity, dependent on a given 
country’s unemployment rate.  
Methods of estimating productivity loss costs notwithstanding, an investment in MISS may be 
associated with a positive cost offset in terms of productivity gains from a company’s 
perspective. The actual cost offset for a given company will depend on the socioeconomic 
context of the company as the context will dictate the relevant investment costs and which 
assumptions underlying the methods of valuing productivity changes best approach the 
reality of company. Given that the trend is toward knowledge-based industries, in which work 
is more often team-based and cognitive in nature, the estimation derived with the inclusion of 
the median wage multiplier may be the most accurate.  
To the authors’ current knowledge, this is the first economic evaluation to compare two 
different approaches by GPs in managing persons with mild stress-related mental health 
problems. Recently, Brouwers et al. [39] reported on the cost-effectiveness and cost-benefit 
of an activating intervention by social workers compared to usual care by GPs in persons in a 
similar group of primary care patients. The results indicated that the intervention by social 
workers was not more cost-effective than usual care by GPs. There were no significant 
differences in neither medical consumption nor sick leave duration. Mynors-Wallis et al.[40] 
found that health care costs associated with a problem-solving treatment for emotional 
disorders given by community nurses was offset by savings in the cost of sick leave 
compared to usual care by GPs, with a caveat that such benefit is dependent, again, on the 
selection of appropriate patients. In a 3-arm pragmatic randomized control trial comparing 
generic care or problem-solving treatment by community nurses and usual GP care for adults 
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with anxiety, depression or reaction to life difficulties, Kendrick et al. [41] found that neither 
nursing care was more cost-effective than usual care by GPs.  
Finally, there are two methodological limitations to be addressed. First, the small(er) sample 
size of complete cases decreases the power to detect relevant differences with regards to 
skewed cost data [42]. As there were no significant differences between baseline 
characteristics or symptom severity scores between drop-outs and completers, it is not 
expected that the cost-effectiveness of MISS compared to UC would be different for drop-
outs. Moreover, the findings of the sensitivity analysis with imputed data indicated that the 
results of the main analyses were fairly robust. Second, work-presenteeism was not included 
in assessing the functional recovery of workers [3,7,43]. Before and following periods of sick 
leave, the work performance/productivity of individuals with stress-related mental health 
problems may be suboptimal [44,45]. Thus, there may be an underestimation of productivity 
loss, and conversely, an incomplete picture of functional recovery.  
 
Conclusion 
While the minimal intervention strategy for workers with stress-related sick leave (MISS) was 
not associated with a superior clinical or economic impact than usual GP care for a 
heterogeneous population with stress-related mental health problems, it may be a promising 
intervention for the subgroup, stress-related mental disorders. Future research should aim to 
confirm this observation.  
Also, the ability to work is an important functional outcome for adults of working age whose 
productive capacity is (temporarily) impaired for health-related reasons. Further attention to 
how changes in health-related productivity are conceptualized, measured and valued is 
needed in order to improve the meaningfulness of future economic evaluations. 
 
 
 
Figure legends  
 
Figure 1:  
Cost-effectiveness planes representing the uncertainty around the incremental cost-effectiveness ratio 
for the mean difference in total investment costs divided by the mean difference in gross sick leave 
days for the total group and subgroups.  
 
Figure 2: 
Cost-effectiveness acceptability curves showing the probability that the MISS is cost-effective 
compared to UC in terms of incremental investment costs and gross sick leave days for the total group 
and subgroups. 
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Abstract 
Background Mental health problems are a major medical and societal burden, associated 
with reduced quality of life, dysfunctioning and high costs due to sick leave. The worldwide 
reported prevalence of mental health problems in the working population ranges from 10 –18 
%, and in up to 90% of the disability benefits paid because of mental health problems, the 
initial context or cause is stress- related. We developed a generic Minimal Intervention 
teaching package to help GPs in the management of Stress-related mental disorders with 
Sick leave (MISS). The aims of the MISS are to reduce the number of days of sick leave and 
to prevent chronicity of symptoms in patients with relevant dimensions of psychopathology in 
which the initial context or cause is clearly related to stress. These aims can be achieved by 
the assignment of a correct diagnosis, providing information and advice, monitoring the 
symptoms and –when necessary- referral to more extensive care. We conducted this study 
alongside a randomised controlled trail assessing the effectiveness in general practice. The 
aim of the present study was to evaluate the potential differences between the MISS and 
usual care (UC) in application of treatment-components.  
Method 46 GPs joined the study. Twenty-four GPs were randomly assigned to the MISS 
group, 23 of whom completed the 11-hour MISS training. Information on application of the 
treatment components was derived from questionnaires filled in by both the GP and patients, 
and from the electronic medical record of the patient.    
Results A psychological diagnosis was more frequently diagnosed by the GPs in the MISS 
group than by the GPs in the UC group (78.1% versus 67.4%, p=0.020). Furthermore, the 
GPs in the MISS group more often used a mental health questionnaire (the 4DSQ) (16.1% 
vs. 1.3%, p=0.000), handed out information leaflets (28.3% vs. 10.8%, p=0.001) and knew 
how the patients were doing two months after baseline (76.4% vs. 65.7%, p=0.041). The 
treatment components advice and referral did not show significant differences between MISS 
and UC.   
Conclusion GPs can be trained to apply the MISS intervention on patients with SMDs on 
sick leave, and also are able to apply the necessary skills for successful treatment in daily 
practice. 
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Background 
Mental health problems are a major medical and societal burden, associated with reduced 
quality of life, dysfunctioning and high costs due to sick leave 1-4. The worldwide reported 
prevalence of mental health problems in the working population ranges from 10 –18 % 5;6 
and in up to 90% of the disability benefits paid because of mental health problems, the initial 
context or cause is stress- related 1-3;7. A wide range of symptoms is present, accompanied 
by a significant amount of psychological distress8. These stress states are often sub-acute, 
but not yet chronic, and are referred to as adjustment disorder (DSM-IV)9;10, neurasthenia 
(ICD-10)11 or ‘nervous breakdown’. Since there is a lack of generally accepted criteria for this 
highly prevalent condition, we refer to it here as Stress-related Mental Disorder (SMD). 
Subsequent to SMDs, persistent distress contributes to more severe psychopathology and 
chronic conditions, such as depression and anxiety disorders12.  
GPs are usually the first, and in many cases the only health professionals who are involved 
in the management of mental health problems13. There are general practice guidelines 
available for the treatment of depression14 and anxiety15, but these do not cover stress as a 
separate aspect of the problem or consider functional recovery as an effect-generator for 
well-being. The care that is provided for SMD patients on sick leave is very heterogeneous 
and sub-optimal16. We therefore developed a generic Minimal Intervention teaching package 
to help GPs in the management of  Stress-related mental disorders with Sick leave (MISS) 
and conducted an RCT to assess the effectiveness of the MISS in general practice. The 
focus was on a reduction in days of sick leave and SMD symptoms. The patients were 
screened by the research team for elevated levels of distress and sick leave, and the GPs 
were trained, but not obliged to make use of the training. Although the results showed no 
overall effects at patient level, our expectation that the patients in the MISS group would 
return to work more quickly than patients in the UC group was confirmed in ancillary 
analyses on the sub-group of patients in which the GP had actually diagnosed SMD 
(HR1.72, p=0.005).  
Subsequently, we wanted to find out if there were differences between MISS and Usual Care 
(UC) in application of treatment-components.   
 
Methods 
The present study is a cluster-randomised controlled effectiveness trial in which GPs were 
randomised to an intervention group, which was trained to deliver a minimal intervention for 
stress-related mental disorders, or to a control group that delivered care as usual. Distressed 
patients on sick leave visiting the practices of both GP groups were screened, included and 
followed-up for 1 year. The Medical Ethics Committee of the VU University Medical Centre 
approved the study protocol and procedures. 
 
Objective 
The aim of this study was to assess the performance of the GPs on the MISS- treatment 
components.  
We hypothesised that the GPs in the intervention group could be trained to diagnose a 
psychosocial diagnosis, and would apply the learned skills on information, advice, monitoring 
and referral in daily practice. The performance of the UC group is considered to be the 
standard of current practice on the different components. Differences between MISS and UC 
are considered to be an effect of our training. 
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GPs: randomisation and training sessions  
The GPs were randomised to the MISS intervention group or to a control group providing 
usual care. In order for the MISS to be helpful in routine general practice consultations, the 
necessary set of skills was clearly defined and taught to the GPs in a short training course. 
Case-management principles17;18 were used in the design of the intervention. Over a period 
of 6-10 weeks, the MISS training comprised two sessions of 3.5 hours and 2 regular follow-
up sessions of 2 hours (total 11 hours). The tutors during the training were the GP who 
developed the intervention (BT), and an occupational physician. During the training, the GPs 
were instructed to use specific methods of communication to help the patient, within 3 
consultations on a time-contingent course, to achieve functional recovery. The MISS takes 
into account the time-constraints under which a GP works, as well as the position of a GP as 
a generalist who does not have the capacity to apply highly specialized interventions.  
Firstly, the GPs were taught to diagnose an SMD, preferably during the first consultation. 
They were taught how to use the Four-Dimensional Symptom Questionnaire (4DSQ)19, a 
multidimensional psychopathological indicator to quantify the levels of distress, and to detect 
symptoms of depression, anxiety and somatization. They were then taught how to use the 
information leaflet, the purpose of which is to help the GPs in promoting the patient’s 
understanding and to emphasize the importance of the patient’s active role with regard to 
successful return to work. Subsequently, they practised giving advice on the content of 
functional rehabilitation. The GPs were taught how to underline the importance of a balance 
between resting and addressing the problems that caused the SMD and sick leave, and to 
recommend the patient to contact the occupational physician. Furthermore, the GPs were 
invited to suggest a home assignment (i.e. writing, brooding), in order to assist the patient to 
formulate the problems. For the second consultation, after one week, the GPs were taught 
active monitoring  to evaluate whether the patient had made efforts to translate the 
(work)situation into a problem that could be solved. If helpful, further advice was given. For 
the last consultation, after four weeks, the GPs were taught to monitor whether the patient 
had begin to focus on problems and solutions, instead of on complaints. If not, the GPs were 
instructed to consider referral to more specialised care because no progress had been made, 
and the patient was not likely to benefit from more time off work.  
Throughout the training, the skills needed for successful treatment were accentuated, and 
information was given about the content of relevant work-related polices and regulations. The 
GPs own experiences were discussed and evaluated, and they provided case-histories in 
order to practise the different parts of the intervention during the training. The GPs in the UC 
group received no information or advices about the content of the intervention beforehand, 
but were offered the training at the end of the trial.  
 
Patients: screening and recruitment  
After assigning the GPs, and after 7 hours of training had been completed, the research 
team started screening the patients. This was done to prevent selection bias, since 
recognition of SMD and other mental health problems by the GPs could be influenced by 
education in the MISS intervention group. Furthermore, overlap and co-morbidity of SMDs 
with other common mental disorders was likely to occur in some patients, and these patients 
may also benefit from the MISS. SMD was defined as elevated levels of self- reported 
distress, in combination with sick leave. Patients received a screening questionnaire if they 
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were 20-60 years old and had visited their GP during the previous one or two weeks, 
according to the electronic medical records (EMR). Only those indicated by the GP as having 
a very severe psychiatric disorder (mania or psychosis), terminal illness or inadequate 
command of the Dutch language did not receive a screening questionnaire. Patients were 
asked only to return the questionnaire if they met the following criteria: 1) a moderately 
elevated level of distress, according to the 4DSQ and 2) on sick leave from their paid job for 
no longer than three months20. Final recruitment took place in a telephone survey, after the 
patient had received the relevant information and had given oral informed consent. The 
patients and interviewers were unaware that two different interventions were being studied.  
Actual treatment decisions concerning the patients were left to the professional discretion of 
the GPs, who were informed  about a patient’s participation after two months. Follow-up of 
patients, by means of telephone and postal questionnaires took place up to and including 1 
year after baseline. The Medical Ethics Committee of the VU University Medical Centre 
approved the protocol of the study and the procedures. 
 
Outcome measures  
The treatment-components were assessed by analysing reports from the patients and the 
GPs, and data on the patient’s EMR. Only data on patients who, subsequent to oral, had 
given written informed consent were considered. Two months after inclusion, the GPs filled in 
a questionnaire, partly based on information from the EMR. Because we did not want to 
reveal specific MISS components to the GPs in the UC group, there were items we did not 
ask about directly. Therefore, two months after the baseline measurement, the patients were 
asked about those components of the MISS. At the end of the follow- up we collected 
information from the EMRs. 
To analyse the diagnoses, data from the GPs were divided into three sub-groups: SMDs, 
other mental health problems, and somatic diagnosis. Use of the 4DSQ was assessed by 
studying the notes in the EMR, that were collected at the end of the follow-up. The patients 
were asked whether the GP had handed out information leaflets. For the specific advice 
directed at functioning, we also analysed data reported by the patients. For monitoring, which 
was difficult to measure without directly asking the GPs, we analysed reports from the GPs 
and the patients and the information from the EMR. The number of visits to the GP from the 
first day of sick leave until three months after sick leave (a time span in which the MISS, if 
considered, should at least have been applied) was also extracted from the EMRs. Finally, 
referral was measured by means of the information given by the GP on the questionnaire 
after two months.  
Statistical analysis 
All analyses were conducted according to the intention-to-treat principle. For dichotomous or 
categorical data, proportions were calculated and tested with Chi-square. For numerical data, 
means were calculated and tested. The differences between MISS and UC were expressed 
as p-values. First, we assessed whether GPs in the MISS group were more successful than 
GPs in the UC group in the identification of SMDs and other mental health problems. 
Second, we evaluated the application of MISS treatment-components and the resulting 
difference the MISS group and the UC group. Third, outcomes were analysed at sub-group 
level, since modification of treatment effects was likely to occur when a GP actually 
diagnosed SMD. All analyses were performed with SPSS 12.0.  
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Results  
Of the 139 GPs who were invited by mail, 46 were able and willing to participate. Twenty-four 
GPs were randomised to the MISS group, 23 of whom completed the training. Table 1 shows 
that characteristics of GPs and patients were largely similar. Data on the application of 
treatment-components, reported by the GPs, were available for 201 patients (88.5%) in the 
MISS group and 172 patients (83.5%) in the UC group. Missing data were due to the fact that 
patients had not given written informed consent. Information from the EMRs was available for 
180 patients (79.3%) in the MISS group and 153 patients (74.3%) in the UC group. Again 
only data on patients who had given written informed consent were analysed and some 
patients were lost to follow-up on their EMRs. Self-reported data was available from 119 
patients (52.4%) in the MISS group and 99 patients (48.1%) in the UC group. A number of 
patients (MISS n=63, 31.0% and UC n=52, 30.4%) indicated that they had not visit their GP 
during the previous 2,5 months, so questions about providing advice could not be answered 
by these patients. Some other patients (MISS n=45, 16.6% and UC n=55, 21.5%) were lost 
to follow-up on the self-reported patient data.  
 
Table 1 Baseline characteristics  
 
The GP performances on all treatment-components are presented in Table 2. Both SMDs 
and other mental health problems were more often diagnosed by the GPs in the MISS group 
than by GPs in the UC group, with a total of 78.1% versus 67.4% (p=0.020). The GPs in the 
MISS group also more frequently used the 4DSQ to make a diagnosis (16.1% vs. 1.3% in 
UC group, p 0.000), particularly in the subgroup SMDs (MISS 25.6% and UC 3.6%, 
p=0.001).  
According to the patients, information leaflets were handed out by the GPs to 28.3% of the 
patients in the MISS group and 10.8% of the patients in the UC group (p=0.001), again 
particularly in the subgroup of SMDs (MISS 41.1% and UC 5.4%, p=0.000). With regard to 
giving advice, GPs in both the MISS and the UC group GPs often discussed the work 
situation with their patients (74.0% and 74.8%, p=0.865). But giving other advice, on the 
content of work (MISS 41.7% vs. UC 36.9, p=0.865) or with regard to contacting the 
occupational physician (MISS 48.8% vs. UC 46.4%, p=0.421), was less common practice. 
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General Practitioners  
 
MISS (n=24) 
 
UC (n=22) 
Age mean (SD) 43.3 (7.4) 44.8 (7.1) 
Women N (%) 12 (50.0%) 11 (50.0%) 
Years of practice mean  (SD) 16.5 (7.2) 18.3 (6.5) 
   
Patients  MISS (N=227) Usual Care (N=206) 
   
Women N (%) 153 (67) 134 (65) 
Mean age (SD) 41.97 (8.8) 39.50 (9.6) 
Married or cohabiting N (%) 174 (78) 148 (72) 
Level of education N (% )   
 Low 59 (27) 46 (22) 
 Intermediate 94 (42) 102 (50) 
 High 70 (31) 57 (28) 
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With regard to the content of monitoring, the GPs in the MISS group indicated that they more 
often knew how the patient was doing two months after baseline (MISS 76.4% vs.  
UC 65.7%, p=0.041), but not particularly in the subgroup of SMDs. No differences were 
found between the two groups with regard to the number of visits (MISS 2.55 vs. UC 2.50, 
p=0.839), the number of home assignments (MISS 26.2% vs. UC 27.0%, p=0.884), and the 
number of invitations of GPs for return visits (MISS 11.7% vs. UC 9.2%, p=0.468). Finally, 
there was no significant difference in the rate of referral to more extensive mental health care 
between the two groups (MISS 43.4% vs. UC 37.1%, p=0.160). However, referral was more 
frequent in the MISS group in the case of SMDs (MISS 59.6% and UC 43.8%, p=0.053), 
while there was a trend for referral in the UC group for other mental health problems (MISS 
50.0% and UC 62.0%, 0.198).     
 
Discussion 
Our findings confirm that GPs can be trained to apply the MISS successfully, and that they 
are also able to apply at least some of the crucial skills in daily practice. Both SMDs and 
other mental health problems were more frequently diagnosed by the GPs in the MISS group 
than by the GPs in the UC group. GPs in the MISS group more often used the 4DSQ, and 
handed out information leaflets, particularly in the case of SMDs. They also more often knew 
how patients were doing two months after baseline, compared with GPs in the UC group. 
Finally, in the case of SMDs there was a trend for more frequent referral in the MISS group 
than in the UC group.  
Teaching a GP to diagnose an SMD seems to be crucial for the effectiveness of the MISS 
training. The GPs in the MISS group more often quantified the level of distress, depression 
and anxiety with the 4DSQ. Differentiating between distress, on the one hand, and 
depression and anxiety on the other hand, probably brought about better understanding of 
the nature of these symptoms. Subsequently, it appears that knowledge of specific methods 
of communication was retained; MISS-trained GPs had a better grip on the course of SMD 
symptoms, and their actions were more efficient. This is important, because the management 
of SMDs is in some ways different from the management that is commonly applied to mental 
health problems (e.g. guidelines for the treatment of depression21 and anxiety22). For 
example, it is important that GPs are aware that a wait-and-see policy can be of help in the 
treatment of depression23;24,  while this can have reverse consequences in the treatment of 
SMDs because the problems that lead to dysfunctioning (e.g. sick leave) need to be 
challenged, and resting only may provoke long-term sick leave and total withdrawal from 
employment25. Close monitoring was found to be effective in a collaborative care model26, 
and may also be one of the key elements of the effectiveness of the MISS. Case-
management might be one way in which to improve care27, but more is needed if an 
intervention is to achieve change. It must be clearly defined, tailored to a specific setting and 
target groups, and the GPs must be trained. Finally, GPs must be able to explain the 
intervention clearly to patients, within the time-constraints of a relatively brief consultation28. 
All these aspects were addressed in the MISS.  
There are various factors and potential barriers that may affect the successful 
implementation of innovations in routine general practice29. Consistently, there is always a 
gap between best practice and actual clinical care30. The low application rates found for 
some components of the MISS are comparable with the results of earlier research31-35. GPs 
are, by definition, generalists who have to divide their limited time over multiple competing 
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demands. Interactive education, as applied in our study, including discussion of the evidence 
and feedback on performance, promotes awareness, familiarity and motivation for 
change36;37. In earlier research, GPs did not often discuss the patient’s working conditions 
(28.0%)38. In our study, advice was given frequently in both the MISS group and the UC 
group. This may indicate that the GPs who participated were aware of and familiar with 
psychological symptoms and sick leave among their patients. Furthermore, both the social 
and the political context also influence the achievement of changes in patient care39. They 
may also have played a role here, because there is growing awareness that SMDs can be 
treated successfully, and that long-term sick leave can be prevented if SMDs are diagnosed 
and treated in an early stage40.  
Evidence of the effects of brief psychosocial interventions applied by GPs is inconclusive. 
The results of some earlier studies are promising41-43, while others are negative44. On the 
other hand, a complex and extensive intervention for mental health problems (e.g. cognitive 
behavioural therapy for patients with chronic fatigue syndrome) showed a lack of efficacy45. 
More evidence is needed before definite conclusions can be drawn about psychosocial 
intervention applied by the GP.  
Some limitations of this study should be mentioned. In our pragmatic trial we allowed 
considerable variation in the treatment steps. Methodologically, some parts of the 
intervention were difficult to evaluate. Also, we did not structure observation of the 
application of MISS components during consulting hours (which for instance can be done by 
means of a standardised form, and video or audio-taping) because we gave priority to 
addressing the performances of the GPs and their application of the intervention in daily 
practice. Furthermore, in addition to the single self-reported GP measurement, we used the 
EMRs and patient questionnaires to analyse the data. Although these widely reflect the care 
provided, they were not designed to specifically test the application of treatment components. 
On the other hand, the use of different data-sources strengthens our findings with regard to 
the effectiveness of the MISS compared to UC, and we have no reason to suspect biased 
registrations.   
This study also has certain specific strengths, and many elements indicating quality46 were 
incorporated. We carried out a randomised controlled trial to test effectiveness of the MISS, 
and thereby allowed considerable variation in context, diagnosis and treatment. 
Consequently, the flattering of performances or the over-estimation of application is not likely 
to have occurred. Instead, this increased the relevance of our results because it reflects daily 
practice, and not ideal circumstances. Finally, we included a large number of GPs (MISS 24 
and UC 22) in our trial, so bias due to variation in performance of the GPs is not likely to 
have occurred. Moreover, the large number of patients made it possible to analyse at patient 
sub-group level.   
 
Implications for general practice  
We assume that the components that were found to be more effective than UC (diagnosis, 
use of 4DSQ, handing out information leaflets, monitoring, and more frequent referral in the 
case of SMD) are the effect generators of the positive results found at patient sub-group 
level. Clearly, however, there is room for improvement, since the new skills and knowledge 
gained from the MISS training were not applied to all patients with SMD, and patients with 
other mental health problems did not benefit from the MISS. However, the difference found 
between the sub-groups of diagnoses supports a generic approach, which initially aims at the 
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level of distress. Differentiating between distress (e.g. SMD), on the one hand, and 
depression and anxiety (e.g. other mental health problems) on the other hand, appears to be 
crucial for the effectiveness of the MISS compared to UC.  
The MISS can be taught to GPs in 11 hours of training, and has the potential to impact 
beneficially on large numbers of patients in routine practice, given the burden of mental 
health problems in general practice. To achieve this, in future more attention must be paid to 
the definition and diagnosis of an SMD, with the distress as a characteristic and return to 
work as a strategy for generating effect on well-being. Distress underlies more chronic and 
severe psychopathological states, such as major depression and anxiety disorder, but 
distress also represents a highly prevalent and relevant condition of SMD. This study 
supports the hypothesis that the management of this condition can be carried out within the 
time-constraints of a brief consultation. However, the necessary communication with patients 
differs from the techniques that are commonly applied for mental health problems. Therefore, 
training in the use of the MISS components is essential.   
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Table 2. GPs performances on treatment components. Values are N (%), unless stated otherwise 
  
 
 
Total Group 
   
 
1 
 
Diagnosis  Source 
Data available  
MISS 
 
UC 
 
p 
 
Subgroup stress-related mental 
disorders 
 
Subgroup other mental health 
problems 
 
Subgroup somatic diagnosis 
 Psychosocial diagnosis (SMD or other mental 
health problems) 
GP MISS n= 201 
UC n= 172 
 
157 
 (78.1) 
116 
 (67.4) 
0.020 MISS UC p MISS 
 
UC p MISS UC p 
 4DSQ use  
 
EMR   MISS n=180 
UC n=153 
29  
 (16.1)  
2 
 (1.3)  
0.000 20  
(25.6)  
2  
(3.6)   
0.001 7  
(13.5)   
0  
(0.0)  
0.016 1  
2.4)  
0 
 (0.0)  
0.272 
2 Information  
 
   
 
  
 
  
 
  
 
 Information leaflets received  Patient MISS n=119 
UC n=99  
36 
 (28.3)  
12 
 (10.8)  
0.001 23  
(41.1)   
2 
 (5.4)  
0.000 6  
(15.4)  
5  
(13.9)  
0.855 5  
(20.8)  
4  
(15.4)  
0.616 
3 Advice 
 
   
 
  
 
  
 
  
 
 Work situation discussed  Patient MISS n=119 
UC n=99 
 
94 
 (74.0)  
83 
 (74.8)  
0.865 46 
 (82.1)  
30 
 (81.1)   
0.897 29 
 (74.4) 
31 
 (86.1) 
0.204 14 
(58.3) 
15 
 (57.7)  
0.963 
 Advice given on the content of work  Patient MISS n=119 
UC n=99 
 
53 
 (41.7)  
41 
 (36.9) 
0.421 29 
 (51.8)  
14 
 (37.8)  
0.187 14 
 (35.9) 
15 
 (41.7)  
0.608 8 
(33.3) 
7 
 (26.9) 
0.621 
 Contact with occupational physician discussed  
 
Patient MISS n=119 
UC n=99 
61 
 (48.4)  
51 
 (46.4) 
0.753 30 
 (53.6)  
20 
 (54.1)  
0.964 18 
 (46.2) 
16 
 (45.7) 
0.970 9 
(37.5) 
7 
 (26.9)  
0.423 
4 Monitoring 
 
   
 
  
 
  
 
  
 
 GP evaluation on the course of patient   
 
GP MISS n= 201 
UC n= 172 
150 (75.4) 111 (65.7) 0.041 71 (79.8) 48 (73.8) 0.386 56 (83.6) 37 (75.5) 0.281 23 
(53.3) 
26 (47.3) 0.541 
 Number of visits from the day of sick leave + 3 
months Mean (SD) 
 
EMR MISS n=180 
UC n=153 
2.55 
 (2.12) 
2.50 
 (2.23) 
0.839 2.60 
 (1.92) 
2.34 
 (1.84) 
0.435 3.13 
(2.73) 
3.20 
(2.88) 
0.905 2.03 
(1.59) 
1.88 
(1.73) 
0.679 
 Home assignment given by the GP  Patient MISS n=119 
UC n=99 
 
33 
 (26.2)  
30 
 (27.0)  
0.884 17 
 (30.4) 
12 
 (32.4)  
0.833 10 
 (25.6) 
7 
 (19.4)  
0.522 5 
(20.8) 
8 
 (30.8) 
0.424 
 Invitation for return-visit EMR MISS n=180 
UC n=153 
21 
 (11.7)  
14 
 (9.2) 
0.468 15 
 (19.2)  
5 
 (8.9) 
0.099 4 (7.7) 4 (10.0)  0.697 2 
 (4.9) 
5 
 (10.2) 
0.347 
5 Referral  
 
   
 
  
 
  
 
  
 
 Referral to more extensive mental health care  GP MISS n= 201 
UC n= 172 
86 
 (43.4) 
63 
 (37.1) 
0.160 53 
 (59.6) 
28 
 (43.8) 
0.053 33 
 (50.0) 
31 
 (62.0) 
0.198 0 
 (0.0) 
4 
 (7.1) 
0.074 
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Abstract 
Background The Primary Care Evaluation of Mental Disorders (PRIME-MD) can be seen as 
characteristic for the process of successive refinements of criteria and structured interview 
techniques for diagnosing psychiatric disorders in primary care. It is one of the most widely 
used instruments, but there is no evidence to support its test-retest reliability.  
Method With one- week intervals between interviews, a test-retest study of the PRIME-MD 
was conducted in a general practice population of one hundred distressed patients (20-60 
years old) who were on sick leave.  
Results Almost everyone (89%) received one or more diagnoses at both measurements, 
and there was fair total agreement (ĸ .27). The best agreement was found for more severe 
threshold disorders (major depressive disorder [ĸ .58], dysthymia [ĸ .57], and generalised 
anxiety disorder [ĸ .59]), while agreement for the sub-threshold disorders was not satisfactory 
(anxiety disorder not otherwise specified [NOS] [ĸ .30], minor depressive disorder [ĸ -.03], 
and somatoform disorder NOS [ĸ .11]).  
Conclusion The PRIME-MD is one of the few instruments in primary care that actually 
diagnoses specific mental disorders according to the DSM criteria. However, its test-retest 
reliability was not satisfactory for the sub-threshold disorders. Mental disorders, as seen in 
primary care, encompass important specific symptoms and clinical syndromes that vary in 
duration and severity over time, but they also encompass an admixture of somatic and 
psychological symptoms that do not match current diagnostic systems. This probably 
contributes to the failure to adequately classify sub-threshold disorders with the PRIME-MD. 
Diagnostic criteria in psychiatry need to be operationalised for use in primary care and 
require further evaluation. 
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Background 
The historically poor reliability of the diagnosis of mental disorders has been the basis for the 
development and successive refinements of diagnostic criteria1;2 and structured interview 
techniques3. In clinical practice, the availability of symptom-based criteria has been shown to 
increase diagnostic agreement4 and to facilitate communication among mental health 
professionals5. Furthermore, the classification of patients according to a symptom profile can 
support a prognosis and demonstrate changes in that profile over time. At the moment, the 
use of structured interviews for mental disorders is the standard in research settings2, 
because these procedures signify consistency6. However, shortcomings in the diagnostic 
criteria for to the categorisation of mental disorders in primary care are well known7-10. For 
instance, the dimensional symptom severity gradient should also be considered11.  
In primary care there are some obstacles that limit the willingness of general practitioners 
(GPs) to accept and implement extended structured interviews12-14. For instance, the 
symptoms must be clarified in a limited amount of time. Another problem is that many 
instruments fail to take into account the elusive and multidimensional nature of mental 
disorders, which is typical in primary care patients. To overcome these obstacles, and also to 
clear up uncertainty about which questions are suitable to assess the diagnostic criteria, the 
Primary Care Evaluation of Mental Disorders (PRIME-MD)15 was developed. The PRIME-MD 
was the first instrument for use in primary care to diagnose specific mental disorders, based 
on criteria from the diagnostic and statistical manual of mental disorders (DSM-III-R16 and 
DSM-IV17), and it is still one of the most widely used instruments in clinical research18. The 
PRIME-MD has proven to be feasible and effective in achieving higher rates of detection for 
the most common mental disorders in primary care19-21.  
However, the issue of its reliability continues to be of foremost importance22 and there is no 
evidence to support the test-retest reliability of the PRIME-MD. In the leading PRIME-MD 
1000 study, Spitzer et al. found modest inter-rater reliability between the PRIME-MD 
diagnoses made by GPs and those made by mental health professionals, and it was 
particularly difficult to achieve high agreement for sub-threshold disorders15. Consistency of 
measurement is a necessity, but is not sufficient proof of the accuracy of any test. Test-retest 
reliability indicates whether or not a test (e.g. the PRIME-MD) is able to produce the same 
result on two different occasions under similar conditions, with the assumption that the 
measured attribute (e.g. symptoms leading to a diagnosis) has remained unchanged23. The 
present study was conducted to determine the test-retest reliability of the PRIME-MD.   
 
Methods 
PRIME-MD 
The PRIME-MD is based on a two-stage system, in which the patient first completes a 26-
item self-administered patient questionnaire (PQ) that screens for the following five most 
common mental disorders in primary care: mood disorders, anxiety disorders, alcohol 
consumption, somatoform disorders, and eating disorders. The PQ serves as an initial 
symptom-screening, and the response categories are dichotomous (yes/ no). Positive 
answers on this questionnaire trigger the modules of a decision scheme15. In the Dutch 
version of the PRIME-MD24 16 possible diagnoses can be made, 8 of which are specific DSM 
Axis I threshold diagnoses: major depressive disorder, partial remission or recurrence of 
major depressive disorder, dysthymia, panic disorder, generalised anxiety disorder, bulimia 
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non-purging type, bulimia purging type, and multi-somatoform disorder. Five of the diagnoses 
are sub-threshold diagnoses: minor depressive disorder, anxiety disorder not otherwise 
specified (NOS), probable alcohol abuse or dependence, binge eating disorder, and 
somatoform disorder NOS.  Furthermore, there are 3 diagnosis of rule-out (R/O) disorders: 
R/O bipolar disorder, R/O depressive disorder and R/O anxiety disorder24. With regard to the 
rule-out disorders, we only studied R/O bipolar disorder, because our independent 
interviewers did not have accurate information to confirm R/O depressive or anxiety disorder 
due to physical disorder, medication or other drugs. The original version of the PRIME-MD 
was based on the DSM-III-R16; the Dutch PRIME-MD24 is based on the DSM-IV17.   
 
Patients 
The data were collected within the framework of a larger study25 for which the design, 
protocol and procedures were approved by the Medical Ethics Committee of the VU 
University Medical Centre. To estimate the reliability of the PRIME-MD, a consecutive 
sample of primary care patients (20-60 years of age) who consulted the participating GPs, 
and who had been confirmed by the by the research team as being on sick leave and being 
distressed, were included in the study. The screening questionnaire included 3 questions 
from the Four-Dimensional Symptom Questionnaire (4DSQ)26 distress scale and one 
question on sickness absenteeism (see Box 1). Only those patients who, according to the 
GP had a mania, psychosis or terminal illness, or had inadequate command of the Dutch 
language, did not receive a screening questionnaire.  
 
Box 1 Screening questionnaire 
 
Table 1 Baseline characteristics (N=100) 
 
Age 
 
 
Mean (SD) 
  
Range 
Male N=32 42.0 (9.1)  20-56 
Female N=68 39.7 (9.2)  21-58 
Total N=100 40.4 (9.2)  20-58 
 
Level of education Low Medium High 
Male 7 15 10 
Female 16 33 19 
Total 23 48 29 
 
Marital status Single/ divorced Married/ cohabiting 
Male 14 18 
Female  32 36 
Total 46 54 
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No 
 
Sometimes 
 
Regularly or often 
1. During the past week, did you suffer from worry? 0 1 2 
2. During the past week, did you suffer from listlessness?  0 1 2 
3. During the past week, did you feel tense? 0 1 2 
4. Total score 4 or higher?  
  Yes  No 
5. Do you currently have a paid job?  
 Yes  No 
6. Are you currently on sick leave for a period no longer than three 
months?  
 Yes  No 
The patients were asked only to return the questionnaire if they answered three times “yes” and were willing to participate in the study. 
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In the period from June to September 2004, 135 consecutive patients were included in the 
study. Data on these distressed patients, who were on sick leave, were collected by trained 
interviewers (n=7) in a computerised PRIME-MD telephone interview, with a retest interview 
after one week, if feasible by the same interviewer.  
Fourteen of the 135 patients who completed the first questionnaire dropped out of the study 
before the retest interview. Twenty-one of them were not available for a retest (due to holiday 
season we were unable to contact the patients in time). Thus, data on 100 patients could be 
included in the test-retest analyses. 
 
Analyses   
The prevalence rates for each diagnostic category and the percentage of agreement 
(number of patients in the same category both times, positive or negative) were calculated. 
We computed kappa, which summarises the total agreement between the two 
measurements beyond what could be expected by chance27. A kappa higher than .80 was 
considered as ‘very good’, higher than .60 as ‘good’, kappa’s between .41 and .60 were 
considered as ‘moderate’. A kappa between .21 and .40 was considered as ‘fair’, and scores 
kappa’s below .20 were considered as ‘poor’27. All analyses were performed in SPSS 12.0.  
 
Results  
The patient characteristics, which all had a normal distribution, are presented in Table 1. The 
mean age of the patients was 40.4 years (SD 9.2), and 68% were female. In 89 out of 100 
patients, the same interviewer performed both test and retest. The mean number of days 
between the two assessments was 7.13 (SD 1.46). 
 
Table 2. Prevalence and agreement between the two measurements for PQ screen (N=100) 
 
Table 2 presents the results of the PQ as a screener for identifying which modules should be 
administered. Many patients (77- 94%) were entered the mood, anxiety and somatoform 
modules. This resulted in kappa values ranging from fair to moderate (ĸ .32 - ĸ .47). The 
prevalence of patients entering the alcohol and eating module was lower (23-32%), and 
showed good agreement (κ .69 & ĸ .65). In all modules there was agreement of at least 84%. 
Table 3 shows the results of diagnoses based on the PRIME-MD. Almost everyone (89%) 
received one or more diagnoses in both assessments, (97% test and 90% retest). There was 
fair total agreement between the two measurements (ĸ .27).  
The diagnosis “any mood disorder” had high prevalence rates (84% and 72%), and 
agreement between the two assessments was moderate (ĸ .49). Within any mood disorder, 
major depressive disorder and dysthymia showed the highest total agreement (ĸ .58 and ĸ 
.57). Major depressive disorder was diagnosed most frequently; in 64% and 58% of the 
patients, and agreement was fair for partial remission or recurrence of major depressive  
disorder (ĸ .30) and R/O bipolar disorder (ĸ .39). For the diagnosis of minor depressive  
 
PRIME-MD 
MODULE 
 
Frequency 
T0            T1 
 
 
T0 + T1 
 
 
Raw agreement 
 
 
Kappa 
 
 
95% CI 
Mood 87 77 74 84 .47 .25 - .68 
Anxiety 94 85 83 87 .32 .05 - .59 
Alcohol 24 23 18 89 .69 .53 - .86 
Eating 32 31 24 85 .65 .49 - .81 
Somatoform  93 84 83 89 .47 .21 - .73 
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Table 3. Prevalence and agreement between the two measurements for diagnoses (N=100) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
¹ 95% Confidence Interval (CI)= Kappa (K) +/- 1.96 x Standard Error (SE)  
 
disorder no agreement was found (ĸ -.03); very few patients (2-5%) were diagnosed with this 
disorder, and none of them received this diagnosis at both test and retest. In 55 versus 42 
patients, “any anxiety disorder” was diagnosed with the PRIME-MD, and agreement was 
moderate (ĸ .51). Within any anxiety disorder, generalised anxiety disorder had the highest 
total agreement between the two measurements (ĸ .59), and was diagnosed twice in 18 
patients. Agreement for the less common panic disorder (2 vs. 5 patients, positive agreement 
on one) was fair (ĸ .27), and for the sub-threshold diagnosis anxiety disorder NOS, 
agreement was also fair (ĸ .30). Probable alcohol abuse or dependence also showed good 
total agreement (ĸ .65), and the diagnosis was not very common (5-10%). Good agreement 
(ĸ .74) and low prevalence (4%) was found for the diagnosis “any eating disorder”. None of 
the patients had Bulimia nervosa, ‘purging’ type, but 2 patients had the ‘non-purging type’ (ĸ 
1.0). Binge eating disorder was diagnosed in 2 patients, and there was agreement on one (ĸ 
.49). In 31 versus 29 patients “any somatoform disorder” was diagnosed, and there was 
positive agreement on 11 patients (ĸ .33). Multi-somatoform disorder was diagnosed most 
frequently, and positive agreement was found in 8 patients (ĸ .39). No agreement was found 
for sub-threshold somatoform disorder NOS (ĸ .11). 
  
Discussion  
Summary of main findings   
In this PRIME-MD test-retest reliability study, there was fair total agreement between the two 
measurements (ĸ .27). The best agreement was found for more severe threshold disorders 
(major depressive disorder [ĸ .58], dysthymia [ĸ .57], and generalised anxiety disorder [ĸ 
 Frequency  
Raw 
agreement 
 
 
Kappa 
 
 
95% CI¹ 
Disorder:   
T0 
 
T1 
 
T0 + T1 
Any psychiatric disorder 97 90 89 91 .27 -.05 - .60 
Any mood disorder 84 72 69 82 .49 .29 - .68 
Minor depressive disorder  2 5 0 93 -.03 -.06 - .00 
Major depressive disorder  64 58 51 80 .58 .42 - .74 
Partial remission or recurrence of major 
depressive disorder  
17 9 5 84 .30 .05 - .55 
Dysthymia 29 24 18 83 .57 .38 - .75 
R/O bipolar disorder  2 3 1 97 .39 -.17 - .94 
Any anxiety disorder 55 42 36 75 .51 .35 - .67 
Panic disorder  2 5 1 95 .27 -.18 - .71 
Anxiety disorder NOS 23 21 10 76 .30 .08 - .52 
Generalised anxiety disorder  32 20 18 84 .59 .42 - .76 
Probable alcohol abuse/ dependence 10 5 5 95 .64 .36 - .93 
Any eating disorder  4 4 3 98 .74 .39 - 1.00 
Bulimia nervosa, ‘purging’ type 0 0 0 100 - - 
Bulimia nervosa, ‘nonpurging’ type 2 2 2 100 1.00 1.00 - 1.00 
Binge eating disorder  2 2 1 98 .49 -0.12 - 1.00 
Any somatoform disorder 31 29 16 72 .33 -.14 - .53 
Multi-somatoform disorder  20 13 8 83 .39 .15 - .62 
Somatoform disorder NOS 11 16 3 79 .11 -.12 - .33  
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.59]), while agreement for the sub-threshold disorders was not satisfactory (anxiety disorder 
NOS [ĸ 0.30], minor depressive disorder [ĸ -.03], somatoform disorder NOS [ĸ .11]). Notably, 
in our primary care sample, threshold disorders were diagnosed more frequently than sub-
threshold disorders.     
 
Comparison with previous research  
As far as we know, this is the first study in which the test-retest reliability of the PRIME-MD 
has been assessed. Comparison of our results with results on the other aspect of reliability, 
i.e. inter-rater reliability, which was investigated in the leading publication on the PRIME-MD, 
was possible for 12 disorder categories. For 10 out of 12 comparative diagnoses the same 
level of agreement was found in our study and in the PRIME-MD 1000 study. Different 
agreement values were found for “any psychiatric disorder” (ĸ .27 in our study, and ĸ .71 in 
the PRIME-MD 1000 study) and “panic disorder” (ĸ .27 in our study, and ĸ .60 in the PRIME-
MD 1000 study). For most threshold disorders there was moderate or (close to) good 
agreement in both studies. This applies to major depressive disorder, dysthymia, generalised 
anxiety disorder and bulimia nervosa. As far as the sub-threshold disorders are concerned, 
only probable alcohol abuse or dependence showed good agreement in both studies; for 
sub-threshold anxiety disorder NOS and minor depressive disorder there was fair agreement 
in both studies. For binge eating disorder and somatoform disorder NOS, which were only 
analysed in our study, there was moderate and fair agreement.  
 
Methodological considerations  
Test-rest reliability is determined by many factors. For example, it is dependent on the 
context in which it was produced 2, the nature of the questions asked, and the conditions in 
which the interview was held. In our study, all the questions were structured and computer-
directed, on the basis of dichotomous answers, and almost all retests were performed by the 
same interviewer. The rationale for a one-week interval between test and retest in our study 
was the minimisation of patient changes that could contaminate the results; clinically 
important changes were not expected to occur within one week. However, test-retest 
reliability may be affected by the patient remembering and repeating earlier responses, or by 
a patient’s tendency to avoid repetitiveness, thereby offering new information. Furthermore, 
attenuation, e.g. the tendency of patients to report less symptomatology on successive 
interviews, may affect test-retest reliability. Our retest took place after one week, and all 
diagnoses were made less frequently in the retest (see Table 3).  
The prevalence, range and complexity of the disorders under study can also play a role in 
test-retest reliability. The PRIME-MD can be used for patients with suspected mental 
disorders15, such as our sample of patients. However, the difficulty here is that the estimate 
of the kappa statistic depends on the prevalence27, and in our sample of patients almost 
everyone (89%) received a psychiatric diagnosis, which may have resulted in an under-
estimation of the actual level of agreement. In contrast, the prevalence rate of any psychiatric 
disorder was much lower in the PRIME-MD 1000 study, e.g. 26% in a sample from the 
general population, and there was good inter-rater agreement for “any psychiatric disorder”.  
Because of our pre-selection, an immediate comparison of the results of the two samples 
must be interpreted with some caution. Clearly, in our sample at least some symptoms of 
distress were already present, so the group was possibly too homogeneous for distinguishing 
between diagnoses with the PRIME-MD. Yet, an important aspect of diagnostic criteria is 
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also to distinguish between homogeneous groups with respect to both prevention and 
treatment response28. Adequately differentiating patients with mild symptoms (e.g. sub-
threshold disorders) from those who will benefit from specialised treatment (e.g. threshold 
disorders) and those who do not need treatment (e.g. no disorder) is important, because 
there is a gradient in adverse consequences associated with the severity of symptoms29. 
Adequate differentiation may be feasible if there is a second confirmation after a few weeks, 
or a check on the severity of the symptoms.  
 
Generalisability of our findings into clinical practice   
In primary care, a wide clinical variation can be expected in the accuracy of diagnoses; e.g. 
many patients find it difficult to acknowledge mental symptoms, a substantial number of 
mental problems in primary care are self-limiting, and there is (somatic) co-morbidity. None 
of these topics are addressed explicitly in the PRIME-MD. Therefore, a structured telephone 
assessment, made by trained interviewers, cannot replace a face-to-face interview with a 
GP, who is likely to take several relevant factors into account that cannot be addressed in a 
structural interview such as the PRIME-MD. This may result in an underestimation of the 
actual level of agreement. Moreover, several factors that play a role in diagnosing mental 
disorders were not taken into consideration in our study, because the interviewers did not 
have the necessary information to assess them, among which the R/O depressive and 
anxiety disorders, which are actually a part of the PRIME-MD. Yet, it is not likely that this 
influenced our findings with regard to test-retest agreement. In conclusion, these factors 
should be taken into account, because of their implications for the generalisation of our 
findings to clinical practice. The reliability estimates we found are representative for research 
settings with trained interviewers, but should be applied with some caution in clinical practice.   
On the basis of the literature and previous experience, we expected more cases to be mild, 
and also that there would be more diagnosis of a sub-threshold disorder in our sample of 
distressed patients30-32. Yet, it appears that most of the selected patients had a threshold 
diagnosis on the PRIME-MD. The rates of co-morbidity also seem to be unlikely high. It is 
argued that the psychological distress that often occurs in primary care patients cannot be 
defined according to criteria-based diagnostic categories but rather in terms of dimensions 
and severity of symptoms33-35. In our study, every patient had at least some non-specific 
symptoms that may indicate the presence of a mental disorder, and this made it more difficult 
to distinguish between threshold, sub-threshold and non-cases. The PRIME-MD tends to 
diagnose most elevated levels of distress as threshold disorders, rather than sub-threshold 
disorders. This study provides support for considering the severity gradient of symptoms 
before assigning a diagnosis in primary care. 
 
Conclusion  
In this PRIME-MD test-retest reliability study, the best agreement was found for the more 
severe threshold disorders, while agreement for the sub-threshold disorders was not 
satisfactory. Based on the results of several studies, it can be concluded that the PRIME-MD 
has its value in the feasible and effective time-efficient diagnosis of threshold mental 
disorders for both clinical and research purposes. The ability of GPs to assess mental health 
problems varies widely, and this may improve substantially if they make more use of a 
diagnostic tool such as the PRIME-MD. The DSM criteria are widely accepted, and the 
PRIME-MD is one of the few instruments in primary care that actually diagnoses specific 
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mental disorders according to the DSM criteria. But then again, test-retest reliability of the 
PRIME-MD was not satisfactory for the sub-threshold disorders, and the PRIME MD is overly 
inclusive for threshold disorders. There clearly are some limitations in the current diagnostic 
process, and as was already stated by Wittchen, Üstün and Kessler36, the most appropriate 
way forward may be to recognize that standardised interviews are necessary, and to be 
sensitive to the fact that these interviews are not completely perfect. Mental disorders, as 
seen in primary care, encompass important specific symptoms and clinical syndromes that 
vary in duration and severity over time, but they also encompass an admixture of somatic 
and psychological symptoms that do not match current diagnostic systems. This probably 
contributes to the failure to adequately classify sub-threshold disorders with the PRIME-MD. 
Diagnostic criteria in psychiatry need to be operationalised for use in primary care and 
require further evaluation. Dimensional models can offer information that is additional to the 
categorical diagnosis, but there are still no widely accepted dimensional models and there is 
a clear need for their usefulness to be compared with that of accepted criteria for the 
diagnosis of mental disorders in primary care.  
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8 
General discussion 
  
In this chapter some important issues regarding the design and the results will be discussed. 
Our research provides us with some answers but creates even more questions. The effect of 
our minimal intervention for stress-related mental disorders at patient level was less than 
expected. Results showed no evidence that the MISS is superior to UC on the total group 
level. Subgroup analyses showed effectiveness and cost-effectiveness of MISS over UC on 
days of sick leave for the patients that actually were diagnosed by their GP as having a SMD. 
At the process level, there were improvements on diagnosing psychosocial complaints.  
In order to strengthen the body of evidence for (in)effectiveness of the MISS, some 
considerations covering the foregoing chapters will be discussed. First, the realization of our 
trial in the general practice setting and key methodological issues will be dealt with. Next, 
critical factors within the patient population under study, our intervention (the MISS) and the 
role of GPs will be considered briefly. Finally, the inferences of our research will be explored 
in terms of overall evidence, recommendations for further research and implications for 
general practice. 
 
Realization of our trial in the general practice setting 
At the start of our study, the perceived relevance on the subject of SMDs and the prevention 
of long term sick leave was high on the agenda of government policy and the Dutch College 
of GPs. Nevertheless, we paid ample attention to successful recruitment, because failure to 
recruit enough GPs and patients frequently threatens the progress of research projects in 
general practice1;2. Attention for our research project was drawn with the help of leading GPs 
within the network of the Department of General Practice of VU University Medical Center. 
Receiving the MISS-training was one of the appealing factors for participation in our trail, but 
some of the GPs indicated that they had a lack of time to take part in the training. We 
planned to recruit 40 GPs, a total of 46 wanted to participate. We wanted to minimize the 
research burden for the GP and thus decided to screen the patients ourselves. The GPs did 
not have to be alert during consultations; the patients were informed by mail. As a result of 
our screening procedure, the actual number of patients recruited exceeded the pre-planned 
number (433 vs. 415). We had simple inclusion procedures, and only recruited incident 
cases. In doing so, we aimed to select patients with SMDs on sick leave for no longer than 
three months. Beforehand, we thought overlap with depressive disorder and anxiety disorder 
would be some 25%. We choose this way of screening because 1) no other short and simple 
inclusion procedure, which is crucial for successful screening of patients, was available and 
2) we considered that primary care patients having a variability of psychopathology might 
also benefit from our intervention.   
 
Methodological issues    
In chapter 4-6, some strengths and limitations of our RCT were already discussed at length. 
In short, clear strengths of this study include the procedures for cluster randomization, in 
which primary care practitioners were randomized, rather than patients. This process 
ensures that only patients assigned to the intervention arm received the benefits of the 
intervention, and “contamination” between intervention and control groups was avoidable. 
Patients were kept unaware that two interventions were being compared, which also has the 
advantage of preventing selective withdrawal from the study3. This may bring about ethical 
concerns4, but we decided that the benefits outweighed the adverse consequences. The 
medical ethics committee of the VU University Medical Centre approved our design.  
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The main methodological comment on our study concerns the timing of the diagnosis and 
measurement of the target condition, SMDs, during the intervention instead of at baseline. 
One can argue that this approach may have been biased, and that the correct way to handle 
the issue of subgroups would be to assess the disorders in question in the baseline 
assessment, not in a follow-up assessment based on GP assessment that could be 
confounded by training in the MISS. Indeed, the proportion of patients described by the GP 
as having a psychosocial disorder is higher in the MISS group than in the control group. This 
can be seen as evidence that the MISS sensitised GPs to this diagnosis, making it invalid to 
compare patients with this diagnosis across the treatment and control groups. This is a key 
issue, because our secondary analysis shows that the MISS worked among the subgroup of 
patients diagnosed with SMD. 
Now we will explore our choices with regard to the subgroup analysis step by step. At 
baseline, we measured severity of complaints with the Four Dimensional Symptom 
Questionnaire (4DSQ5), and we used the Primary Care Evaluation of Mental Disorders 
(PRIME-MD6) because it is one of the few instruments in primary care that actually 
diagnoses specific mental disorders according to the DSM-IV criteria7. However, we tested 
the PRIME-MD’s reliability, and it was not satisfactory for the sub-threshold disorders (i.e. 
minor depression, anxiety nos). In our sample of patients, almost everyone (89%) received a 
psychiatric diagnosis with the PRIME-MD. The prevalence, range and complexity of the 
disorder under study probably played a role8. The latent distress, present in our group of 
patients, may have caused the failure in distinguishing between diagnoses at baseline with 
the PRIME-MD. So, unfortunately, as was expected with the PRIME-MD, we could not 
separate those patients with depressive disorder or anxiety disorder at baseline in a reliable 
way from those with relevant dimensions of psychopathology which are sub-acute, but not 
yet chronic, and clearly related to stress (e.g. SMDs). Furthermore, we choose to take the 
diagnoses from the Electronic Medical Record (EMR) of the GPs, because next to important 
specific symptoms and clinical syndromes (4DSQ, PRIME-MD) that vary in duration and 
severity over time, we also had to take into account that primary care patients typically have 
an admixture of somatic and psychological symptoms9;10. Since we failed in reliably 
determining subgroups of patients at baseline by using PRIME-MD scores, the pre-planned 
subgroups were determined by means of diagnoses stated by the GP, and corrected in the 
analyses for severity of complaints on the 4DSQ. To collect the data needed on diagnosis, 
two months after the baseline assessment the GPs in both groups were asked to fill in a 
structured questionnaire on the care provided and any diagnoses or working hypotheses in 
the past three months according to their electronic medical record (EMR). We had access to 
the EMR, so we could confirm that the diagnoses filled in by the GP was alike those stated in 
their EMR. Furthermore, the GPs did not know at once which patients entered our study. 
They were informed after a month. So a considerable amount of information on diagnoses or 
working hypotheses from the EMR was filled out before the GP even knew the patient was 
involved in our study. In no case we informed the GPs about the patient’s score levels on the 
4DSQ. However, the diagnosis of a SMD was the first out of five steps in the training, so in 
fact the intervention was likely to sensitise GPs to this diagnosis. And indeed, the proportion 
of patients described by the GPs as having psychosocial problems is higher in the 
intervention group. It seems logical to expect that this result is biased. It is likely that the 
SMD patients in the MISS group were significantly less severely affected than the SMD 
patients in the UC group. So, to make the subgroup comparison on diagnosis valid, we took 
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baseline levels in severity of complaints (distress, depression, anxiety and somatization) into 
account, thereby controlling for flaws due to more sensitive GPs from the MISS group. The 
SMD-patients in the MISS group actually turned out to have somewhat higher baseline levels 
of symptoms than the SMD-patients in the UC group. We conclude that our approach on the 
subgroup analysis was not biased. Nevertheless the findings must be interpreted with 
caution.  
 
The patients under study   
All patients who entered our study had at least some symptoms of stress-related mental 
disorder. According to the GP, a diagnosis of SMD was most frequent (MISS 45%, UC 39%), 
followed by other mental health problems (MISS 33%, UC 29%) and somatic problems 
(MISS 22%, UC 33%). The symptoms decreased significantly over time similarly in both 
groups, although severity still was considerable at the end of follow-up. A substantial part of 
the patients at the end of follow-up still scored above the threshold on symptoms of distress 
(MISS 44.9%, UC 39.6%), depression (MISS 24.0%, UC 28.8%), anxiety (MISS 13.8%, UC 
12.9%) and somatization (MISS 30.5%, UC 33.6%). The threshold was set at moderate 
elevation of scores. Therefore, scores above threshold did not necessarily indicate a 
depressive or anxiety disorder. Nevertheless, some patients may have had conditions that 
were of a more chronic nature and needed more extensive care. 
Early and reliable identification of patients at risk for poor outcome should be considered. In 
chapter 2, we brought up the importance of the concepts of coping and demoralization in the 
diagnosis and treatment of SMDs. It was argued that approach coping instead of avoidant 
coping was the way forward. We did measure problem focused coping and avoidant coping 
with the Ways of Coping Questionnaire11, but exploratory analyses showed only about 10% 
of the patients used either one of these styles. There were no differences in coping style 
between MISS and UC, either at baseline or at follow-up. Unfortunately, these two scales 
were the only coping styles measured. Furthermore, it was argued that demoralization is an 
important link between common mental disorders and sick leave, and may be viewed as a 
combination of distress and subjective incomp0etence, and is distinguishable from 
depression by the absence of anhedonia. However, studying the empirical framework, 
demoralization as a latent structure of symptoms12;13 or demoralization captured within the 
dimension of distress14, exceeded the scope of our trial. As a result, we cannot make 
definitive statements concerning some critical factors within patients, like coping and 
demoralization which play a role in the element of monitoring the patient.  
 
The intervention  
The intervention was developed on the base of three consultations for each patient with 
SMD. One may argue that our MISS lacked intensity to guarantee adequate assessment and 
treatment of symptoms of SMD. Results show that patients did not visit their GP exactly three 
times. The number of visits to GP consulting hours from the first day of sick leave up to three 
months was 2.55 for the total MISS group and 2.50 for the total UC group. Possibly the GPs 
may not have had the ability to apply what they learnt in the training program within less than 
three consultations. But then again, during the training sessions GPs were advised to 
subdivide their intervention in three consultations, but this was not taught as a necessary 
condition. Instead, if the diagnosis (of a SMD) was clear at first consultation and the patients 
already showed efforts to deal with problems and solutions, instead of solely focus on the 
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symptoms, the MISS was suggested to be done in 2 consultations. Moreover, the GP was 
advised, but not obliged, to use the MISS or ask the patients for a return visit. In a 
comparable study in occupational health care effectiveness of the intervention was proven. In 
that study, the OP had to plan four or five consults with a total length of at least 90 minutes15. 
One may be inclined to conclude that more intensive interventions are more effective16, but 
then the question of feasibility of a more intensive intervention in the time schedule of 
general practice raises.  
Next, a possible explanation for the lack of effect is that the contrast between MISS and UC 
was too minimal. The GPs who decided to participate might have been especially interested 
in the diagnosis and treatment of SMDs, although it is a topic that every GP takes notice of in 
daily practice. The content of the control treatment was not standardised, since no guidelines 
were available, but we did have information about the application of MISS-treatment 
components by the GPs in the UC group, and we did have some information available from 
another study17 which evaluated the frequency and content of contact between workers who 
were sick-listed and their GP. In our study, a difference in favour of MISS was seen on 
several treatment components (diagnosis, information and monitoring). In the case of giving 
advice, both the MISS and UC GPs often discussed the work situation with the patient. 
Advice on the content of work were given to 41.7% (MISS) and 36.9% (UC) of the patients, 
and discussing contact with the OP was done according to 48.4% (MISS) and 46.6% (UC) of 
the patients. Anema et al17 report that sick-listed workers discussed working conditions with 
the GP less frequently (28.0%), and according to his study a work related intervention was 
never done by the GP. The numbers found in our study on giving advice on the content of 
work is high compared to those reported by Anema et al. It may have been the case that 
GPs involved in our study already had a high level of knowledge about the issue of sick leave 
and work conditions, influencing this. Unfortunately, we did not test this beforehand, so no 
definitive conclusions can be drawn.    
 
The role of general practitioners   
Dutch general practitioners provide high-quality care, mostly in accordance with national 
guidelines18. General practice acts as a gatekeeper; almost all contacts are handled solely by 
the general practitioner. Moreover, GPs usually have a personal relationship with their 
patients because the care provided is embedded in the health care system to serve one’s 
entire life. The medical responsibility of GPs is extensive, the many demands that are placed 
on them are intensive and their available time is limited and costly16. Many patients visit their 
GP because of problems that are psychological in origin, and at least some of these patients 
do not receive the help they need. It is often argued that the position of GPs in mental health 
care is one of being the observer and gatekeeper, with diagnosing and referral as their task. 
Complex interventions should accordingly not be the task of the already overloaded GP19. In 
most settings, GPs already cooperate with primary care psychologist and social workers, but 
this form of cooperation is not structural. The fact that policy makers decided to include 
treatment of primary care psychologist in basic health care insurance as from 2008 is 
promising. Furthermore, nurse practitioners may be able to deliver psychosocial interventions 
in primary care20. Nowadays, their tasks are mainly focussed on the care for chronic patients 
(e.g. diabetes, cardiovascular diseases). 
Both the GP and OP ought to play an important and complementary role in the process of 
returning a patient to the workplace and to prevent long-term sick leave or disability. It is said 
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that during treatment, the GP is mainly focused on diagnosis and treatment of the mental 
health problem, whereas the OPs are mainly focused on return to work and working 
conditions17;21. Giving advice is one of the elements of the MISS. Perhaps this step needs 
fine-tuning towards work and working conditions. Communication and co-operation between 
OPs and GPs may be fundamental for improvement of care for patients having symptoms of 
SMD. However, realization in practice is unsatisfactory. In the Netherlands, all parties 
involved are concerned about this sub-optimal situation, and try to improve it22. 
 
Overall evidence  
Very little evidence exists regarding the effects of training interventions for improving care of 
patients with stress-related mental health problems. We were the first to study such a 
particular intervention delivered by general practitioners, and the evidence base has to grow 
substantially before definitive conclusions can be drawn. The findings presented in this thesis 
are a first step and many of the issues discussed remain unclear. The results showed no 
evidence that the MISS was superior to UC on the total group level. However, subgroup 
analyses showed effectiveness and cost-effectiveness of MISS over UC, on days of sick 
leave for the patients that were actually diagnosed by their GP as having a SMD.  
In this thesis, we explored possible impeding and stimulating factors within the patients under 
study, the intervention and the role of the GP. On top of that, we can compare our results 
with those in two other studies in the field of SMDs and sick leave. One study carried out in 
an occupational health care setting is in conformity with the positive results found in our 
subgroup23. In that study, patients were beforehand selected as having an adjustment 
disorder. The applied intervention programme was based on the same principles as the 
MISS, but execution was more extensive. Another study in primary care, in which social 
workers were trained to apply an activating intervention while GPs provided UC for patients 
in the other group, did not show positive results24. In this study, patients were diagnosed as 
suffering from emotional distress or minor mental disorders according to GPs and self-report.  
The results found in our subgroup, in addition to those found by Van der Klink et al23, suggest 
that the MISS as an activating intervention is a promising approach for patients suffering 
from psychopathology which is sub-acute, not chronic and clearly related to stress (e.g. 
SMD, adjustment disorder, neurasthenia, nervous breakdown), but so far the MISS has not 
been demonstrated to prevent disability in patients with psychological problems convincingly. 
Differences between treatment groups regarding effectiveness on time to return to work were 
found, but not regarding symptom reduction. There is apparently little synchrony of change 
between symptoms and sick leave25. This suggests that the way forward may be a time-
contingent and symptom-independent scheme, e.g. a focus on functioning and return to work  
instead of complaints26. This focus on functioning is embedded in the MISS. The fourth step, 
monitoring if the patient has moved towards an orientation on solutions, reflects this. And 
also the next step in the MISS, referral, was to be considered when no progress was being 
made on a time- contingent base. So ideally, if necessary the MISS should lead to more 
extensive treatment. Further development of the MISS may take into account an 
improvement of the monitoring abilities for GPs, and also include a more thoroughly stepped 
care program. 
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Further research 
The research agenda on patients having SMDs with sick leave should include the evaluation 
of methods to define and assess disease and disability for both clinical and research 
applications27. Research should focus on more comprehensive nomenclature of 
psychological morbidity. Evidently, dimensions of distress, depression, anxiety and 
somatization are correlated. The role of distress in depression and anxiety versus distress as 
a distinct factor is a subject for debate on nomenclature. This is essential for defining patient 
subgroups in the primary care research setting. Variation in duration of symptoms, and 
symptom constructs based on a dimensional model must be acknowledged in 
operationalization of the diagnostic process. Additionally, in future research patients 
characteristics should be considered for fine-tuning the necessary elements of the MISS. 
Starting not only from well established diagnoses, but also from usual complaints and 
symptoms28;29. In other words, pathways to and from SMDs and sick leave should be 
examined. This can be done by a combined evaluation of factors involved within patients 
(severity of symptoms, coping, autonomy), and context-related factors (family, work, social 
network). Foremost, research on the fit for treatment of (core) dimensions of distress is 
crucial for the further development of elements within the MISS. Assuming the MISS could 
be the way out for preventing disability in patients with psychological problems implies fine-
tuning. Which element needs revision for which subgroup of patients has yet to be 
determined. Considering these needs, only studying effectiveness with a randomised 
controlled trial seems insufficient. Also qualitative research on the above mentioned factors 
involved in SMD symptoms and sick leave is recommended. 
 
Implications for general practice 
Implications of our study for daily general practice are not completely straightforward. Many 
factors outside the direct scope of the GP, e.g. work related factors, presumably play a major 
role in the recovery process and for some patients a more extensive treatment is needed. 
Combined effort and co-operation with other caregivers in the field, like the OP, primary care 
psychologist and social workers may seem of best interest for everyone involved. Yet, also 
for the other caregivers there still is much to gain by the further development, identification 
and implementation of effective care for patients on sick leave having SMDs.  
In case of SMD and the MISS, practice lies ahead of evidence base. Currently, government 
and company policy is aimed at an activating intervention for SMD. A common guideline for 
both GPs and OPs to manage work related mental health disorders was developed in 
200617, and this guideline contains elements of the MISS. Furthermore, the information 
leaflet used in the MISS training is integrated in the official medical information system of 
GPs. Our subgroup analysis supports all these developments, in case a GP diagnosed a 
SMD. In conclusion, these developments in practice certainly are positive and worth 
structural support by training and education, since they reflect a step forward in a field that 
not yet has, but clearly needs, more well defined and structured care.  
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1. Introduction  
As stated in chapter 1, this study is carried out because patients and their care-givers have 
much to gain by the development and implementation of effective care for patients on sick 
leave having stress-related mental disorders (SMDs). Most people having SMDs with sick 
leave consult their general practitioner (GP) at an early stage. Currently, few evidence-based 
therapies exist to help patients to cope and to prevent sick leave, and general practice lacks 
a guideline with a structured treatment plan. We developed a minimal intervention to help 
GPs diagnose and treat patients having SMDs with sick leave. 
 
2. Stress and coping in relation to common mental disorders and the MISS   
In chapter 2, we argue that the concept of stress-related disorders does not fit the existing 
diagnostic classification systems (such as the DSM-IV and the ICD-10), but may be most 
applicable when no formal psychiatric disorders are diagnosable. It may be viewed as an 
important dimension of mental disorders that cuts across all established diagnostic 
categories. In the Minimal Intervention for patients having SMDs with Sick leave (MISS), GPs 
focus on the first stage of the breakdown. After the ‘crisis’ a patient experiences, patients 
need to regain control and start coping again. Otherwise, the long-lasting sick leave could 
have severe consequences like loss of employment, social marginalisation and permanent 
disability. Through the use of relatively simple, empowering interventions such as education, 
support, advice and homework assignments, the intervention specifically aims at damming 
avoiding tendencies and at promoting an active approach of psychosocial problems.   
 
3. Design  
Chapter 3 provides a description of the setting and design of our MISS, and confirms 
compliance with the requirements for a cluster Randomised Controlled Trial (RCT). Our 
hypothesis was that the MISS is more effective compared to usual care (UC) in reducing 
days of sick leave of these patients. Randomisation was at the level of GPs, they received 
the MISS training versus no training, in order to compare the MISS vs. usual care at patient 
level. Enrolment of participants took place after screening the source population, which 
comprised 20-60 year old primary care attendees. Enrolment criteria were: moderately 
elevated distress levels, having a paid job and sick leave for no longer than three months. 
Primary outcome measure after one year follow-up was lasting full return to work. Reduction 
of SMD symptoms was one of the secondary outcome measures. Forty-six GPs and 433 
patients agreed to participate.   
 
4. Effectiveness of the MISS 
Chapter 4 presents the effects of our MISS versus UC. There was no evidence that the MISS 
was superior to UC within the total group on our primary outcome measure days of sick leave 
(HR 1.06, 95% CI 0.87 – 1.29). The median number of days on sick leave before return to 
work was substantial (MISS 96 days and UC 102 days). Subgroup analyses showed 
effectiveness of MISS over UC on days on sick leave for the subgroup, SMDs (HR 1.72, 95% 
CI 1.18- 2.51). The severity of symptoms reduced significantly in both groups during follow 
up. Nevertheless, a considerable amount of patients after 1 year still scored above threshold 
on the self-reported symptoms. Diagnosing SMD turned out to be less straightforward than 
we expected and the evidence-base on effectiveness of the MISS has to grow substantially 
before definitive conclusions can be drawn.  
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 5. Cost-effectiveness of the MISS 
Chapter 5 presents the cost -effectiveness of our MISS compared to UC. The economic 
evaluation was performed alongside our cluster RCT and conducted from both societal and 
company perspective with a follow up of one year. Outcomes were the number of sick leave 
days beginning from the first day of sick leave to 1-year thereafter, quality adjusted life years, 
resource use, investment costs and productivity loss costs.    
In total, 192 (44%) complete cases were available. There were no significant differences in 
outcomes or costs. The incremental costs per day less of gross sick leave was €33, and per 
quality adjusted life years €76,046. The potential cost offset ranged from a loss of € 135 to a 
savings of € 1369. Results of sensitivity analysis were similar to the main findings for the total 
group. With respect to the SMD subgroup, cost-effectiveness of MISS over UC was 
indicated. Those in the MISS group incurred significantly less gross and net sick leave days 
than UC (mean gross difference 74.0 days, 95% CI 14.7 – 132.9). While the MISS was not 
associated with a superior clinical or economic impact than usual GP care for a 
heterogeneous population with symptoms of SMD, it may be a promising intervention for the 
subgroup, patients diagnosed with SMD.  
 
6. Performance of the general practitioners  
The aim of chapter 6 was to evaluate the potential differences between the MISS and UC in 
application of treatment-components. Elements in the MISS were: assignment of a correct 
diagnosis, providing information and advice, monitoring the symptoms and, if necessary, 
referral to more extensive care. Twenty-four GPs were randomly assigned to the MISS-
group, 23 of whom completed the 11-hour MISS training. Information on application of the 
treatment components was derived from questionnaires filled in by both the GP and patients, 
and from the electronic medical record of the patient. Differences in favour of the MISS group 
were found for several elements of the MISS. A psychological diagnosis was more frequently 
diagnosed by the GPs in the MISS group than by the GPs in the UC group (78.1% versus 
67.4%, p=0.020). Furthermore, the GPs in the MISS group more often used a mental health 
questionnaire (the 4DSQ) (16.1% vs. 1.3%, p=0.000), handed out information leaflets (28.3% 
vs. 10.8%, p=0.001) and knew how the patients are doing two months after baseline (76.4% 
vs. 65.7%, p=0.041). The treatment components advice and referral did not show significant 
differences between MISS and UC. In conclusion, GPs can be trained to successfully apply 
at least some of the elements of the MISS intervention.    
   
7. Test- retest reliability of the PRIME-MD 
In chapter 7, test-retest study of the Primary Care Evaluation of Mental Disorders (PRIME 
MD) is described. The PRIME-MD is one of the few instruments in primary care that actually 
diagnoses specific mental disorders according to the DSM criteria. One-hundred distressed 
patients (20-60 years old) who were on sick leave were interviewed, with one-week interval. 
Almost everyone (89%) received one or more diagnoses at both measurements, and there 
was fair total agreement (ĸ .27). The best agreement was found for more severe threshold 
disorders (major depressive disorder [ĸ .58], dysthymia [ĸ .57], and generalised anxiety 
disorder [ĸ .59]), while agreement for the sub-threshold disorders was not satisfactory 
(anxiety disorder not otherwise specified [NOS] [ĸ .30], minor depressive disorder [ĸ -.03], 
and somatoform disorder NOS [ĸ .11]). Mental disorders, as seen in primary care, 
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encompass important specific symptoms and clinical syndromes that vary in duration and 
severity over time, but they also encompass an admixture of somatic and psychological 
symptoms that do not match current diagnostic systems. This probably contributes to the 
overly inclusiveness of threshold disorders and the failure to adequately classify sub-
threshold disorders with the PRIME-MD. In conclusion, diagnostic criteria in psychiatry need 
to be operationalised for use in primary care and require further evaluation. 
 
8. General discussion  
In chapter 8, some important issues and considerations covering the foregoing chapters 
were discussed. The findings presented in this thesis are a first step and many of the issues 
discussed remain unclear. The results showed no evidence that the MISS was superior to 
UC on the total group level. Subgroup analyses showed effectiveness and cost-effectiveness 
of MISS over UC on days of sick leave for the patients that actually were diagnosed by their 
GP as having a SMD. This suggest that the MISS as an activating intervention is a promising 
approach for patients suffering from psychopathology which are sub-acute, not chronic and 
clearly related to stress (e.g. SMD, adjustment disorder, neurasthenia, nervous breakdown), 
but so far the MISS is not the way out for preventing disability in patients with psychological 
problems. The research agenda on patients having (symptoms of) SMDs with sick leave 
should include the evaluation of methods to define and assess disease and disability, and 
patients characteristics should be evaluated for fine-tuning the necessary elements of the 
MISS. Considering these needs, only studying effectiveness with a randomised controlled 
trial may seem insufficient. Also qualitative research on the above mentioned factors involved 
in SMD symptoms and sick leave is recommended. Implications of our study for daily general 
practice are not completely straightforward, yet practice lies ahead of evidence base since 
some elements form the MISS already are implemented. And in conclusion, these 
developments in practice certainly are positive and worth structural support by training and 
education, since they reflect a step forward in a field that not yet has but clearly needs more 
well defined and structured care.  
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Introductie 
Huisartsen en hun patiënten kunnen veel baat kunnen hebben bij een effectieve behandeling 
voor surmenage (overspanning)I De meeste mensen die verzuimen van hun werk en 
overspannen zijn,  gaan langs op het spreekuur van hun huisarts. Toch is er nog geen 
richtlijn beschikbaar voor huisartsen om mensen te helpen omgaan met hun problemen en 
om het ziekteverzuim te reduceren (of te voorkomen). Bedrijfsartsen hebben al wel een 
begeleidingsmodel tot hun beschikkingII, en deze is aangepast voor de huisartspraktijk: de 
Minimale Interventie Strategie voor Surmenage (MISS).   
 
Surmenage en de MISS 
In hoofdstuk 2 wordt uitgebreid ingegaan op het ontstaan en de beloop van surmenage.  
In geval van surmenage gaat het om symptomen van distress als een dimensie van 
psychische klachten. Distress kan licht of ernstig disfunctioneren veroorzaken, bovendien 
loopt een patiënt het risico op verergering of chroniciteit van de klachten. In de diagnostiek 
bij overspanning is het van belang om een onderscheid te kunnen maken tussen 
psychiatrische stoornissen (de meest voorkomende zijn depressieve stoornis en 
angststoornis), en de aanwezigheid van psychische problemen in het algemeen (distress), 
zonder dat er sprake is van een formele psychiatrische stoornis. In de MISS-training wordt 
huisartsen geleerd om dit onderscheid te maken met behulp van de  Vierdimensionale 
Klachtenlijst (4DKL)III. Daarnaast wordt hen geleerd om alert te zijn op het eerste stadium 
van surmenage, de crisisfase. In deze fase hebben patiënten door hun behoefte aan rust de 
neiging om passief te blijven en de problemen op hun beloop te laten. Het is belangrijk dat 
patiënten inzien en accepteren dat het mis gegaan is, en weer grip proberen te krijgen op de 
situatie. Dit kunnen ze doen door te focussen op de problemen die de overspanning 
veroorzaakt hebben in plaats van enkel op de klachten, en door vervolgens te focussen op 
oplossingen voor deze problemen. Doen patiënten dit niet, dan lopen ze het risico om 
langdurig arbeidsongeschikt te raken. Door middel van een activerende interventie, met 
daarin voorlichting, ondersteuning, advies en huiswerkopdrachten wordt vermijding 
tegengegaan en een actieve aanpak van problemen aangespoord.  
 
Onderzoeksopzet 
In hoofdstuk 3 wordt de onderzoeksopzet beschreven. We wilden nagaan of onze MISS 
(kosten) effectiever is dan de gebruikelijke zorg door de huisarts in het reduceren van het 
aantal dagen ziekteverzuim en in het verminderen van de klachten. We hebben 46 
huisartsen voor het onderzoek geworven en willekeurig verdeeld in een groep die een 
training in de MISS ( n=24) gekregen heeft en een controlegroep die gebruikelijke zorg 
leverde (n=22). Volwassen patiënten (20-60 jaar) die bij de deelnemende huisartsen op het 
spreekuur waren geweest, kregen een screeningslijst toegestuurd met vragen over 
spanningsklachten (piekeren, lusteloosheid en gespannenheid), betaald werk en 
ziekteverzuim. Wanneer patiënten een vastgesteld niveau van spanningsklachten hadden, 
                                           
I De diagnose ‘surmenage’ of ‘overspanning’ kent geen internationale equivalent, om de lading in de Engelse taal zo goed 
mogelijk te dekken is voor de term ‘stress- related mental disorder’ gekozen.  
 
II NVAB (Nederlandse Vereniging voor Arbeids- en Bedrijfsgeneeskunde) / J.J.L. van der Klink(red.) (2000). Handelen van de 
bedrijfsarts bij werknemers met psychische klachten. Richtlijnen voor bedrijfsartsen. Eindhoven: NVAB.  
 
III Auteur B. Terluin. www.emgo.nl/researchtools/4dsq.asp 
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en daarbij hun werk verzuimden, werd hen gevraagd om mee te doen met een onderzoek 
naar spanningsklachten en ziekteverzuim. Dit betekent dat we niet alleen patiënten hebben 
geïncludeerd die de diagnose surmenage van hun huisarts hadden gekregen, maar een 
groep patiënten met spanningsklachten. De reden hiervoor is dat we nu konden meten of 
huisartsen die de training gevolgd hebben, psychische klachten ook beter gaan herkennen 
bij hun patiënten. De deelnemende patiënten werden telefonisch geïnterviewd en kregen 
vragenlijsten per post toegestuurd. De patiënten werden vervolgens na 2, 6 en 12 maanden 
opnieuw telefonisch geïnterviewd en kregen opnieuw vragenlijsten. De huisartsen kregen na 
2 maanden een enquête over de diagnostiek en behandeling van elke patiënt. Er werden in 
totaal 433 patiënten geïncludeerd (227 in de MISS-groep en 206 in de controlegroep). 
 
Effectiviteit van de MISS 
Door de groep patiënten van wie de huisarts een training in de MISS heeft gehad te 
vergelijken met de groep patiënten van wie de huisarts de gebruikelijke zorg leverde, kan 
worden nagegaan hoe effectief de MISS is. Zoals in hoofdstuk 4 beschreven staat, hebben 
we geen bewijs gevonden dat de MISS superieur was ten opzichte van de gebruikelijke zorg 
in het verminderen van het aantal dagen ziekteverzuim (Hazard Ratio 1.06, 95% BI 0.87-
1.29). De mediane duur van het ziekteverzuim was hoog: het middenpunt in de verdeling van 
het aantal dagen ziekteverzuim onder de deelnemers lag in de MISS groep op 96 dagen en 
voor de gebruikelijke zorg op 102 dagen. In de subgroep van patiënten met de diagnose 
‘surmenage’ vonden we een statistisch significant verschil in verzuimduur tussen de MISS en 
gebruikelijke zorg (mediaan 97 dagen versus 170 dagen, Hazard Ratio 1.72, 95% BI 1.18-
2.51), dat niet verklaard kon worden uit verschillen in leeftijd, geslacht of ernst van de 
klachten. De klachten verbeterden in beide groepen even sterk, maar aan het eind van het 
jaar had een substantiële groep patiënten nog steeds verhoogde symptomen van distress. 
De diagnostiek van surmenage bleek gecompliceerder dan op voorhand gedacht en 
definitieve conclusies over de bruikbaarheid van de MISS kunnen dan ook niet getrokken 
worden op basis van dit onderzoek.   
 
Kosten effectiviteit van de MISS 
Tijdens het MISS project is er eveneens een economische evaluatie uitgevoerd, vanuit zowel 
maatschappelijk- als bedrijfsperspectief. Dit staat beschreven in hoofdstuk 5. Er is gekeken 
naar het totaal aantal dagen ziekteverzuim gedurende het jaar volgend op de ziekmelding, 
levensjaren in goede gezondheid, het gebruik van middelen en diensten, investeringskosten 
en kosten door productiviteitsverlies. In totaal waren er 192 (44%) complete cases 
beschikbaar, en er zijn geen significante verschillen gevonden in uitkomsten en kosten 
tussen de MISS en de gebruikelijke zorg. De potentiële kosten en baten van de MISS reikten 
van een verlies van  €135,- tot een besparing van €1369,-. Voor de subgroep van patiënten 
met de diagnose ‘surmenage’ leek de MISS kosteneffectief: patiënten in de MISS groep 
hadden een significant lager aantal dagen verzuim in het jaar waarin ze gevolgd werden 
(gemiddeld verschil 74 dagen, 95% BI 14.7-132.9 dagen). Voor deze subgroep lijkt de MISS 
een veelbelovende interventie te zijn, terwijl er geen verschillen in uitkomsten gevonden 
werden voor de gehele groep van patiënten met stressgerelateerde psychische klachten.  
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De MISS-behandeling in de praktijk  
De MISS-huisartsen (n=24) kregen een cursus van in totaal 11 uur, de controle huisartsen 
(n=22) gaven hun patiënten de gebruikelijke zorg. Informatie over diagnostiek en 
daadwerkelijke uitvoer van verschillende behandelstappen (het geven van informatie en 
advies, monitoren en eventueel verwijzing) door de huisartsen is geëvalueerd met behulp 
van gegevens gekregen van zowel de huisartsen als de patiënten, en met behulp van 
gegevens uit het elektronisch medisch dossier. Verschillen ten gunste van de MISS- 
huisartsen werden gevonden voor meerdere behandelstappen. Zij diagnosticeerden vaker 
een psychische klacht (MISS 78.1% versus UC 67.4%, p=0.020) en gebruikten vaker de 
Vierdimensionale Klachtenlijst (4DKL) (16.1% versus 1.3%, p=0.00). Bovendien gaven de 
MISS huisartsen vaker voorlichtingsmateriaal mee (28.3% vs. 10.8%, p=0.001) en waren ze 
beter op de hoogte van de gesteldheid van een patiënt na 2 maanden (76.4% vs. 65.7%, 
p=0.041). Wat betreft het geven van adviezen en verwijzingen naar meer gespecialiseerde 
zorg zijn er geen verschillen gevonden tussen huisartsen die de MISS gevolgd hebben en 
huisartsen die gebruikelijke zorg leverden. Wij concluderen aan de hand van deze gegevens 
dat huisartsen met succes getraind kunnen worden om (in ieder geval een aantal) 
behandelstappen van de MISS toe te passen.  
 
Test- hertest betrouwbaarheid van de PRIME-MD 
In hoofdstuk 7 wordt de betrouwbaarheid van de diagnostiek met behulp van de ‘Primary 
Care Evaluation of Mental Disorders’ (PRIME MD)IVV op basis van een test-hertest 
onderzoek beschreven. The PRIME-MD is een van de weinige vragenlijsten voor de 
huisartspraktijk, die specifieke diagnosesVI stelt op basis van de internationaal geldende 
criteria voor psychische stoornissen. Honderd patiënten met spanningsklachten en 
ziekteverzuim werden, met één week tussentijd, tweemaal geïnterviewd om te kijken hoe 
betrouwbaar de diagnostiek met behulp van de PRIME MD is. Bijna iedereen (89%) kreeg 
één of meerdere diagnoses volgens de PRIME-MD, de overeenstemming tussen beide 
meetmomenten werd als laag beoordeeld (ĸ .27)VII. De beste overeenkomst tussen beide 
meetmomenten werd gevonden bij de zwaardere stoornissen (ernstige depressieve stoornis 
[ĸ .58], dysthymie [ĸ .57], en gegeneraliseerde angststoornis [ĸ .59]). De overeenstemming 
tussen beide meetmomenten was niet zo goed bij de mildere stoornissen (angststoornis niet 
anders omschreven [ĸ .30], milde depressieve stoornis [ĸ -.03], en somatoforme stoornis niet 
anders omschreven [ĸ .11]).  
Het type psychische klachten dat de huisarts tegenkomt op zijn spreekuur is zeer divers, en 
onze voorselectie op spanningsklachten en ziekteverzuim heeft wellicht zijn weerslag gehad 
op de resultaten van onze test-hertest. Er zijn aanwijzingen dat de PRIME-MD onvoldoende 
in staat is om onderscheid te maken tussen ‘geen diagnose’, een ‘lichte stoornis’ of een 
‘zwaardere stoornis’, terwijl dit voor een eventuele behandeling wel een belangrijk 
onderscheid is. Een huisarts heeft te maken met zowel specifieke symptomen en klinische 
                                           
IV
 Spitzer RL et all. Utility of New Procedure for Diagnosing Mental Disorders in Primary-Care - the Prime-Md-1000 Study.    
Journal of the American Medical Association 1994;272:1749-56. 
 
V
 Zitman, F. G. & Van Wetten, M. L. (1995). PRIME MD. Werkboek voor de arts, DSM-IV versie. 
 
VI
 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM). Washington: 1952. 
 
VII
 
4Kappa (ĸ) scores van .80 en hoger worden als ‘zeer goed’ beoordeeld, hoger dan .60 als ‘goed’, kappa’s tussen .41 and .60 
als ‘voldoende’. Een kappa tussen .21 and .40 wordt als ‘matig’ en scores daaronder als ‘slecht’. 
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stoornissen, passend in de internationaal geldende criteria voor psychische stoornissen, als 
meer ‘alledaagse psychische klachten’, waarbij een mix van a-specifieke symptomen 
zichtbaar is. Onze conclusie is dat de diagnostische criteria, zoals gebruikt in de PRIME-MD, 
nog meer aangepast moeten worden voor een betrouwbaar gebruik in de huisartspraktijk.  
 
Discussie 
In hoofdstuk 8 worden ten slotte een aantal belangrijke punten besproken, aansluitend op de 
totale onderzoeksopzet en -uitvoer. Voor zover bekend, is dit de eerste studie naar de 
effectiviteit van een strategie voor huisartsen om patiënten met spanningsklachten en 
ziekteverzuim te helpen omgaan met hun problemen en om het ziekteverzuim te reduceren. 
Er is geen effect gevonden voor de totale groep van patiënten, niet op het ziekteverzuim of 
klachten en niet op de kosten. Subgroep analyses lieten een effect zien op ziekteverzuim en 
kosten voor de groep patiënten die de diagnose ‘surmenage’ hadden gekregen van hun 
huisarts. Dit suggereert dat de MISS, als activerende interventie strategie, een 
veelbelovende behandeling is voor deze patiënten, maar niet voor de gehele groep patiënten 
die spanningsklachten heeft, ongeacht de diagnose. Verdere evaluatie van methoden om 
spanningsklachten beter te definiëren is nodig om meer definitieve uitspraken te kunnen 
doen over de werkzaamheid van de MISS. De verschillen en overeenkomsten in de 
heterogene groep van patiënten met spanningsklachten zullen nader bestudeerd moeten 
worden om de elementen van de MISS verder te ontwikkelen en mogelijk effectiever te 
maken. Hiervoor is meer en eveneens kwalitatief onderzoek wenselijk, om het theoretisch 
concept, onder andere rondom de diagnostiek van spanningsklachten binnen de  
huisartspraktijk, te verstevigen. Uit al het bovenstaande komt naar voren dat er geen 
ondubbelzinning en duidelijk advies voor de praktijk van het gebruik van de MISS mogelijk is. 
Echter, in de praktijk worden al enkele elementen uit de MISS toegepast. Vanuit een 
samenwerking tussen het Nederlands Huisarts Genootschap (NHG) en de Nederlandse 
Vereniging voor Arbeids- en Bedrijfsgeneeskunde (NVAB) is in 2005 de Landelijke 
Eerstelijns Samenwerkings Afspraak (LESA) “Overspanning”VIII gepubliceerd. Deze LESA 
bevat adviezen die we in het MISS-project hebben onderzocht. Bovendien is de 
informatiefolder voor overspannen patiënten, die de huisartsen in de het kader van het 
MISS-project gebruikten, bewerkt tot een tweetal NHG patiëntenbrieven, die geïntegreerd 
IXzijn in het Huisarts Informatie Systeem (elektronisch dossier). Deze initiatieven en 
ontwikkelingen in de praktijk zijn zeer zeker positief, en de moeite waard om verder uit te 
werken. Training en onderwijs in een activerende benadering van spanningsklachten 
markeren een stap verder op een voor de huisartspraktijk deels nog onbekend terrein.   
                                           
VIII
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